TradingFloor Mobile
2025-11-06 / ALL-MARKETS
Full desktop terminal available Open Full Site ↗
Guest Preview Active
Create an account after 20s to keep the mobile market desk live.
Create Account Login
TFAI Command Terminal

Full Market Intelligence

AI-powered RNS digestion, live interactive charts, insider flow and broker targets — all in your pocket.

Create Free Account
Market AI 592 headlines · 32 AI picks today Tap a ticker to open AI chart · Ask AI above -- AI
Find by ticker, company name or close match. Tap + to add alerts.
Loading market intelligence…
Quant BTC Blending

Crypto Dream Desk

BTC structure, AI forecast, macro event odds and listed crypto-beta names blended into one mobile cockpit.

BTC logo
Loading BTC quant blending from the main site engine...
Open full quant desk

Live RNS Feed

49 types
All Market News Today All digested RNS titles 592
EOT logo
All News 15:38
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.104435', '9.413053']
WIZZ logo
All News 15:34
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold ', '0.040000']
MTU logo
All News 15:04
MTU

Holding(s) in Company

Montanaro UK Smaller Companies Investment Trust PLC

TR1 Buy
['IntegraFin Holdings plc', '3.010000', 0]
CPI logo
All News 15:01
CPI

Holding(s) in Company

Capita PLC

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '7.113778', '6.625642']
SDY logo
All News 15:01
SDY

Commercial Agreement & Equity Subscription

Speedy Hire PLC

**Summary**
Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital.
The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
Agreement
BATS logo
All News 14:16
BATS

Director/PDMR Shareholding

British American Tobacco PLC

<mark style="background-coloryellow">Purchase</mark> of ordinary shares under the Partnership Share Scheme - a HMRC approved Share Incentive Plan
CWR logo
All News 14:11
CWR

Holding(s) in Company

Ceres Power Holdings PLC

TR1 Buy
['BNP Paribas Asset Management UK Limited', '2.694800', '3.250800']
IPF logo
All News 14:01
IPF

Form 8.3

International Personal Finance PLC

API logo
All News 10:53
API

Holding(s) in Company

abrdn Property Income Trust Ltd.

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '5.952788']
CLX logo
All News 10:31
CLX

Calnex and Viavi Partnership

Calnex Solutions Plc

**Summary**
Calnex Solutions plc (AIMCLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards.
The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions.
Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
Partner
CPI logo
All News 10:16
CPI

Director/PDMR Shareholding

Capita PLC

b) Nature of the transaction Monthly share <mark style="background-color:yellow">purchase</mark> under the Capita Share Ownership Plan
LSEG logo
All News 10:01
LSEG

LSEG Announces Strategic Partnership with Nasdaq®

London Stock Exchange Group PLC

**Summary**
On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape.
The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization.
LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
Partner
QLT logo
All News 09:01
QLT

Holding(s) in Company

Quilter PLC

TR1 Buy
['Public Investment Corporation SOC Limited', '10.328000', '9.811000']
0R3T logo
All News 08:31
0R3T

UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities

UBS Group AG

**Summary**
UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
Offers
0A3D logo
All News 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

HTWS logo
All News 06:02
HTWS

Helios Towers Share Buyback Programme

Helios Towers Plc

**Summary**
Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
BuyBack
ABDX logo
All News 06:01
ABDX

Launch of seaweed-based lateral flow housings

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
Launch
BUR logo
All News 06:01
BUR

Holding(s) in Company

Burford Capital Limited

<mark style="background-coloryellow">TR1</mark> Buy
['BlackRock, Inc.', '4.68', 'Below 5']
RS1 logo
All News 06:01
RS1

Half-year Financial Report

RS GROUP PLC

**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)**
**Financial Performance Highlights**
**Revenue:** £1403 milliondown 3% year-on-year
like-for-like down 1%with growth in Q2.
**Adjusted Operating Profit** £122 million, down 8% year-on-year
like-for-like down 7%.
**Operating Profit Margin:** 8.7%down 0.5 percentage points.
**Profit Before Tax:** £112 millionup 7% year-on-year.
**Basic Earnings Per Share:** 17.7pup 8% year-on-year.
**Interim Dividend:** 8.7pup 2%.
**Key Performance Indicators**
**Gross Margin** Improved by 0.4 percentage points to 43.1%.
**Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target.
**Net Debt** Reduced by £31 million to £333 million.
**Net Debt to Adjusted EBITDA** Improved to 1.0x from 1.3x.
**Strategic and Operational Progress**
**Restructuring Benefits** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023.
**Growth Accelerators** RS PRO like-for-like revenue up 4%
Service solutions up 7%.
**Organic Investment** £19 million in H1 2025/26, part of planned £35-£40 million for the full year.
**Regional Performance**
**EMEA** Revenue down 2% like-for-like
operating profit down 9%.
**Americas** Revenue up 1% like-for-like
operating profit down 9%.
**Asia Pacific** Revenue up 4% like-for-like
operating profit up 42%.
**Full Year Outlook**
Unchanged, with expectations of slight gross margin improvement and continued cost management.
Capital expenditure forecast at around £50 million.
Progressive dividend policy maintained.
**Sustainability and ESG**
**Better World Product Range** Expanded to over 33,000 products.
**Emissions Intensity** Reduced by 35% from the 2019/20 baseline.
**Employee Engagement** Increased to 73%.
**Going Concern and Risks**
The Board has assessed the Groups ability to continue as a going concern for at least 12 months.
Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change.
**Conclusion**
RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
Here is the HTML table code comparing the financials and debt year on year for RS Group PLC:
MetricH1 2025/26H1 2024/25Change
Revenue£1,403m£1,441m(3%)
Adjusted operating profit£122m£133m(8%)
Adjusted operating profit margin8.7%9.2%(0.5) pts
Adjusted profit before tax£112m£118m(6%)
Adjusted basic earnings per share17.6p18.5p(5%)
Net debt£(333)m£(437)m£104m improvement
Net debt to adjusted EBITDA1.0x1.3x0.3x improvement
**Key takeaways:** * **Revenue decline:** Revenue decreased by 3% year-on-year, primarily due to a 1% like-for-like decline and adverse currency movements. * **Profit margin compression:** Adjusted operating profit margin decreased by 0.5 percentage points due to increased investment in strategic initiatives. * **Improved debt position:** Net debt decreased significantly by £104 million, leading to a lower net debt to adjusted EBITDA ratio, indicating improved financial health. This table provides a concise comparison of key financial metrics and debt levels for RS Group PLC between H1 2025/26 and H1 2024/25.
WISE logo
All News 06:01
WISE

FY26 Half Year Results

Wise plc

**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)**
Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include
### **Financial Performance**
**Revenue Growth**Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million).
**Active Customers**Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion.
**Customer Holdings**Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature.
**Underlying Profit Before Tax (PBT)**Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth.
**Reported Profit Before Tax**Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields.
### **Operational Highlights**
**Infrastructure Expansion**Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly.
**Regulatory Approvals**Secured approvals in the UAE to expand product offerings in the region.
**Product Enhancements**Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil.
**Partnerships**Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume.
### **Strategic Investments**
**Team Growth**: Added over 1000 employeesfocusing on servicingcomplianceand AI-driven efficiencies.
**Marketing**Increased brand marketing spend across key markets to drive awareness and organic growth.
**Technology**Invested £144 million in product development, enhancing core products and launching new features.
### **Future Outlook**
**Dual Listing**On track for a US listing in Q2 2026 to increase visibility and access to capital.
**Growth Targets**Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs.
**Innovation**Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention.
### **Management Commentary**
CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability.
### **Conclusion**
Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
Here’s an HTML table comparing the financials and debt year on year for Wise PLC based on the provided text:
MetricH1 FY2025 (£m)H1 FY2026 (£m)YoY Change (£m)YoY Change (%)
Revenue591.9658.066.111%
Underlying Interest Income (first 1% yield)70.591.521.030%
Underlying Income662.4749.587.113%
Cost of Sales(152.9)(173.7)(20.8)14%
Net Credit Losses on Financial Assets(4.5)(4.6)(0.1)2%
Underlying Gross Profit505.0571.266.213%
Administrative Expenses(366.7)(465.9)(99.2)27%
Net Interest Income from Corporate Investments15.923.77.849%
Other Operating Income, Net2.33.81.565%
Underlying Operating Profit156.5132.8(23.7)(15%)
Finance Expense(9.4)(10.8)(1.4)15%
Underlying Profit Before Tax147.1122.0(25.1)(17%)
Reported Profit Before Tax292.5254.6(37.9)(13%)
Profit for the Period217.3187.2(30.1)(14%)
Borrowings (Revolving Credit Facility)98.1198.5100.4102%
### Key Highlights: 1. **Revenue Growth**: Revenue increased by 11% YoY from £591.9m to £658.0m. 2. **Underlying Income Growth**: Underlying income grew by 13% YoY from £662.4m to £749.5m. 3. **Administrative Expenses Increase**: Administrative expenses rose by 27% YoY from £366.7m to £465.9m. 4. **Underlying Profit Before Tax Decline**: Underlying profit before tax decreased by 17% YoY from £147.1m to £122.0m. 5. **Borrowings Increase**: Borrowings under the Revolving Credit Facility increased by 102% YoY from £98.1m to £198.5m. This table provides a clear comparison of key financial metrics and debt levels between H1 FY2025 and H1 FY2026 for Wise PLC.
VRCI logo
All News 06:01
VRCI

Provider Participation Agreement with Prime Health

Verici Dx Plc

**Summary**
Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future.
**Key Points**
Verici Dx signs Provider Participation Agreement with Prime Health Services.
Agreement leverages Prime Health’s PPO network for predictable healthcare pricing.
Expands Verici Dx’s patient scope and enhances private payor coverage.
Prime Health’s network includes 850,000+ providers and 35 million annual claims.
Partnership seen as a strategic step for Verici Dx’s commercial growth.
Agreement
SFOR logo
All News 06:01
SFOR

Third Quarter Trading Update

S4 Capital PLC

**S4Capital plc Third Quarter Trading Update Summary (November 6, 2025)**
**Key Highlights**
1. **Financial Performance**
**Q3 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 3.4% reported1.0% like-for-like.
Net revenue down 6.9% reported4.4% like-for-likewith sequential improvement from Q2.
Marketing Services net revenue down 2.8% like-for-like
Technology Services down 16.5% like-for-like.
**Nine Months 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 11.1% reported8.4% like-for-like.
Net revenue down 10.8% reported8.2% like-for-like.
Marketing Services net revenue down 5.2% like-for-like
Technology Services down 29.6% like-for-like.
2. **Regional Performance**
**Americas** (80% of net revenue)Q3 net revenue up 1.6% like-for-like
nine months down 5.6%.
**EMEA**Q3 net revenue down 26.2%
nine months down 17.3%.
**Asia-Pacific**Q3 net revenue down 16.2%
nine months down 15.3%.
3. **Outlook**
Full-year 2025 like-for-like net revenue expected to decline by upper single digits.
Operational EBITDA target remains unchanged, broadly similar to 2024.
Net debt target for year-end£100–£140 million.
Potential for enhanced final dividend if second-half performance and liquidity targets are met.
4. **New Business and AI Focus**
Significant new business wins, including General Motors, Amazon, T-Mobile, and two unannounced US-based Global FMCG companies.
AI-driven initiatives improving visualisation, copywriting, and hyper-personalisation, with clients excited about cost savings and ROI.
Revenue model shifting from time-based to output-based, leveraging AI tools like Runway, Luma, and Unreal.
5. **Balance Sheet and Liquidity**
Q3 net debt at £151 million (1.8x EBITDA), up slightly due to dividend payments, restructuring costs, and FX headwinds.
Sufficient liquidity with long-dated debt maturities and covenant compliance.
6. **ESG Commitment**
Continued focus on people fulfilmentenvironmental responsibilityand transparency.
Maintained B Corp status and improved Ecovadis score.
7. **Strategic Focus**
Unitary digital transformation model resonating with clients, emphasizing "faster, better, cheaper, more."
Rebranded as Monks, with streamlined Marketing and Technology Services practices.
**Executive Commentary (Sir Martin Sorrell):**
Clients remain cautious due to global macroeconomic volatility, particularly in technology sectors.
AI adoption is accelerating, with significant opportunities for efficiency and growth.
Cost control and cash management remain priorities, with a focus on profitability and debt reduction.
**Conclusion**
Despite challenging market conditions, S4Capital is leveraging AI-driven innovation and cost restructuring to improve performance, with a focus on new business wins and operational efficiency. The company remains committed to its digital transformation strategy and long-term growth objectives.
Here’s an HTML table comparing the financials and debt year-on-year based on the provided text:
MetricThree Months Ended 30 Sep 2025Nine Months Ended 30 Sep 2025Three Months Ended 30 Sep 2024Nine Months Ended 30 Sep 2024
Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (£m)Reported (£m)Like-for-like (£m)
Billings490.95.1%1,416.85.1%481.65.1%1,390.55.1%
Revenue191.7-1.0%552.1-8.4%198.4-1.0%620.9-8.4%
Net Revenue167.0-4.4%495.2-8.2%179.3-4.4%555.4-8.2%
Net Debt (£m)151-151-180194180194
Leverage (x EBITDA)1.8-1.8-----
### Key Notes: 1. **Billings**: Both reported and like-for-like figures show a 1.9% increase for the nine months ended 30 Sep 2025 compared to 2024. 2. **Revenue**: Reported revenue decreased by 3.4% for Q3 2025 and 11.1% for the nine months, while like-for-like figures show a smaller decline of 1.0% and 8.4%, respectively. 3. **Net Revenue**: Reported net revenue decreased by 6.9% for Q3 2025 and 10.8% for the nine months, with like-for-like figures showing a 4.4% and 8.2% decline, respectively. 4. **Net Debt**: Net debt decreased to £151 million in 2025 from £180 million in 2024 (or £194 million on a like-for-like basis). 5. **Leverage**: Leverage ratio improved to 1.8x EBITDA in 2025 from a covenant limit of 4.5x EBITDA. This table provides a clear comparison of key financial metrics and debt levels between 2024 and 2025.
AZN logo
All News 06:01
AZN

9M and Q3 2025 results

AstraZeneca PLC

## AstraZeneca 9M and Q3 2025 Results Summary
**Strong Performance and Pipeline Progress:**
AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements.
**Financial Highlights (9M 2025)**
* **Revenue Growth** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%).
* **Core EPS Growth** Core EPS rose by 15% to $7.04, reflecting improved profitability.
* **Operating Profit Increase** Core operating profit grew by 13%, demonstrating operational efficiency.
**Pipeline Achievements**
* **16 Positive Phase III Readouts** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas.
* **31 Regulatory Approvals** The company secured 31 approvals in major regions for various medicines, expanding patient access.
* **Strong Oncology Pipeline** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi.
**Strategic Initiatives**
* **US Expansion** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs.
* **Acquisition of SixPeaks Bio AG** This acquisition strengthens AstraZenecas position in weight management therapies.
* **Koselugo Agreement with Merck** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency.
**Future Outlook**
* **Reiterated Guidance** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth.
* **Sustainability Leadership** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings.
**Key Takeaways**
AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
Here is a comparison of AstraZeneca's financials and debt year on year, presented as an HTML table:
Metric9M 20259M 2024% ChangeQ3 2025Q3 2024% Change
Total Revenue$43,236m$39,182m10%$15,191m$13,565m12%
Reported EPS ($)$5.10$3.5743%$1.64$0.9277%
Core EPS ($)$7.04N/A15%$2.38N/A14%
Net Debt$23,965m$26,348m-9%N/AN/AN/A
Capital Expenditure$2,091m$1,415m48%N/AN/AN/A

Note: The above table provides a high-level comparison of key financials and debt metrics. For a detailed analysis, please refer to the original text.

Key Observations:

  • Total Revenue increased by 10% year-on-year in 9M 2025, driven by growth in all Therapy Areas.
  • Reported EPS increased significantly by 43% in 9M 2025, while Core EPS increased by 15%.
  • Net Debt decreased by 9% in the nine months to 30 September 2025, reflecting improved financial position.
  • Capital Expenditure increased by 48% in 9M 2025, primarily due to investment in manufacturing projects and technology upgrades.
This table provides a concise comparison of AstraZeneca's financials and debt year on year, highlighting key metrics such as Total Revenue, Reported EPS, Core EPS, Net Debt, and Capital Expenditure. The observations section summarizes the main trends and changes in these metrics.
SBRY logo
All News 06:01
SBRY

Half-Year Report

J Sainsbury PLC

**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)**
**Financial Performance Highlights**
**Sales Growth** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%.
**Profitability** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year.
**Cash Flow** Retail free cash flow was £310 million, on track to exceed £500 million for the full year.
**Bank Disposal** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks.
**Dividends** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million.
**Strategic Initiatives and Market Position:**
**Value and Quality Focus** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items.
**Innovation and Range Expansion** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains.
**Operational Efficiency** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases.
**Sustainability** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts.
**Outlook and Guidance**
**Profit Guidance** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million.
**Strategic Commitments** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction.
**Nectar Loyalty Program** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth.
**Argos Transformation** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency.
**Conclusion**
Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
Here is the comparison of financials and debt year on year in an HTML table format:
Metric2024/25 (28 weeks)2025/26 (28 weeks)YoY Change
Retail sales (excl. VAT, excl. fuel)£14,865m£15,577m4.8%
Retail underlying operating profit£503m£504m0.2%
Underlying profit before tax£309m£340m10%
Retail free cash flow£425m£310m(£115)m
Net debt (inc. lease liabilities)£(5,584)m£(5,527)m£57m
Non-lease net debt£(152)m£(81)m£71m
**Key Observations:** * **Sales Growth:** Retail sales (excluding VAT and fuel) increased by 4.8% year-on-year, driven by grocery and general merchandise sales growth. * **Profitability:** Underlying profit before tax increased by 10%, while retail underlying operating profit remained relatively stable with a slight increase of 0.2%. * **Cash Flow:** Retail free cash flow decreased by £115 million, primarily due to reduced working capital inflow and higher capital expenditure. * **Debt:** Net debt (including lease liabilities) decreased by £57 million, and non-lease net debt decreased by £71 million, indicating improved liquidity. This table provides a concise overview of the key financial metrics and debt position, highlighting areas of growth, stability, and changes in liquidity.
AFC logo
All News 06:01
AFC

Trading Update for Year Ended 31 October 2025

AFC Energy plc

**Summary**
AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including
1. **Partnerships and Deployments**Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner.
2. **Product Development**The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026.
3. **Joint Ventures**A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting.
4. **Strategic Restructuring**A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments.
5. **Financials**Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability.
6. **Market Opportunities**AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition.
CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
MetricFY24FY25Change
Cash, Cash Equivalents, and Short-Term Deposits (£m)15.425.3+9.9 (+64.3%)
Revenue (£k)4,000107-3,893 (-97.3%)
Headcount ReductionN/A-17N/A
Annualised Cost Savings in FY26 (£m)N/A1.5N/A
### Explanation: 1. **Cash, Cash Equivalents, and Short-Term Deposits**: Increased from £15.4m in FY24 to £25.3m in FY25, a rise of £9.9m (+64.3%). 2. **Revenue**: Decreased significantly from £4m in FY24 to £107k in FY25, a drop of £3.893m (-97.3%), attributed to the strategic reset announced in March 2025. 3. **Headcount Reduction**: FY25 saw a net reduction of 17 employees as part of the business reorganisation. 4. **Annualised Cost Savings**: Expected savings of £1.5m in FY26 due to restructuring efforts. This table provides a clear year-on-year comparison of key financial metrics and debt-related changes.
DGE logo
All News 06:01
DGE

Diageo issues fiscal 26 Q1 trading statement

Diageo PLC

**Diageo Fiscal 26 Q1 Trading Statement Summary**
**Key Highlights**
**Flat Organic Net Sales Growth** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact.
**Regional Performance**
**Strengths** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM).
**Weaknesses** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%.
**Strategic Focus** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics.
**Fiscal 26 Outlook**
Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness.
Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings.
Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years.
**Management Commentary** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture.
**Regional Breakdown**
1. **North America (38% of net sales)** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence.
2. **Europe (25% of net sales)** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye.
3. **Asia Pacific (18% of net sales)** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India.
4. **LAC (11% of net sales)** Organic net sales grew 10.9%, led by Brazil’s double-digit growth.
5. **Africa (8% of net sales)** Organic net sales grew 8.9%, with strong performance in East and South Africa.
**Key Initiatives**
**Accelerate Programme** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications.
**Disposals** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations.
**Financial Guidance**
Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion.
Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28.
**Conclusion**
Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
Below is the HTML table code comparing the financials and debt year on year based on the provided text:
MetricF26 (2025)F25 (2024)Reported Growth YoY %Organic Growth YoY %
Net Sales$4,875$4,986(2.2)0.0
Volume++-2.9
Price/Mix--(2.8)(2.8)
Free Cash Flow$3,000$2,70011.1-
Capital Expenditure$1.2-1.3bn$1.5bn(13.3)-(20.0)-
Effective Interest Rate4.0%4.1%(2.4)-
Tax Rate25.0%24.9%0.4-
Net Debt to Adjusted EBITDATarget: 2.5-3.0x by F28---
### Notes: 1. **Net Sales**: Reported net sales declined by 2.2% YoY, while organic net sales growth was flat. 2. **Volume**: Organic volume growth was 2.9%. 3. **Price/Mix**: Organic price/mix declined by 2.8%. 4. **Free Cash Flow**: Expected to increase to $3 billion in F26 from $2.7 billion in F25. 5. **Capital Expenditure**: Expected to be at the lower end of $1.2-1.3 billion in F26 compared to $1.5 billion in F25. 6. **Effective Interest Rate**: Slightly decreased to 4.0% in F26 from 4.1% in F25. 7. **Tax Rate**: Expected to be around 25.0% in F26 compared to 24.9% in F25. 8. **Net Debt to Adjusted EBITDA**: Target is to be within 2.5-3.0x by F28. This table provides a clear comparison of key financial metrics and debt-related figures between F26 (2025) and F25 (2024).
HIK logo
All News 06:01
HIK

November Trading Statement

Hikma Pharmaceuticals PLC

**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:**
Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include
1. **Performance Across Segments**
**Injectables** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%.
**Branded** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%.
**Hikma Rx** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%.
2. **Organisational Changes**
Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies.
Dr Bill Larkins stepped down as head of Injectables
CEO Riad Mishlawi will serve as interim head until a replacement is found.
3. **Full Year 2025 Outlook**
Group revenue growth maintained at 4-6%.
Core operating profit range tightened to $730-$750 million, in line with market expectations.
4. **Medium-Term Outlook (2024-2027)**
Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges.
Group revenue CAGR revised to the lower end of 6-8%.
Core operating profit growth adjusted to 5-7%, down from 7-9%.
Long-term target of $5 billion revenue by 2030 remains unchanged.
5. **Strategic Focus**
Continued investment in R&D and manufacturing capacity expansion to support growth.
Confidence in revised targets despite medium-term adjustments.
Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
The provided text does not contain specific financial or debt figures for a year-on-year comparison. However, I can create a general HTML table structure based on the guidance and outlook provided in the text. If you have specific financial data, please provide it, and I can tailor the table accordingly. Here’s a basic HTML table structure based on the available information: < lang="en">Hikma Pharmaceuticals Financials and Debt Comparison

Hikma Pharmaceuticals Financials and Debt Comparison (2024 vs 2025 Guidance)

Metric2024 (Actual)2025 (Guidance)Change
Group Revenue GrowthN/A4% to 6%N/A
Injectables Revenue GrowthN/A7% to 9%N/A
Injectables Core Operating MarginN/A32% to 33%N/A
Branded Revenue GrowthN/A6% to 7%N/A
Branded Core EBIT MarginN/A~25%N/A
Hikma Rx Revenue GrowthN/ABroadly flatN/A
Hikma Rx Core Operating MarginN/A~16%N/A
Group Core Operating ProfitN/A$730M to $750MN/A
Medium-Term Group Revenue CAGR (2024-2027)N/A6% to 8% (lower end)N/A
Medium-Term Group Core Operating Profit GrowthN/A5% to 7%N/A

Note: Actual 2024 figures are not provided in the text. The table reflects 2025 guidance and medium-term outlook.

If you have specific financial or debt figures for 2024 or any other year, please provide them, and I can update the table accordingly.
AUTO logo
All News 06:01
AUTO

Half Year Results

Auto Trader Group plc

**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)**
**Financial Performance Highlights**
**Revenue Growth** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million).
**Profitability** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million.
**EPS Growth** Basic earnings per share (EPS) increased by 11% to 17.26 pence.
**Cash Flow** Cash generated from operations rose by 7% to £215.4 million.
**Shareholder Returns** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence).
**Strategic and Operational Updates**
**AI Innovation** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts.
**Deal Builder Growth** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025).
**Market Position** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly.
**New Car Market** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined.
**Used Car Market** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed.
**Future Outlook**
Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities.
Continued focus on AI opportunities to enhance performance, efficiency, and customer experience.
Scaling Deal Builder as the core consumer proposition, deepening competitive advantage.
**Sustainability and Governance**
Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi).
Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC.
**Conclusion**
Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
Here is the HTML table code comparing the financials and debt year on year for Auto Trader Group PLC:
MetricH1 2026H1 2025Change
Revenue£317.7m£302.5m5%
Operating Profit£200.1m£188.4m6%
Operating Profit Margin63%62%1% pts
Profit Before Tax£199.3m£187.5m6%
Basic Earnings Per Share17.26p15.56p11%
Cash Generated from Operations£215.4m£201.6m7%
Net Cash£5.2m£15.1m(£9.9m)
Debt (Syndicated RCF)£15.0m£0m£15.0m
**Key Observations:** * **Revenue and Profit Growth:** Auto Trader Group PLC experienced a 5% increase in revenue and a 6% increase in operating profit year on year. * **Margin Improvement:** Operating profit margin improved by 1 percentage point to 63%. * **Earnings Per Share Growth:** Basic earnings per share increased by 11% to 17.26p. * **Cash Flow Improvement:** Cash generated from operations increased by 7% to £215.4m. * **Debt Increase:** The company drew £15.0m from its Syndicated RCF, resulting in a decrease in net cash from £15.1m to £5.2m. This table provides a concise overview of the key financial metrics and debt position of Auto Trader Group PLC, highlighting the year-on-year changes.
HGT logo
All News 06:01
HGT

3rd Quarter Results

HG Capital Trust PLC

**Summary**
HgCapital Trust PLC (HgT) announced its third-quarter results for the period ending September 30, 2025, highlighting a resilient performance driven by its portfolio of software and services businesses. Key highlights include
1. **NAV Performance**Net Asset Value (NAV) per share increased by 2.4%, reaching £5.50, with total net assets at £2.5 billion.
2. **Share Price**The share price decreased by 2.7% to £4.99, resulting in a market capitalization of £2.3 billion.
3. **Portfolio Growth**Strong trading performance contributed 4% to portfolio growth, partially offset by lower valuation multiples and increased net debt.
4. **Long-Term Performance**The portfolio reported 18% sales growth and 19% EBITDA growth over the last 12 months, with a 33% EBITDA margin.
5. **Liquidity and Investments**Available liquid resources stood at £379 million (15% of NAV), with £49.7 million invested in Q3, primarily in A-LIGN, a cyber compliance services provider.
6. **Realisations**£7 million was realized from the partial sale of Trackunit, with an additional £30 million expected from the post-period exit of GTreasury.
7. **Historical Returns**An investment of £1,000 twenty years ago would now be worth £13,364, outperforming the FTSE All-Share Index, which would be worth £3,762.
HgT remains focused on delivering consistent long-term returns by investing in unquoted companies with potential for strategic and operational value creation. The trust continues to screen an attractive pipeline of opportunities, with further liquidity events expected in the coming months.
Below is the HTML table code comparing the key financials and debt year on year based on the provided text. Since the text only provides data for Q3 2025, I’ve structured the table to compare Q3 2025 with implied or assumed Q3 2024 data (where available). If no direct comparison is possible, the table reflects only the 2025 data.
MetricQ3 2024 (Assumed/Implied)Q3 2025Change
NAV per Share£5.37 (implied from +2.4% growth)£5.50+2.4%
Net Assets£2.44 billion (implied)£2.5 billion+2.5%
Share Price£5.13 (implied from -2.7% decrease)£4.99-2.7%
Market Capitalisation£2.36 billion (implied)£2.3 billion-2.5%
Portfolio Growth (Trading)N/A+4%N/A
Sales Growth (Last 12 Months)N/A+18%N/A
EBITDA Growth (Last 12 Months)N/A+19%N/A
EBITDA MarginN/A33%N/A
Net DebtN/AIncreased (exact figure not provided)N/A
Liquid ResourcesN/A£379 millionN/A
Bank Facility DrawnN/A£46 millionN/A
Co-investments as % of NAV9%10%+1%
### Notes: 1. **Assumed/Implied Values**: For metrics like NAV per share and share price, implied 2024 values are calculated based on the percentage changes provided for 2025. 2. **Missing Data**: Some metrics (e.g., net debt, liquid resources in 2024) are not provided in the text, so they are marked as "N/A". 3. **Percentage Changes**: Changes are calculated where possible, but some metrics lack historical data for comparison. This table provides a structured comparison based on the available information.
FTC logo
All News 06:01
FTC

€7m contract for satellite constellation programme

Filtronic

**Summary**
Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
NewContract
IMI logo
All News 06:01
IMI

Trading Update

IMI PLC

**Summary**
IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**.
Key highlights include
**Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%).
**Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**.
Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers.
The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns.
Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
Below is an HTML table comparing the year-on-year financials and debt based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and organic growth comparisons.
Metric2024 (Previous Year)2025 (Current Year)Year-on-Year Change
Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Automation Sector Organic Revenue Growth (Year-to-Date)N/A+8%+8% (from 2024 baseline)
Process Automation Organic Revenue Growth (Year-to-Date)N/A+14%+14% (from 2024 baseline)
Life Technology Sector Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Climate Control Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Life Science & Fluid Control Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Transport Organic Revenue Growth (Year-to-Date)N/A-9%-9% (from 2024 baseline)
Exchange Rate Impact on Revenue (Full Year)N/A-1%-1% (compared to 2024)
Exchange Rate Impact on Adjusted Operating Profit (Full Year)N/A-1.5%-1.5% (compared to 2024)
Adjusted Basic Earnings per Share (Full Year Guidance)N/A129p - 136pN/A (Guidance for 2025)
Debt (Year-on-Year)Not ProvidedNot ProvidedN/A
### Notes: 1. **Debt Information**: The provided text does not include specific debt figures, so the table reflects this as "Not Provided." 2. **Organic Growth**: All organic growth figures are based on the comparisons provided in the text for 2025 relative to 2024. 3. **Exchange Rate Impact**: The impact of exchange rates on revenue and adjusted operating profit is included as per the text. 4. **Earnings per Share**: The adjusted basic earnings per share guidance for 2025 is included as provided. This table can be embedded in an HTML document for display.
ITV logo
All News 06:01
ITV

ITV plc Q3 Trading Update

ITV PLC

**ITV PLC Q3 Trading Update Summary (November 2025):**
ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include
**Revenue Growth** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX.
**Advertising Performance** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty.
**Cost Management** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand.
**ITV Studios** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms.
**Digital Growth** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026.
**Outlook** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness.
**Liquidity** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025.
CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
Below is an HTML table comparing the financials and debt year-on-year based on the provided text:
Metric2024 (£m)2025 (£m)Change (£m)Change (%)
Total Group Revenue2,7412,795542%
Total Group External Revenue2,3212,404834%
ITV Studios Revenue1,2171,35013311%
Media & Entertainment (M&E) Revenue1,5241,445(79)(5%)
Total Advertising Revenue (TAR)1,3131,247(66)(5%)
Digital Advertising RevenueN/AUp 15%Growth driven by ITVX
Total Digital Revenue3844324813%
Net DebtN/A508(78)Decreased from £586m (June 2025)
### Key Notes: 1. **Revenue Comparisons**: All figures are for the nine months ending 30 September, comparing 2025 to 2024. 2. **Debt**: Net debt is provided for 2025, with a decrease from £586 million in June 2025 to £508 million in September 2025. 3. **Digital Revenue**: 2024 figures were restated to £384 million due to changes in categorization. 4. **TAR**: Expected to decline by 6% for the full year 2025 compared to 2024, with a 9% decline in Q4 2025. This table provides a concise comparison of key financials and debt between 2024 and 2025 based on the provided text.
FDEV logo
All News 06:01
FDEV

A STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO

Frontier Developments Plc

**Summary**
Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*.
**Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum.
**Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion.
Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later.
The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
Launch
HWDN logo
All News 06:01
HWDN

Trading Update

Howden Joinery Group Plc

**Summary**
Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include
1. **Sales Growth**
**Group Sales**+2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis.
**UK Sales**+2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1.
**International Sales**+14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland.
2. **Performance Drivers**
Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens.
High stock availability, market-leading product lineup, and exceptional customer service supported growth.
3. **Outlook**
The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million.
CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives.
4. **Operational Highlights**
£8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%.
Continued expansion of the in-stocktrade model internationally.
Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
Below is the HTML table code comparing the financials and sales growth year-on-year based on the provided text: < lang="en">Howden Joinery Group PLC Financials Comparison

Howden Joinery Group PLC - Sales Growth Comparison (2024 vs 2025)

MetricPeriods 7 to 11Year-to-dateSame Depot Basis (Periods 7 to 11)Same Depot Basis (Year-to-date)
UK Sales Growth (%)+2.4%+2.7%+1.1%+1.4%
International Sales Growth (%)+14.7%+13.4%+9.3%+9.6%
Group Sales Growth (%)+2.8%+3.0%+1.4%+1.7%

Notes:

  • 1. There were two fewer trading days in H1 2025 versus the prior year. Numbers reported are unadjusted.
  • 2. Same depot basis excludes depots opened in the current year and the prior year.
  • 3. International growth is shown in local currency.
  • 4. 2025 Full Year Profit Before Tax consensus is £331m (2024: £328.1m).
### Key Features of the Table: 1. **Metrics Compared**: Sales growth percentages for UK, International, and Group segments. 2. **Periods**: Compares Periods 7 to 11 and Year-to-date for both 2024 and 2025. 3. **Same Depot Basis**: Includes growth excluding newly opened depots for a like-for-like comparison. 4. **Notes**: Additional context for adjustments and definitions. This table provides a clear year-on-year comparison of Howden Joinery Group PLC's financial performance based on the provided text.
PMGR logo
All News 06:01
PMGR

Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company

Portmeirion Group

**Summary**
Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options
1. **Rollover Option**Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance.
2. **Cash Option**Receive a cash exit at net asset value, less associated costs.
The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs.
Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed.
The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter.
The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
Proposals
CRH logo
All News 06:01
CRH

CRH Reports Third Quarter 2025 Results

CRH PLC

**Summary of CRHs Third Quarter 2025 Results:**
CRH PLC, a leading provider of building materials, reported strong third-quarter 2025 results, highlighting continued growth and strategic advancements. Key takeaways include
1. **Financial Performance**
**Revenue Growth** Total revenues increased by 5% year-over-year to $11.1 billion, driven by favorable demand, strong commercial execution, and contributions from acquisitions.
**Net Income and EBITDA** Net income rose by 9% to $1.5 billion, while Adjusted EBITDA grew by 10% to $2.7 billion. Margins expanded, with net income margin up 50 basis points to 13.7% and Adjusted EBITDA margin up 100 basis points to 24.3%.
**Earnings Per Share (EPS)** Diluted EPS increased by 12% to $2.21.
2. **Strategic Initiatives**
**Acquisitions** CRH invested $3.5 billion in 27 value-accretive acquisitions year-to-date, including nine acquisitions totaling $2.5 billion in Q3. The company maintains an active pipeline of opportunities.
**Shareholder Returns** CRH returned $1.1 billion to shareholders year-to-date through share buybacks and declared a quarterly dividend of $0.37 per share, a 6% increase year-over-year.
3. **Segment Performance**
**Americas Materials Solutions** Revenues grew by 6%, with Adjusted EBITDA up 5%, driven by strong demand and pricing momentum.
**Americas Building Solutions** Revenues increased by 2%, with Adjusted EBITDA up 22%, supported by acquisitions and optimization initiatives.
**International Solutions** Revenues rose by 5%, with Adjusted EBITDA up 15%, driven by operational efficiencies and acquisitions.
4. **Outlook**
**2025 Guidance** CRH reaffirmed its net income guidance and raised the midpoint of its Adjusted EBITDA guidance, reflecting continued strategic execution and market strength.
**2026 Expectations** The company anticipates favorable market dynamics, supported by infrastructure investment and reindustrialization activity, despite subdued residential new-build activity.
5. **Balance Sheet and Liquidity**
**Net Debt** Increased to $15.0 billion due to acquisitions, shareholder returns, and capital expenditures, partially offset by operating cash flows. CRH maintains a robust balance sheet with $4.3 billion in cash and equivalents.
**Credit Rating** CRH remains committed to maintaining its investment-grade credit rating.
6. **Leadership Commentary**
CEO Jim Mintern emphasized CRH’s superior strategy, connected portfolio, and leading performance, positioning the company for continued growth and value creation in 2026.
Overall, CRH’s Q3 2025 results underscore its strong operational execution, strategic growth initiatives, and commitment to shareholder value, despite a dynamic market environment.
Here’s an HTML table comparing the financials and debt year-on-year for CRH based on the provided text:
MetricQ3 2025Q3 2024YoY Change
Total Revenues$11.1bn$10.5bn+5%
Net Income$1.5bn$1.4bn+9%
Net Income Margin13.7%13.2%+50bps
Adjusted EBITDA$2.7bn$2.5bn+10%
Adjusted EBITDA Margin24.3%23.3%+100bps
Diluted Earnings Per Share$2.21$1.97+12%
Total Short and Long-Term Debt$18.7bn$14.0bn+33.6%
Net Debt$15.0bn$10.5bn+42.9%
### Explanation: - **Total Revenues, Net Income, Margins, and EPS**: These metrics are directly compared year-on-year, showing growth rates or margin improvements. - **Debt Metrics**: Total short and long-term debt and Net Debt are compared, highlighting the significant increase in debt levels year-on-year. This table provides a clear comparison of key financial and debt metrics between Q3 2025 and Q3 2024.
CRH logo
All News 06:01
CRH

CRH Continues Share Buyback Program

CRH PLC

**Summary**
CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018.
CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States.
Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission.
**Key Points**
CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018.
A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026.
Repurchased shares will be canceled to reduce share capital.
Future buybacks depend on capital needs and market conditions.
Forward-looking statements are subject to risks and uncertainties.
BuyBack
AI 1 news title 1
Acquisitions 5 news titles 5
Agreement 3 news titles 3
SDY logo
Agreement 15:01
SDY

Commercial Agreement & Equity Subscription

Speedy Hire PLC

**Summary**
Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital.
The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
Agreement
VRCI logo
Agreement 06:01
VRCI

Provider Participation Agreement with Prime Health

Verici Dx Plc

**Summary**
Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future.
**Key Points**
Verici Dx signs Provider Participation Agreement with Prime Health Services.
Agreement leverages Prime Health’s PPO network for predictable healthcare pricing.
Expands Verici Dx’s patient scope and enhances private payor coverage.
Prime Health’s network includes 850,000+ providers and 35 million annual claims.
Partnership seen as a strategic step for Verici Dx’s commercial growth.
Agreement
Approvals 0 news titles 0

No news for this category in the selected date range.

Authorisation 0 news titles 0

No news for this category in the selected date range.

Awards 0 news titles 0

No news for this category in the selected date range.

BTC 0 news titles 0

No news for this category in the selected date range.

Blockchain 0 news titles 0

No news for this category in the selected date range.

Breakthrough 0 news titles 0

No news for this category in the selected date range.

BuyBack 2 news titles 2
HTWS logo
BuyBack 06:02
HTWS

Helios Towers Share Buyback Programme

Helios Towers Plc

**Summary**
Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
BuyBack
CRH logo
BuyBack 06:01
CRH

CRH Continues Share Buyback Program

CRH PLC

**Summary**
CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018.
CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States.
Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission.
**Key Points**
CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018.
A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026.
Repurchased shares will be canceled to reduce share capital.
Future buybacks depend on capital needs and market conditions.
Forward-looking statements are subject to risks and uncertainties.
BuyBack
Cancellations 2 news titles 2
CashOffer 0 news titles 0

No news for this category in the selected date range.

Collaborate 0 news titles 0

No news for this category in the selected date range.

ContractWin 0 news titles 0

No news for this category in the selected date range.

Covid-19 0 news titles 0

No news for this category in the selected date range.

Deals 0 news titles 0

No news for this category in the selected date range.

Diamond 0 news titles 0

No news for this category in the selected date range.

DirectorDealing 25 news titles 25
BATS logo
DirectorDealing 14:16
BATS

Director/PDMR Shareholding

British American Tobacco PLC

<mark style="background-coloryellow">Purchase</mark> of ordinary shares under the Partnership Share Scheme - a HMRC approved Share Incentive Plan
MGCI logo
DirectorDealing 11:09
MGCI

Director/PDMR Shareholding

M&G Credit Income Investment Trust PLC

<mark style="background-coloryellow">Purchase</mark> of Shares
CPI logo
DirectorDealing 10:16
CPI

Director/PDMR Shareholding

Capita PLC

b) Nature of the transaction Monthly share <mark style="background-color:yellow">purchase</mark> under the Capita Share Ownership Plan
Discovery 0 news titles 0

No news for this category in the selected date range.

Exceeded 0 news titles 0

No news for this category in the selected date range.

FCA 0 news titles 0

No news for this category in the selected date range.

FDA 0 news titles 0

No news for this category in the selected date range.

Grants 0 news titles 0

No news for this category in the selected date range.

InvestmentPlan 0 news titles 0

No news for this category in the selected date range.

JV 0 news titles 0

No news for this category in the selected date range.

Launch 3 news titles 3
ABDX logo
Launch 06:01
ABDX

Launch of seaweed-based lateral flow housings

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
Launch
FDEV logo
Launch 06:01
FDEV

A STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO

Frontier Developments Plc

**Summary**
Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*.
**Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum.
**Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion.
Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later.
The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
Launch
Litigation 0 news titles 0

No news for this category in the selected date range.

NewContract 1 news title 1
FTC logo
NewContract 06:01
FTC

€7m contract for satellite constellation programme

Filtronic

**Summary**
Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
NewContract
Offers 1 news title 1
0R3T logo
Offers 08:31
0R3T

UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities

UBS Group AG

**Summary**
UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
Offers
Offtake 0 news titles 0

No news for this category in the selected date range.

Orders 0 news titles 0

No news for this category in the selected date range.

Partner 2 news titles 2
CLX logo
Partner 10:31
CLX

Calnex and Viavi Partnership

Calnex Solutions Plc

**Summary**
Calnex Solutions plc (AIMCLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards.
The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions.
Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
Partner
LSEG logo
Partner 10:01
LSEG

LSEG Announces Strategic Partnership with Nasdaq®

London Stock Exchange Group PLC

**Summary**
On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape.
The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization.
LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
Partner
Patents 0 news titles 0

No news for this category in the selected date range.

Placing 3 news titles 3
Positive 0 news titles 0

No news for this category in the selected date range.

Proposals 2 news titles 2
PMGR logo
Proposals 06:01
PMGR

Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company

Portmeirion Group

**Summary**
Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options
1. **Rollover Option**Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance.
2. **Cash Option**Receive a cash exit at net asset value, less associated costs.
The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs.
Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed.
The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter.
The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
Proposals
Reports 12 news titles 12
RS1 logo
Reports 06:01
RS1

Half-year Financial Report

RS GROUP PLC

**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)**
**Financial Performance Highlights**
**Revenue:** £1403 milliondown 3% year-on-year
like-for-like down 1%with growth in Q2.
**Adjusted Operating Profit** £122 million, down 8% year-on-year
like-for-like down 7%.
**Operating Profit Margin:** 8.7%down 0.5 percentage points.
**Profit Before Tax:** £112 millionup 7% year-on-year.
**Basic Earnings Per Share:** 17.7pup 8% year-on-year.
**Interim Dividend:** 8.7pup 2%.
**Key Performance Indicators**
**Gross Margin** Improved by 0.4 percentage points to 43.1%.
**Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target.
**Net Debt** Reduced by £31 million to £333 million.
**Net Debt to Adjusted EBITDA** Improved to 1.0x from 1.3x.
**Strategic and Operational Progress**
**Restructuring Benefits** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023.
**Growth Accelerators** RS PRO like-for-like revenue up 4%
Service solutions up 7%.
**Organic Investment** £19 million in H1 2025/26, part of planned £35-£40 million for the full year.
**Regional Performance**
**EMEA** Revenue down 2% like-for-like
operating profit down 9%.
**Americas** Revenue up 1% like-for-like
operating profit down 9%.
**Asia Pacific** Revenue up 4% like-for-like
operating profit up 42%.
**Full Year Outlook**
Unchanged, with expectations of slight gross margin improvement and continued cost management.
Capital expenditure forecast at around £50 million.
Progressive dividend policy maintained.
**Sustainability and ESG**
**Better World Product Range** Expanded to over 33,000 products.
**Emissions Intensity** Reduced by 35% from the 2019/20 baseline.
**Employee Engagement** Increased to 73%.
**Going Concern and Risks**
The Board has assessed the Groups ability to continue as a going concern for at least 12 months.
Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change.
**Conclusion**
RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
Here is the HTML table code comparing the financials and debt year on year for RS Group PLC:
MetricH1 2025/26H1 2024/25Change
Revenue£1,403m£1,441m(3%)
Adjusted operating profit£122m£133m(8%)
Adjusted operating profit margin8.7%9.2%(0.5) pts
Adjusted profit before tax£112m£118m(6%)
Adjusted basic earnings per share17.6p18.5p(5%)
Net debt£(333)m£(437)m£104m improvement
Net debt to adjusted EBITDA1.0x1.3x0.3x improvement
**Key takeaways:** * **Revenue decline:** Revenue decreased by 3% year-on-year, primarily due to a 1% like-for-like decline and adverse currency movements. * **Profit margin compression:** Adjusted operating profit margin decreased by 0.5 percentage points due to increased investment in strategic initiatives. * **Improved debt position:** Net debt decreased significantly by £104 million, leading to a lower net debt to adjusted EBITDA ratio, indicating improved financial health. This table provides a concise comparison of key financial metrics and debt levels for RS Group PLC between H1 2025/26 and H1 2024/25.
SBRY logo
Reports 06:01
SBRY

Half-Year Report

J Sainsbury PLC

**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)**
**Financial Performance Highlights**
**Sales Growth** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%.
**Profitability** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year.
**Cash Flow** Retail free cash flow was £310 million, on track to exceed £500 million for the full year.
**Bank Disposal** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks.
**Dividends** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million.
**Strategic Initiatives and Market Position:**
**Value and Quality Focus** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items.
**Innovation and Range Expansion** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains.
**Operational Efficiency** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases.
**Sustainability** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts.
**Outlook and Guidance**
**Profit Guidance** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million.
**Strategic Commitments** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction.
**Nectar Loyalty Program** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth.
**Argos Transformation** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency.
**Conclusion**
Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
Here is the comparison of financials and debt year on year in an HTML table format:
Metric2024/25 (28 weeks)2025/26 (28 weeks)YoY Change
Retail sales (excl. VAT, excl. fuel)£14,865m£15,577m4.8%
Retail underlying operating profit£503m£504m0.2%
Underlying profit before tax£309m£340m10%
Retail free cash flow£425m£310m(£115)m
Net debt (inc. lease liabilities)£(5,584)m£(5,527)m£57m
Non-lease net debt£(152)m£(81)m£71m
**Key Observations:** * **Sales Growth:** Retail sales (excluding VAT and fuel) increased by 4.8% year-on-year, driven by grocery and general merchandise sales growth. * **Profitability:** Underlying profit before tax increased by 10%, while retail underlying operating profit remained relatively stable with a slight increase of 0.2%. * **Cash Flow:** Retail free cash flow decreased by £115 million, primarily due to reduced working capital inflow and higher capital expenditure. * **Debt:** Net debt (including lease liabilities) decreased by £57 million, and non-lease net debt decreased by £71 million, indicating improved liquidity. This table provides a concise overview of the key financial metrics and debt position, highlighting areas of growth, stability, and changes in liquidity.
Results 18 news titles 18
WISE logo
Results 06:01
WISE

FY26 Half Year Results

Wise plc

**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)**
Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include
### **Financial Performance**
**Revenue Growth**Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million).
**Active Customers**Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion.
**Customer Holdings**Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature.
**Underlying Profit Before Tax (PBT)**Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth.
**Reported Profit Before Tax**Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields.
### **Operational Highlights**
**Infrastructure Expansion**Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly.
**Regulatory Approvals**Secured approvals in the UAE to expand product offerings in the region.
**Product Enhancements**Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil.
**Partnerships**Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume.
### **Strategic Investments**
**Team Growth**: Added over 1000 employeesfocusing on servicingcomplianceand AI-driven efficiencies.
**Marketing**Increased brand marketing spend across key markets to drive awareness and organic growth.
**Technology**Invested £144 million in product development, enhancing core products and launching new features.
### **Future Outlook**
**Dual Listing**On track for a US listing in Q2 2026 to increase visibility and access to capital.
**Growth Targets**Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs.
**Innovation**Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention.
### **Management Commentary**
CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability.
### **Conclusion**
Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
Here’s an HTML table comparing the financials and debt year on year for Wise PLC based on the provided text:
MetricH1 FY2025 (£m)H1 FY2026 (£m)YoY Change (£m)YoY Change (%)
Revenue591.9658.066.111%
Underlying Interest Income (first 1% yield)70.591.521.030%
Underlying Income662.4749.587.113%
Cost of Sales(152.9)(173.7)(20.8)14%
Net Credit Losses on Financial Assets(4.5)(4.6)(0.1)2%
Underlying Gross Profit505.0571.266.213%
Administrative Expenses(366.7)(465.9)(99.2)27%
Net Interest Income from Corporate Investments15.923.77.849%
Other Operating Income, Net2.33.81.565%
Underlying Operating Profit156.5132.8(23.7)(15%)
Finance Expense(9.4)(10.8)(1.4)15%
Underlying Profit Before Tax147.1122.0(25.1)(17%)
Reported Profit Before Tax292.5254.6(37.9)(13%)
Profit for the Period217.3187.2(30.1)(14%)
Borrowings (Revolving Credit Facility)98.1198.5100.4102%
### Key Highlights: 1. **Revenue Growth**: Revenue increased by 11% YoY from £591.9m to £658.0m. 2. **Underlying Income Growth**: Underlying income grew by 13% YoY from £662.4m to £749.5m. 3. **Administrative Expenses Increase**: Administrative expenses rose by 27% YoY from £366.7m to £465.9m. 4. **Underlying Profit Before Tax Decline**: Underlying profit before tax decreased by 17% YoY from £147.1m to £122.0m. 5. **Borrowings Increase**: Borrowings under the Revolving Credit Facility increased by 102% YoY from £98.1m to £198.5m. This table provides a clear comparison of key financial metrics and debt levels between H1 FY2025 and H1 FY2026 for Wise PLC.
AZN logo
Results 06:01
AZN

9M and Q3 2025 results

AstraZeneca PLC

## AstraZeneca 9M and Q3 2025 Results Summary
**Strong Performance and Pipeline Progress:**
AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements.
**Financial Highlights (9M 2025)**
* **Revenue Growth** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%).
* **Core EPS Growth** Core EPS rose by 15% to $7.04, reflecting improved profitability.
* **Operating Profit Increase** Core operating profit grew by 13%, demonstrating operational efficiency.
**Pipeline Achievements**
* **16 Positive Phase III Readouts** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas.
* **31 Regulatory Approvals** The company secured 31 approvals in major regions for various medicines, expanding patient access.
* **Strong Oncology Pipeline** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi.
**Strategic Initiatives**
* **US Expansion** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs.
* **Acquisition of SixPeaks Bio AG** This acquisition strengthens AstraZenecas position in weight management therapies.
* **Koselugo Agreement with Merck** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency.
**Future Outlook**
* **Reiterated Guidance** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth.
* **Sustainability Leadership** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings.
**Key Takeaways**
AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
Here is a comparison of AstraZeneca's financials and debt year on year, presented as an HTML table:
Metric9M 20259M 2024% ChangeQ3 2025Q3 2024% Change
Total Revenue$43,236m$39,182m10%$15,191m$13,565m12%
Reported EPS ($)$5.10$3.5743%$1.64$0.9277%
Core EPS ($)$7.04N/A15%$2.38N/A14%
Net Debt$23,965m$26,348m-9%N/AN/AN/A
Capital Expenditure$2,091m$1,415m48%N/AN/AN/A

Note: The above table provides a high-level comparison of key financials and debt metrics. For a detailed analysis, please refer to the original text.

Key Observations:

  • Total Revenue increased by 10% year-on-year in 9M 2025, driven by growth in all Therapy Areas.
  • Reported EPS increased significantly by 43% in 9M 2025, while Core EPS increased by 15%.
  • Net Debt decreased by 9% in the nine months to 30 September 2025, reflecting improved financial position.
  • Capital Expenditure increased by 48% in 9M 2025, primarily due to investment in manufacturing projects and technology upgrades.
This table provides a concise comparison of AstraZeneca's financials and debt year on year, highlighting key metrics such as Total Revenue, Reported EPS, Core EPS, Net Debt, and Capital Expenditure. The observations section summarizes the main trends and changes in these metrics.
AUTO logo
Results 06:01
AUTO

Half Year Results

Auto Trader Group plc

**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)**
**Financial Performance Highlights**
**Revenue Growth** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million).
**Profitability** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million.
**EPS Growth** Basic earnings per share (EPS) increased by 11% to 17.26 pence.
**Cash Flow** Cash generated from operations rose by 7% to £215.4 million.
**Shareholder Returns** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence).
**Strategic and Operational Updates**
**AI Innovation** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts.
**Deal Builder Growth** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025).
**Market Position** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly.
**New Car Market** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined.
**Used Car Market** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed.
**Future Outlook**
Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities.
Continued focus on AI opportunities to enhance performance, efficiency, and customer experience.
Scaling Deal Builder as the core consumer proposition, deepening competitive advantage.
**Sustainability and Governance**
Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi).
Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC.
**Conclusion**
Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
Here is the HTML table code comparing the financials and debt year on year for Auto Trader Group PLC:
MetricH1 2026H1 2025Change
Revenue£317.7m£302.5m5%
Operating Profit£200.1m£188.4m6%
Operating Profit Margin63%62%1% pts
Profit Before Tax£199.3m£187.5m6%
Basic Earnings Per Share17.26p15.56p11%
Cash Generated from Operations£215.4m£201.6m7%
Net Cash£5.2m£15.1m(£9.9m)
Debt (Syndicated RCF)£15.0m£0m£15.0m
**Key Observations:** * **Revenue and Profit Growth:** Auto Trader Group PLC experienced a 5% increase in revenue and a 6% increase in operating profit year on year. * **Margin Improvement:** Operating profit margin improved by 1 percentage point to 63%. * **Earnings Per Share Growth:** Basic earnings per share increased by 11% to 17.26p. * **Cash Flow Improvement:** Cash generated from operations increased by 7% to £215.4m. * **Debt Increase:** The company drew £15.0m from its Syndicated RCF, resulting in a decrease in net cash from £15.1m to £5.2m. This table provides a concise overview of the key financial metrics and debt position of Auto Trader Group PLC, highlighting the year-on-year changes.
HGT logo
Results 06:01
HGT

3rd Quarter Results

HG Capital Trust PLC

**Summary**
HgCapital Trust PLC (HgT) announced its third-quarter results for the period ending September 30, 2025, highlighting a resilient performance driven by its portfolio of software and services businesses. Key highlights include
1. **NAV Performance**Net Asset Value (NAV) per share increased by 2.4%, reaching £5.50, with total net assets at £2.5 billion.
2. **Share Price**The share price decreased by 2.7% to £4.99, resulting in a market capitalization of £2.3 billion.
3. **Portfolio Growth**Strong trading performance contributed 4% to portfolio growth, partially offset by lower valuation multiples and increased net debt.
4. **Long-Term Performance**The portfolio reported 18% sales growth and 19% EBITDA growth over the last 12 months, with a 33% EBITDA margin.
5. **Liquidity and Investments**Available liquid resources stood at £379 million (15% of NAV), with £49.7 million invested in Q3, primarily in A-LIGN, a cyber compliance services provider.
6. **Realisations**£7 million was realized from the partial sale of Trackunit, with an additional £30 million expected from the post-period exit of GTreasury.
7. **Historical Returns**An investment of £1,000 twenty years ago would now be worth £13,364, outperforming the FTSE All-Share Index, which would be worth £3,762.
HgT remains focused on delivering consistent long-term returns by investing in unquoted companies with potential for strategic and operational value creation. The trust continues to screen an attractive pipeline of opportunities, with further liquidity events expected in the coming months.
Below is the HTML table code comparing the key financials and debt year on year based on the provided text. Since the text only provides data for Q3 2025, I’ve structured the table to compare Q3 2025 with implied or assumed Q3 2024 data (where available). If no direct comparison is possible, the table reflects only the 2025 data.
MetricQ3 2024 (Assumed/Implied)Q3 2025Change
NAV per Share£5.37 (implied from +2.4% growth)£5.50+2.4%
Net Assets£2.44 billion (implied)£2.5 billion+2.5%
Share Price£5.13 (implied from -2.7% decrease)£4.99-2.7%
Market Capitalisation£2.36 billion (implied)£2.3 billion-2.5%
Portfolio Growth (Trading)N/A+4%N/A
Sales Growth (Last 12 Months)N/A+18%N/A
EBITDA Growth (Last 12 Months)N/A+19%N/A
EBITDA MarginN/A33%N/A
Net DebtN/AIncreased (exact figure not provided)N/A
Liquid ResourcesN/A£379 millionN/A
Bank Facility DrawnN/A£46 millionN/A
Co-investments as % of NAV9%10%+1%
### Notes: 1. **Assumed/Implied Values**: For metrics like NAV per share and share price, implied 2024 values are calculated based on the percentage changes provided for 2025. 2. **Missing Data**: Some metrics (e.g., net debt, liquid resources in 2024) are not provided in the text, so they are marked as "N/A". 3. **Percentage Changes**: Changes are calculated where possible, but some metrics lack historical data for comparison. This table provides a structured comparison based on the available information.
CRH logo
Results 06:01
CRH

CRH Reports Third Quarter 2025 Results

CRH PLC

**Summary of CRHs Third Quarter 2025 Results:**
CRH PLC, a leading provider of building materials, reported strong third-quarter 2025 results, highlighting continued growth and strategic advancements. Key takeaways include
1. **Financial Performance**
**Revenue Growth** Total revenues increased by 5% year-over-year to $11.1 billion, driven by favorable demand, strong commercial execution, and contributions from acquisitions.
**Net Income and EBITDA** Net income rose by 9% to $1.5 billion, while Adjusted EBITDA grew by 10% to $2.7 billion. Margins expanded, with net income margin up 50 basis points to 13.7% and Adjusted EBITDA margin up 100 basis points to 24.3%.
**Earnings Per Share (EPS)** Diluted EPS increased by 12% to $2.21.
2. **Strategic Initiatives**
**Acquisitions** CRH invested $3.5 billion in 27 value-accretive acquisitions year-to-date, including nine acquisitions totaling $2.5 billion in Q3. The company maintains an active pipeline of opportunities.
**Shareholder Returns** CRH returned $1.1 billion to shareholders year-to-date through share buybacks and declared a quarterly dividend of $0.37 per share, a 6% increase year-over-year.
3. **Segment Performance**
**Americas Materials Solutions** Revenues grew by 6%, with Adjusted EBITDA up 5%, driven by strong demand and pricing momentum.
**Americas Building Solutions** Revenues increased by 2%, with Adjusted EBITDA up 22%, supported by acquisitions and optimization initiatives.
**International Solutions** Revenues rose by 5%, with Adjusted EBITDA up 15%, driven by operational efficiencies and acquisitions.
4. **Outlook**
**2025 Guidance** CRH reaffirmed its net income guidance and raised the midpoint of its Adjusted EBITDA guidance, reflecting continued strategic execution and market strength.
**2026 Expectations** The company anticipates favorable market dynamics, supported by infrastructure investment and reindustrialization activity, despite subdued residential new-build activity.
5. **Balance Sheet and Liquidity**
**Net Debt** Increased to $15.0 billion due to acquisitions, shareholder returns, and capital expenditures, partially offset by operating cash flows. CRH maintains a robust balance sheet with $4.3 billion in cash and equivalents.
**Credit Rating** CRH remains committed to maintaining its investment-grade credit rating.
6. **Leadership Commentary**
CEO Jim Mintern emphasized CRH’s superior strategy, connected portfolio, and leading performance, positioning the company for continued growth and value creation in 2026.
Overall, CRH’s Q3 2025 results underscore its strong operational execution, strategic growth initiatives, and commitment to shareholder value, despite a dynamic market environment.
Here’s an HTML table comparing the financials and debt year-on-year for CRH based on the provided text:
MetricQ3 2025Q3 2024YoY Change
Total Revenues$11.1bn$10.5bn+5%
Net Income$1.5bn$1.4bn+9%
Net Income Margin13.7%13.2%+50bps
Adjusted EBITDA$2.7bn$2.5bn+10%
Adjusted EBITDA Margin24.3%23.3%+100bps
Diluted Earnings Per Share$2.21$1.97+12%
Total Short and Long-Term Debt$18.7bn$14.0bn+33.6%
Net Debt$15.0bn$10.5bn+42.9%
### Explanation: - **Total Revenues, Net Income, Margins, and EPS**: These metrics are directly compared year-on-year, showing growth rates or margin improvements. - **Debt Metrics**: Total short and long-term debt and Net Debt are compared, highlighting the significant increase in debt levels year-on-year. This table provides a clear comparison of key financial and debt metrics between Q3 2025 and Q3 2024.
Significant 0 news titles 0

No news for this category in the selected date range.

Speculation 0 news titles 0

No news for this category in the selected date range.

Strategic 0 news titles 0

No news for this category in the selected date range.

Suspension 0 news titles 0

No news for this category in the selected date range.

TR1 39 news titles 39
EOT logo
TR1 15:38
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.104435', '9.413053']
WIZZ logo
TR1 15:34
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold ', '0.040000']
MTU logo
TR1 15:04
MTU

Holding(s) in Company

Montanaro UK Smaller Companies Investment Trust PLC

TR1 Buy
['IntegraFin Holdings plc', '3.010000', 0]
CPI logo
TR1 15:01
CPI

Holding(s) in Company

Capita PLC

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '7.113778', '6.625642']
CWR logo
TR1 14:11
CWR

Holding(s) in Company

Ceres Power Holdings PLC

TR1 Buy
['BNP Paribas Asset Management UK Limited', '2.694800', '3.250800']
API logo
TR1 10:53
API

Holding(s) in Company

abrdn Property Income Trust Ltd.

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '5.952788']
QLT logo
TR1 09:01
QLT

Holding(s) in Company

Quilter PLC

TR1 Buy
['Public Investment Corporation SOC Limited', '10.328000', '9.811000']
BUR logo
TR1 06:01
BUR

Holding(s) in Company

Burford Capital Limited

<mark style="background-coloryellow">TR1</mark> Buy
['BlackRock, Inc.', '4.68', 'Below 5']
Takeover 1 news title 1
Understanding 0 news titles 0

No news for this category in the selected date range.

Updates 24 news titles 24
SFOR logo
Updates 06:01
SFOR

Third Quarter Trading Update

S4 Capital PLC

**S4Capital plc Third Quarter Trading Update Summary (November 6, 2025)**
**Key Highlights**
1. **Financial Performance**
**Q3 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 3.4% reported1.0% like-for-like.
Net revenue down 6.9% reported4.4% like-for-likewith sequential improvement from Q2.
Marketing Services net revenue down 2.8% like-for-like
Technology Services down 16.5% like-for-like.
**Nine Months 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 11.1% reported8.4% like-for-like.
Net revenue down 10.8% reported8.2% like-for-like.
Marketing Services net revenue down 5.2% like-for-like
Technology Services down 29.6% like-for-like.
2. **Regional Performance**
**Americas** (80% of net revenue)Q3 net revenue up 1.6% like-for-like
nine months down 5.6%.
**EMEA**Q3 net revenue down 26.2%
nine months down 17.3%.
**Asia-Pacific**Q3 net revenue down 16.2%
nine months down 15.3%.
3. **Outlook**
Full-year 2025 like-for-like net revenue expected to decline by upper single digits.
Operational EBITDA target remains unchanged, broadly similar to 2024.
Net debt target for year-end£100–£140 million.
Potential for enhanced final dividend if second-half performance and liquidity targets are met.
4. **New Business and AI Focus**
Significant new business wins, including General Motors, Amazon, T-Mobile, and two unannounced US-based Global FMCG companies.
AI-driven initiatives improving visualisation, copywriting, and hyper-personalisation, with clients excited about cost savings and ROI.
Revenue model shifting from time-based to output-based, leveraging AI tools like Runway, Luma, and Unreal.
5. **Balance Sheet and Liquidity**
Q3 net debt at £151 million (1.8x EBITDA), up slightly due to dividend payments, restructuring costs, and FX headwinds.
Sufficient liquidity with long-dated debt maturities and covenant compliance.
6. **ESG Commitment**
Continued focus on people fulfilmentenvironmental responsibilityand transparency.
Maintained B Corp status and improved Ecovadis score.
7. **Strategic Focus**
Unitary digital transformation model resonating with clients, emphasizing "faster, better, cheaper, more."
Rebranded as Monks, with streamlined Marketing and Technology Services practices.
**Executive Commentary (Sir Martin Sorrell):**
Clients remain cautious due to global macroeconomic volatility, particularly in technology sectors.
AI adoption is accelerating, with significant opportunities for efficiency and growth.
Cost control and cash management remain priorities, with a focus on profitability and debt reduction.
**Conclusion**
Despite challenging market conditions, S4Capital is leveraging AI-driven innovation and cost restructuring to improve performance, with a focus on new business wins and operational efficiency. The company remains committed to its digital transformation strategy and long-term growth objectives.
Here’s an HTML table comparing the financials and debt year-on-year based on the provided text:
MetricThree Months Ended 30 Sep 2025Nine Months Ended 30 Sep 2025Three Months Ended 30 Sep 2024Nine Months Ended 30 Sep 2024
Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (£m)Reported (£m)Like-for-like (£m)
Billings490.95.1%1,416.85.1%481.65.1%1,390.55.1%
Revenue191.7-1.0%552.1-8.4%198.4-1.0%620.9-8.4%
Net Revenue167.0-4.4%495.2-8.2%179.3-4.4%555.4-8.2%
Net Debt (£m)151-151-180194180194
Leverage (x EBITDA)1.8-1.8-----
### Key Notes: 1. **Billings**: Both reported and like-for-like figures show a 1.9% increase for the nine months ended 30 Sep 2025 compared to 2024. 2. **Revenue**: Reported revenue decreased by 3.4% for Q3 2025 and 11.1% for the nine months, while like-for-like figures show a smaller decline of 1.0% and 8.4%, respectively. 3. **Net Revenue**: Reported net revenue decreased by 6.9% for Q3 2025 and 10.8% for the nine months, with like-for-like figures showing a 4.4% and 8.2% decline, respectively. 4. **Net Debt**: Net debt decreased to £151 million in 2025 from £180 million in 2024 (or £194 million on a like-for-like basis). 5. **Leverage**: Leverage ratio improved to 1.8x EBITDA in 2025 from a covenant limit of 4.5x EBITDA. This table provides a clear comparison of key financial metrics and debt levels between 2024 and 2025.
AFC logo
Updates 06:01
AFC

Trading Update for Year Ended 31 October 2025

AFC Energy plc

**Summary**
AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including
1. **Partnerships and Deployments**Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner.
2. **Product Development**The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026.
3. **Joint Ventures**A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting.
4. **Strategic Restructuring**A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments.
5. **Financials**Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability.
6. **Market Opportunities**AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition.
CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
MetricFY24FY25Change
Cash, Cash Equivalents, and Short-Term Deposits (£m)15.425.3+9.9 (+64.3%)
Revenue (£k)4,000107-3,893 (-97.3%)
Headcount ReductionN/A-17N/A
Annualised Cost Savings in FY26 (£m)N/A1.5N/A
### Explanation: 1. **Cash, Cash Equivalents, and Short-Term Deposits**: Increased from £15.4m in FY24 to £25.3m in FY25, a rise of £9.9m (+64.3%). 2. **Revenue**: Decreased significantly from £4m in FY24 to £107k in FY25, a drop of £3.893m (-97.3%), attributed to the strategic reset announced in March 2025. 3. **Headcount Reduction**: FY25 saw a net reduction of 17 employees as part of the business reorganisation. 4. **Annualised Cost Savings**: Expected savings of £1.5m in FY26 due to restructuring efforts. This table provides a clear year-on-year comparison of key financial metrics and debt-related changes.
DGE logo
Updates 06:01
DGE

Diageo issues fiscal 26 Q1 trading statement

Diageo PLC

**Diageo Fiscal 26 Q1 Trading Statement Summary**
**Key Highlights**
**Flat Organic Net Sales Growth** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact.
**Regional Performance**
**Strengths** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM).
**Weaknesses** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%.
**Strategic Focus** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics.
**Fiscal 26 Outlook**
Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness.
Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings.
Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years.
**Management Commentary** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture.
**Regional Breakdown**
1. **North America (38% of net sales)** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence.
2. **Europe (25% of net sales)** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye.
3. **Asia Pacific (18% of net sales)** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India.
4. **LAC (11% of net sales)** Organic net sales grew 10.9%, led by Brazil’s double-digit growth.
5. **Africa (8% of net sales)** Organic net sales grew 8.9%, with strong performance in East and South Africa.
**Key Initiatives**
**Accelerate Programme** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications.
**Disposals** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations.
**Financial Guidance**
Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion.
Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28.
**Conclusion**
Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
Below is the HTML table code comparing the financials and debt year on year based on the provided text:
MetricF26 (2025)F25 (2024)Reported Growth YoY %Organic Growth YoY %
Net Sales$4,875$4,986(2.2)0.0
Volume++-2.9
Price/Mix--(2.8)(2.8)
Free Cash Flow$3,000$2,70011.1-
Capital Expenditure$1.2-1.3bn$1.5bn(13.3)-(20.0)-
Effective Interest Rate4.0%4.1%(2.4)-
Tax Rate25.0%24.9%0.4-
Net Debt to Adjusted EBITDATarget: 2.5-3.0x by F28---
### Notes: 1. **Net Sales**: Reported net sales declined by 2.2% YoY, while organic net sales growth was flat. 2. **Volume**: Organic volume growth was 2.9%. 3. **Price/Mix**: Organic price/mix declined by 2.8%. 4. **Free Cash Flow**: Expected to increase to $3 billion in F26 from $2.7 billion in F25. 5. **Capital Expenditure**: Expected to be at the lower end of $1.2-1.3 billion in F26 compared to $1.5 billion in F25. 6. **Effective Interest Rate**: Slightly decreased to 4.0% in F26 from 4.1% in F25. 7. **Tax Rate**: Expected to be around 25.0% in F26 compared to 24.9% in F25. 8. **Net Debt to Adjusted EBITDA**: Target is to be within 2.5-3.0x by F28. This table provides a clear comparison of key financial metrics and debt-related figures between F26 (2025) and F25 (2024).
HIK logo
Updates 06:01
HIK

November Trading Statement

Hikma Pharmaceuticals PLC

**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:**
Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include
1. **Performance Across Segments**
**Injectables** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%.
**Branded** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%.
**Hikma Rx** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%.
2. **Organisational Changes**
Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies.
Dr Bill Larkins stepped down as head of Injectables
CEO Riad Mishlawi will serve as interim head until a replacement is found.
3. **Full Year 2025 Outlook**
Group revenue growth maintained at 4-6%.
Core operating profit range tightened to $730-$750 million, in line with market expectations.
4. **Medium-Term Outlook (2024-2027)**
Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges.
Group revenue CAGR revised to the lower end of 6-8%.
Core operating profit growth adjusted to 5-7%, down from 7-9%.
Long-term target of $5 billion revenue by 2030 remains unchanged.
5. **Strategic Focus**
Continued investment in R&D and manufacturing capacity expansion to support growth.
Confidence in revised targets despite medium-term adjustments.
Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
The provided text does not contain specific financial or debt figures for a year-on-year comparison. However, I can create a general HTML table structure based on the guidance and outlook provided in the text. If you have specific financial data, please provide it, and I can tailor the table accordingly. Here’s a basic HTML table structure based on the available information: < lang="en">Hikma Pharmaceuticals Financials and Debt Comparison

Hikma Pharmaceuticals Financials and Debt Comparison (2024 vs 2025 Guidance)

Metric2024 (Actual)2025 (Guidance)Change
Group Revenue GrowthN/A4% to 6%N/A
Injectables Revenue GrowthN/A7% to 9%N/A
Injectables Core Operating MarginN/A32% to 33%N/A
Branded Revenue GrowthN/A6% to 7%N/A
Branded Core EBIT MarginN/A~25%N/A
Hikma Rx Revenue GrowthN/ABroadly flatN/A
Hikma Rx Core Operating MarginN/A~16%N/A
Group Core Operating ProfitN/A$730M to $750MN/A
Medium-Term Group Revenue CAGR (2024-2027)N/A6% to 8% (lower end)N/A
Medium-Term Group Core Operating Profit GrowthN/A5% to 7%N/A

Note: Actual 2024 figures are not provided in the text. The table reflects 2025 guidance and medium-term outlook.

If you have specific financial or debt figures for 2024 or any other year, please provide them, and I can update the table accordingly.
IMI logo
Updates 06:01
IMI

Trading Update

IMI PLC

**Summary**
IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**.
Key highlights include
**Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%).
**Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**.
Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers.
The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns.
Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
Below is an HTML table comparing the year-on-year financials and debt based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and organic growth comparisons.
Metric2024 (Previous Year)2025 (Current Year)Year-on-Year Change
Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Automation Sector Organic Revenue Growth (Year-to-Date)N/A+8%+8% (from 2024 baseline)
Process Automation Organic Revenue Growth (Year-to-Date)N/A+14%+14% (from 2024 baseline)
Life Technology Sector Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Climate Control Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Life Science & Fluid Control Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Transport Organic Revenue Growth (Year-to-Date)N/A-9%-9% (from 2024 baseline)
Exchange Rate Impact on Revenue (Full Year)N/A-1%-1% (compared to 2024)
Exchange Rate Impact on Adjusted Operating Profit (Full Year)N/A-1.5%-1.5% (compared to 2024)
Adjusted Basic Earnings per Share (Full Year Guidance)N/A129p - 136pN/A (Guidance for 2025)
Debt (Year-on-Year)Not ProvidedNot ProvidedN/A
### Notes: 1. **Debt Information**: The provided text does not include specific debt figures, so the table reflects this as "Not Provided." 2. **Organic Growth**: All organic growth figures are based on the comparisons provided in the text for 2025 relative to 2024. 3. **Exchange Rate Impact**: The impact of exchange rates on revenue and adjusted operating profit is included as per the text. 4. **Earnings per Share**: The adjusted basic earnings per share guidance for 2025 is included as provided. This table can be embedded in an HTML document for display.
ITV logo
Updates 06:01
ITV

ITV plc Q3 Trading Update

ITV PLC

**ITV PLC Q3 Trading Update Summary (November 2025):**
ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include
**Revenue Growth** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX.
**Advertising Performance** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty.
**Cost Management** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand.
**ITV Studios** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms.
**Digital Growth** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026.
**Outlook** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness.
**Liquidity** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025.
CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
Below is an HTML table comparing the financials and debt year-on-year based on the provided text:
Metric2024 (£m)2025 (£m)Change (£m)Change (%)
Total Group Revenue2,7412,795542%
Total Group External Revenue2,3212,404834%
ITV Studios Revenue1,2171,35013311%
Media & Entertainment (M&E) Revenue1,5241,445(79)(5%)
Total Advertising Revenue (TAR)1,3131,247(66)(5%)
Digital Advertising RevenueN/AUp 15%Growth driven by ITVX
Total Digital Revenue3844324813%
Net DebtN/A508(78)Decreased from £586m (June 2025)
### Key Notes: 1. **Revenue Comparisons**: All figures are for the nine months ending 30 September, comparing 2025 to 2024. 2. **Debt**: Net debt is provided for 2025, with a decrease from £586 million in June 2025 to £508 million in September 2025. 3. **Digital Revenue**: 2024 figures were restated to £384 million due to changes in categorization. 4. **TAR**: Expected to decline by 6% for the full year 2025 compared to 2024, with a 9% decline in Q4 2025. This table provides a concise comparison of key financials and debt between 2024 and 2025 based on the provided text.
HWDN logo
Updates 06:01
HWDN

Trading Update

Howden Joinery Group Plc

**Summary**
Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include
1. **Sales Growth**
**Group Sales**+2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis.
**UK Sales**+2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1.
**International Sales**+14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland.
2. **Performance Drivers**
Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens.
High stock availability, market-leading product lineup, and exceptional customer service supported growth.
3. **Outlook**
The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million.
CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives.
4. **Operational Highlights**
£8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%.
Continued expansion of the in-stocktrade model internationally.
Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
Below is the HTML table code comparing the financials and sales growth year-on-year based on the provided text: < lang="en">Howden Joinery Group PLC Financials Comparison

Howden Joinery Group PLC - Sales Growth Comparison (2024 vs 2025)

MetricPeriods 7 to 11Year-to-dateSame Depot Basis (Periods 7 to 11)Same Depot Basis (Year-to-date)
UK Sales Growth (%)+2.4%+2.7%+1.1%+1.4%
International Sales Growth (%)+14.7%+13.4%+9.3%+9.6%
Group Sales Growth (%)+2.8%+3.0%+1.4%+1.7%

Notes:

  • 1. There were two fewer trading days in H1 2025 versus the prior year. Numbers reported are unadjusted.
  • 2. Same depot basis excludes depots opened in the current year and the prior year.
  • 3. International growth is shown in local currency.
  • 4. 2025 Full Year Profit Before Tax consensus is £331m (2024: £328.1m).
### Key Features of the Table: 1. **Metrics Compared**: Sales growth percentages for UK, International, and Group segments. 2. **Periods**: Compares Periods 7 to 11 and Year-to-date for both 2024 and 2025. 3. **Same Depot Basis**: Includes growth excluding newly opened depots for a like-for-like comparison. 4. **Notes**: Additional context for adjustments and definitions. This table provides a clear year-on-year comparison of Howden Joinery Group PLC's financial performance based on the provided text.
Vaccine 0 news titles 0

No news for this category in the selected date range.

Wins 0 news titles 0

No news for this category in the selected date range.

Worth 0 news titles 0

No news for this category in the selected date range.

Trading Floor
2025-11-06
592
Headlines
49
News Types
News Flow 592 items today
AI
1
Acquisitions
5
Agreement
3
Approvals
0
Authorisation
0
Awards
0
BTC
0
Blockchain
0
Breakthrough
0
BuyBack
2
Cancellations
2
CashOffer
0
Collaborate
0
ContractWin
0
Covid-19
0
Deals
0
Diamond
0
DirectorDealing
25
Discovery
0
Exceeded
0
FCA
0
FDA
0
Grants
0
InvestmentPlan
0
JV
0
Launch
3
Litigation
0
NewContract
1
Offers
1
Offtake
0
Orders
0
Partner
2
Patents
0
Placing
3
Positive
0
Proposals
2
Reports
12
Results
18
Significant
0
Speculation
0
Strategic
0
Suspension
0
TR1
39
Takeover
1
Understanding
0
Updates
24
Vaccine
0
Wins
0
Worth
0
Loading LSTM picks & Results Radar…

My Watchlist

RNS Alerts

Tap any ticker row to open its mobile stock terminal. Today’s move updates from the same stock-terminal feed.

No tickers on your watchlist yet.

RNS Alerts

Push Notifications
Alert me when a watchlist ticker gets new RNS
Email Alerts
2025-11-06 32 picks
80 Positive
SDY
Speedy Hire PLC
Positive
Commercial Agreement & Equity Subscription
**Summary:** Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital. The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
**Summary**
Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital.
The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
Agreement
15:01
Open Terminal ↗ RNS Source
80 Positive
CLX
Calnex Solutions Plc
Positive
Calnex and Viavi Partnership
**Summary:** Calnex Solutions plc (AIM: CLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards. The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions. Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
**Summary**
Calnex Solutions plc (AIMCLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards.
The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions.
Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
Partner
10:31
Open Terminal ↗ RNS Source
80 Positive
LSEG
London Stock Exchange Group PLC
Positive
LSEG Announces Strategic Partnership with Nasdaq®
**Summary:** On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape. The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization. LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
**Summary**
On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape.
The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization.
LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
Partner
10:01
Open Terminal ↗ RNS Source
80 Positive
0R3T
UBS Group AG
Positive
UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities
**Summary:** UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
**Summary**
UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
Offers
08:31
Open Terminal ↗ RNS Source
80 Positive
HTWS
Helios Towers Plc
Positive
Helios Towers Share Buyback Programme
**Summary:** Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
**Summary**
Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
BuyBack
06:02
Open Terminal ↗ RNS Source
80 Positive
ABDX
Abingdon Health Plc
Positive
Launch of seaweed-based lateral flow housings
**Summary:** Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
Launch
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
RS1
RS GROUP PLC
Positive
Half-year Financial Report
**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)** **Financial Performance Highlights:** - **Revenue:** £1,403 million, down 3% year-on-year; like-for-like down 1%, with growth in Q2. - **Adjusted Operating Profit:** £122 million, down 8% year-on-year; like-for-like down 7%. - **Operating Profit Margin:** 8.7%, down 0.5 percentage points. - **Profit Before Tax:** £112 million, up 7% year-on-year. - **Basic Earnings Per Share:** 17.7p, up 8% year-on-year. - **Interim Dividend:** 8.7p, up 2%. **Key Performance Indicators:** - **Gross Margin:** Improved by 0.4 percentage points to 43.1%. - **Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target. - **Net Debt:** Reduced by £31 million to £333 million. - **Net Debt to Adjusted EBITDA:** Improved to 1.0x from 1.3x. **Strategic and Operational Progress:** - **Restructuring Benefits:** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023. - **Growth Accelerators:** RS PRO like-for-like revenue up 4%; Service solutions up 7%. - **Organic Investment:** £19 million in H1 2025/26, part of planned £35-£40 million for the full year. **Regional Performance:** - **EMEA:** Revenue down 2% like-for-like; operating profit down 9%. - **Americas:** Revenue up 1% like-for-like; operating profit down 9%. - **Asia Pacific:** Revenue up 4% like-for-like; operating profit up 42%. **Full Year Outlook:** - Unchanged, with expectations of slight gross margin improvement and continued cost management. - Capital expenditure forecast at around £50 million. - Progressive dividend policy maintained. **Sustainability and ESG:** - **Better World Product Range:** Expanded to over 33,000 products. - **Emissions Intensity:** Reduced by 35% from the 2019/20 baseline. - **Employee Engagement:** Increased to 73%. **Going Concern and Risks:** - The Board has assessed the Groups ability to continue as a going concern for at least 12 months. - Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change. **Conclusion:** RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)**
**Financial Performance Highlights**
**Revenue:** £1403 milliondown 3% year-on-year
like-for-like down 1%with growth in Q2.
**Adjusted Operating Profit** £122 million, down 8% year-on-year
like-for-like down 7%.
**Operating Profit Margin:** 8.7%down 0.5 percentage points.
**Profit Before Tax:** £112 millionup 7% year-on-year.
**Basic Earnings Per Share:** 17.7pup 8% year-on-year.
**Interim Dividend:** 8.7pup 2%.
**Key Performance Indicators**
**Gross Margin** Improved by 0.4 percentage points to 43.1%.
**Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target.
**Net Debt** Reduced by £31 million to £333 million.
**Net Debt to Adjusted EBITDA** Improved to 1.0x from 1.3x.
**Strategic and Operational Progress**
**Restructuring Benefits** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023.
**Growth Accelerators** RS PRO like-for-like revenue up 4%
Service solutions up 7%.
**Organic Investment** £19 million in H1 2025/26, part of planned £35-£40 million for the full year.
**Regional Performance**
**EMEA** Revenue down 2% like-for-like
operating profit down 9%.
**Americas** Revenue up 1% like-for-like
operating profit down 9%.
**Asia Pacific** Revenue up 4% like-for-like
operating profit up 42%.
**Full Year Outlook**
Unchanged, with expectations of slight gross margin improvement and continued cost management.
Capital expenditure forecast at around £50 million.
Progressive dividend policy maintained.
**Sustainability and ESG**
**Better World Product Range** Expanded to over 33,000 products.
**Emissions Intensity** Reduced by 35% from the 2019/20 baseline.
**Employee Engagement** Increased to 73%.
**Going Concern and Risks**
The Board has assessed the Groups ability to continue as a going concern for at least 12 months.
Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change.
**Conclusion**
RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
Here is the HTML table code comparing the financials and debt year on year for RS Group PLC:
MetricH1 2025/26H1 2024/25Change
Revenue£1,403m£1,441m(3%)
Adjusted operating profit£122m£133m(8%)
Adjusted operating profit margin8.7%9.2%(0.5) pts
Adjusted profit before tax£112m£118m(6%)
Adjusted basic earnings per share17.6p18.5p(5%)
Net debt£(333)m£(437)m£104m improvement
Net debt to adjusted EBITDA1.0x1.3x0.3x improvement
**Key takeaways:** * **Revenue decline:** Revenue decreased by 3% year-on-year, primarily due to a 1% like-for-like decline and adverse currency movements. * **Profit margin compression:** Adjusted operating profit margin decreased by 0.5 percentage points due to increased investment in strategic initiatives. * **Improved debt position:** Net debt decreased significantly by £104 million, leading to a lower net debt to adjusted EBITDA ratio, indicating improved financial health. This table provides a concise comparison of key financial metrics and debt levels for RS Group PLC between H1 2025/26 and H1 2024/25.
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
WISE
Wise plc
Positive
FY26 Half Year Results
**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)** Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include: ### **Financial Performance** - **Revenue Growth**: Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million). - **Active Customers**: Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion. - **Customer Holdings**: Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature. - **Underlying Profit Before Tax (PBT)**: Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth. - **Reported Profit Before Tax**: Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields. ### **Operational Highlights** - **Infrastructure Expansion**: Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly. - **Regulatory Approvals**: Secured approvals in the UAE to expand product offerings in the region. - **Product Enhancements**: Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil. - **Partnerships**: Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume. ### **Strategic Investments** - **Team Growth**: Added over 1,000 employees, focusing on servicing, compliance, and AI-driven efficiencies. - **Marketing**: Increased brand marketing spend across key markets to drive awareness and organic growth. - **Technology**: Invested £144 million in product development, enhancing core products and launching new features. ### **Future Outlook** - **Dual Listing**: On track for a US listing in Q2 2026 to increase visibility and access to capital. - **Growth Targets**: Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs. - **Innovation**: Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention. ### **Management Commentary** CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability. ### **Conclusion** Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)**
Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include
### **Financial Performance**
**Revenue Growth**Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million).
**Active Customers**Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion.
**Customer Holdings**Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature.
**Underlying Profit Before Tax (PBT)**Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth.
**Reported Profit Before Tax**Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields.
### **Operational Highlights**
**Infrastructure Expansion**Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly.
**Regulatory Approvals**Secured approvals in the UAE to expand product offerings in the region.
**Product Enhancements**Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil.
**Partnerships**Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume.
### **Strategic Investments**
**Team Growth**: Added over 1000 employeesfocusing on servicingcomplianceand AI-driven efficiencies.
**Marketing**Increased brand marketing spend across key markets to drive awareness and organic growth.
**Technology**Invested £144 million in product development, enhancing core products and launching new features.
### **Future Outlook**
**Dual Listing**On track for a US listing in Q2 2026 to increase visibility and access to capital.
**Growth Targets**Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs.
**Innovation**Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention.
### **Management Commentary**
CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability.
### **Conclusion**
Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
Here’s an HTML table comparing the financials and debt year on year for Wise PLC based on the provided text:
MetricH1 FY2025 (£m)H1 FY2026 (£m)YoY Change (£m)YoY Change (%)
Revenue591.9658.066.111%
Underlying Interest Income (first 1% yield)70.591.521.030%
Underlying Income662.4749.587.113%
Cost of Sales(152.9)(173.7)(20.8)14%
Net Credit Losses on Financial Assets(4.5)(4.6)(0.1)2%
Underlying Gross Profit505.0571.266.213%
Administrative Expenses(366.7)(465.9)(99.2)27%
Net Interest Income from Corporate Investments15.923.77.849%
Other Operating Income, Net2.33.81.565%
Underlying Operating Profit156.5132.8(23.7)(15%)
Finance Expense(9.4)(10.8)(1.4)15%
Underlying Profit Before Tax147.1122.0(25.1)(17%)
Reported Profit Before Tax292.5254.6(37.9)(13%)
Profit for the Period217.3187.2(30.1)(14%)
Borrowings (Revolving Credit Facility)98.1198.5100.4102%
### Key Highlights: 1. **Revenue Growth**: Revenue increased by 11% YoY from £591.9m to £658.0m. 2. **Underlying Income Growth**: Underlying income grew by 13% YoY from £662.4m to £749.5m. 3. **Administrative Expenses Increase**: Administrative expenses rose by 27% YoY from £366.7m to £465.9m. 4. **Underlying Profit Before Tax Decline**: Underlying profit before tax decreased by 17% YoY from £147.1m to £122.0m. 5. **Borrowings Increase**: Borrowings under the Revolving Credit Facility increased by 102% YoY from £98.1m to £198.5m. This table provides a clear comparison of key financial metrics and debt levels between H1 FY2025 and H1 FY2026 for Wise PLC.
06:01
Open Terminal ↗ RNS Source
80 Positive
VRCI
Verici Dx Plc
Positive
Provider Participation Agreement with Prime Health
**Summary:** Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future. **Key Points:** - Verici Dx signs Provider Participation Agreement with Prime Health Services. - Agreement leverages Prime Health’s PPO network for predictable healthcare pricing. - Expands Verici Dx’s patient scope and enhances private payor coverage. - Prime Health’s network includes 850,000+ providers and 35 million annual claims. - Partnership seen as a strategic step for Verici Dx’s commercial growth.
**Summary**
Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future.
**Key Points**
Verici Dx signs Provider Participation Agreement with Prime Health Services.
Agreement leverages Prime Health’s PPO network for predictable healthcare pricing.
Expands Verici Dx’s patient scope and enhances private payor coverage.
Prime Health’s network includes 850,000+ providers and 35 million annual claims.
Partnership seen as a strategic step for Verici Dx’s commercial growth.
Agreement
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
AZN
AstraZeneca PLC
Positive
9M and Q3 2025 results
## AstraZeneca 9M and Q3 2025 Results Summary: **Strong Performance and Pipeline Progress:** AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements. **Financial Highlights (9M 2025):** * **Revenue Growth:** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%). * **Core EPS Growth:** Core EPS rose by 15% to $7.04, reflecting improved profitability. * **Operating Profit Increase:** Core operating profit grew by 13%, demonstrating operational efficiency. **Pipeline Achievements:** * **16 Positive Phase III Readouts:** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas. * **31 Regulatory Approvals:** The company secured 31 approvals in major regions for various medicines, expanding patient access. * **Strong Oncology Pipeline:** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi. **Strategic Initiatives:** * **US Expansion:** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs. * **Acquisition of SixPeaks Bio AG:** This acquisition strengthens AstraZenecas position in weight management therapies. * **Koselugo Agreement with Merck:** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency. **Future Outlook:** * **Reiterated Guidance:** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth. * **Sustainability Leadership:** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings. **Key Takeaways:** AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
## AstraZeneca 9M and Q3 2025 Results Summary
**Strong Performance and Pipeline Progress:**
AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements.
**Financial Highlights (9M 2025)**
* **Revenue Growth** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%).
* **Core EPS Growth** Core EPS rose by 15% to $7.04, reflecting improved profitability.
* **Operating Profit Increase** Core operating profit grew by 13%, demonstrating operational efficiency.
**Pipeline Achievements**
* **16 Positive Phase III Readouts** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas.
* **31 Regulatory Approvals** The company secured 31 approvals in major regions for various medicines, expanding patient access.
* **Strong Oncology Pipeline** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi.
**Strategic Initiatives**
* **US Expansion** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs.
* **Acquisition of SixPeaks Bio AG** This acquisition strengthens AstraZenecas position in weight management therapies.
* **Koselugo Agreement with Merck** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency.
**Future Outlook**
* **Reiterated Guidance** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth.
* **Sustainability Leadership** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings.
**Key Takeaways**
AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
Here is a comparison of AstraZeneca's financials and debt year on year, presented as an HTML table:
Metric9M 20259M 2024% ChangeQ3 2025Q3 2024% Change
Total Revenue$43,236m$39,182m10%$15,191m$13,565m12%
Reported EPS ($)$5.10$3.5743%$1.64$0.9277%
Core EPS ($)$7.04N/A15%$2.38N/A14%
Net Debt$23,965m$26,348m-9%N/AN/AN/A
Capital Expenditure$2,091m$1,415m48%N/AN/AN/A

Note: The above table provides a high-level comparison of key financials and debt metrics. For a detailed analysis, please refer to the original text.

Key Observations:

  • Total Revenue increased by 10% year-on-year in 9M 2025, driven by growth in all Therapy Areas.
  • Reported EPS increased significantly by 43% in 9M 2025, while Core EPS increased by 15%.
  • Net Debt decreased by 9% in the nine months to 30 September 2025, reflecting improved financial position.
  • Capital Expenditure increased by 48% in 9M 2025, primarily due to investment in manufacturing projects and technology upgrades.
This table provides a concise comparison of AstraZeneca's financials and debt year on year, highlighting key metrics such as Total Revenue, Reported EPS, Core EPS, Net Debt, and Capital Expenditure. The observations section summarizes the main trends and changes in these metrics.
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
SBRY
J Sainsbury PLC
Positive
Half-Year Report
**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)** **Financial Performance Highlights:** - **Sales Growth:** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%. - **Profitability:** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year. - **Cash Flow:** Retail free cash flow was £310 million, on track to exceed £500 million for the full year. - **Bank Disposal:** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks. - **Dividends:** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million. **Strategic Initiatives and Market Position:** - **Value and Quality Focus:** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items. - **Innovation and Range Expansion:** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains. - **Operational Efficiency:** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases. - **Sustainability:** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts. **Outlook and Guidance:** - **Profit Guidance:** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million. - **Strategic Commitments:** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction. - **Nectar Loyalty Program:** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth. - **Argos Transformation:** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency. **Conclusion:** Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)**
**Financial Performance Highlights**
**Sales Growth** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%.
**Profitability** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year.
**Cash Flow** Retail free cash flow was £310 million, on track to exceed £500 million for the full year.
**Bank Disposal** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks.
**Dividends** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million.
**Strategic Initiatives and Market Position:**
**Value and Quality Focus** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items.
**Innovation and Range Expansion** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains.
**Operational Efficiency** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases.
**Sustainability** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts.
**Outlook and Guidance**
**Profit Guidance** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million.
**Strategic Commitments** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction.
**Nectar Loyalty Program** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth.
**Argos Transformation** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency.
**Conclusion**
Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
Here is the comparison of financials and debt year on year in an HTML table format:
Metric2024/25 (28 weeks)2025/26 (28 weeks)YoY Change
Retail sales (excl. VAT, excl. fuel)£14,865m£15,577m4.8%
Retail underlying operating profit£503m£504m0.2%
Underlying profit before tax£309m£340m10%
Retail free cash flow£425m£310m(£115)m
Net debt (inc. lease liabilities)£(5,584)m£(5,527)m£57m
Non-lease net debt£(152)m£(81)m£71m
**Key Observations:** * **Sales Growth:** Retail sales (excluding VAT and fuel) increased by 4.8% year-on-year, driven by grocery and general merchandise sales growth. * **Profitability:** Underlying profit before tax increased by 10%, while retail underlying operating profit remained relatively stable with a slight increase of 0.2%. * **Cash Flow:** Retail free cash flow decreased by £115 million, primarily due to reduced working capital inflow and higher capital expenditure. * **Debt:** Net debt (including lease liabilities) decreased by £57 million, and non-lease net debt decreased by £71 million, indicating improved liquidity. This table provides a concise overview of the key financial metrics and debt position, highlighting areas of growth, stability, and changes in liquidity.
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
AFC
AFC Energy plc
Positive
Trading Update for Year Ended 31 October 2025
**Summary:** AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including: 1. **Partnerships and Deployments**: Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner. 2. **Product Development**: The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026. 3. **Joint Ventures**: A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting. 4. **Strategic Restructuring**: A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments. 5. **Financials**: Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability. 6. **Market Opportunities**: AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition. CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
**Summary**
AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including
1. **Partnerships and Deployments**Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner.
2. **Product Development**The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026.
3. **Joint Ventures**A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting.
4. **Strategic Restructuring**A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments.
5. **Financials**Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability.
6. **Market Opportunities**AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition.
CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
MetricFY24FY25Change
Cash, Cash Equivalents, and Short-Term Deposits (£m)15.425.3+9.9 (+64.3%)
Revenue (£k)4,000107-3,893 (-97.3%)
Headcount ReductionN/A-17N/A
Annualised Cost Savings in FY26 (£m)N/A1.5N/A
### Explanation: 1. **Cash, Cash Equivalents, and Short-Term Deposits**: Increased from £15.4m in FY24 to £25.3m in FY25, a rise of £9.9m (+64.3%). 2. **Revenue**: Decreased significantly from £4m in FY24 to £107k in FY25, a drop of £3.893m (-97.3%), attributed to the strategic reset announced in March 2025. 3. **Headcount Reduction**: FY25 saw a net reduction of 17 employees as part of the business reorganisation. 4. **Annualised Cost Savings**: Expected savings of £1.5m in FY26 due to restructuring efforts. This table provides a clear year-on-year comparison of key financial metrics and debt-related changes.
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
DGE
Diageo PLC
Positive
Diageo issues fiscal 26 Q1 trading statement
**Diageo Fiscal 26 Q1 Trading Statement Summary** **Key Highlights:** - **Flat Organic Net Sales Growth:** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact. - **Regional Performance:** - **Strengths:** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM). - **Weaknesses:** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%. - **Strategic Focus:** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics. - **Fiscal 26 Outlook:** - Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness. - Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings. - Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years. - **Management Commentary:** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture. **Regional Breakdown:** 1. **North America (38% of net sales):** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence. 2. **Europe (25% of net sales):** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye. 3. **Asia Pacific (18% of net sales):** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India. 4. **LAC (11% of net sales):** Organic net sales grew 10.9%, led by Brazil’s double-digit growth. 5. **Africa (8% of net sales):** Organic net sales grew 8.9%, with strong performance in East and South Africa. **Key Initiatives:** - **Accelerate Programme:** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications. - **Disposals:** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations. **Financial Guidance:** - Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion. - Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28. **Conclusion:** Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
**Diageo Fiscal 26 Q1 Trading Statement Summary**
**Key Highlights**
**Flat Organic Net Sales Growth** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact.
**Regional Performance**
**Strengths** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM).
**Weaknesses** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%.
**Strategic Focus** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics.
**Fiscal 26 Outlook**
Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness.
Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings.
Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years.
**Management Commentary** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture.
**Regional Breakdown**
1. **North America (38% of net sales)** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence.
2. **Europe (25% of net sales)** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye.
3. **Asia Pacific (18% of net sales)** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India.
4. **LAC (11% of net sales)** Organic net sales grew 10.9%, led by Brazil’s double-digit growth.
5. **Africa (8% of net sales)** Organic net sales grew 8.9%, with strong performance in East and South Africa.
**Key Initiatives**
**Accelerate Programme** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications.
**Disposals** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations.
**Financial Guidance**
Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion.
Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28.
**Conclusion**
Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
Below is the HTML table code comparing the financials and debt year on year based on the provided text:
MetricF26 (2025)F25 (2024)Reported Growth YoY %Organic Growth YoY %
Net Sales$4,875$4,986(2.2)0.0
Volume++-2.9
Price/Mix--(2.8)(2.8)
Free Cash Flow$3,000$2,70011.1-
Capital Expenditure$1.2-1.3bn$1.5bn(13.3)-(20.0)-
Effective Interest Rate4.0%4.1%(2.4)-
Tax Rate25.0%24.9%0.4-
Net Debt to Adjusted EBITDATarget: 2.5-3.0x by F28---
### Notes: 1. **Net Sales**: Reported net sales declined by 2.2% YoY, while organic net sales growth was flat. 2. **Volume**: Organic volume growth was 2.9%. 3. **Price/Mix**: Organic price/mix declined by 2.8%. 4. **Free Cash Flow**: Expected to increase to $3 billion in F26 from $2.7 billion in F25. 5. **Capital Expenditure**: Expected to be at the lower end of $1.2-1.3 billion in F26 compared to $1.5 billion in F25. 6. **Effective Interest Rate**: Slightly decreased to 4.0% in F26 from 4.1% in F25. 7. **Tax Rate**: Expected to be around 25.0% in F26 compared to 24.9% in F25. 8. **Net Debt to Adjusted EBITDA**: Target is to be within 2.5-3.0x by F28. This table provides a clear comparison of key financial metrics and debt-related figures between F26 (2025) and F25 (2024).
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
HIK
Hikma Pharmaceuticals PLC
Positive
November Trading Statement
**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:** Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include: 1. **Performance Across Segments:** - **Injectables:** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%. - **Branded:** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%. - **Hikma Rx:** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%. 2. **Organisational Changes:** - Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies. - Dr Bill Larkins stepped down as head of Injectables; CEO Riad Mishlawi will serve as interim head until a replacement is found. 3. **Full Year 2025 Outlook:** - Group revenue growth maintained at 4-6%. - Core operating profit range tightened to $730-$750 million, in line with market expectations. 4. **Medium-Term Outlook (2024-2027):** - Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges. - Group revenue CAGR revised to the lower end of 6-8%. - Core operating profit growth adjusted to 5-7%, down from 7-9%. - Long-term target of $5 billion revenue by 2030 remains unchanged. 5. **Strategic Focus:** - Continued investment in R&D and manufacturing capacity expansion to support growth. - Confidence in revised targets despite medium-term adjustments. Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:**
Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include
1. **Performance Across Segments**
**Injectables** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%.
**Branded** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%.
**Hikma Rx** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%.
2. **Organisational Changes**
Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies.
Dr Bill Larkins stepped down as head of Injectables
CEO Riad Mishlawi will serve as interim head until a replacement is found.
3. **Full Year 2025 Outlook**
Group revenue growth maintained at 4-6%.
Core operating profit range tightened to $730-$750 million, in line with market expectations.
4. **Medium-Term Outlook (2024-2027)**
Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges.
Group revenue CAGR revised to the lower end of 6-8%.
Core operating profit growth adjusted to 5-7%, down from 7-9%.
Long-term target of $5 billion revenue by 2030 remains unchanged.
5. **Strategic Focus**
Continued investment in R&D and manufacturing capacity expansion to support growth.
Confidence in revised targets despite medium-term adjustments.
Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
The provided text does not contain specific financial or debt figures for a year-on-year comparison. However, I can create a general HTML table structure based on the guidance and outlook provided in the text. If you have specific financial data, please provide it, and I can tailor the table accordingly. Here’s a basic HTML table structure based on the available information: < lang="en">Hikma Pharmaceuticals Financials and Debt Comparison

Hikma Pharmaceuticals Financials and Debt Comparison (2024 vs 2025 Guidance)

Metric2024 (Actual)2025 (Guidance)Change
Group Revenue GrowthN/A4% to 6%N/A
Injectables Revenue GrowthN/A7% to 9%N/A
Injectables Core Operating MarginN/A32% to 33%N/A
Branded Revenue GrowthN/A6% to 7%N/A
Branded Core EBIT MarginN/A~25%N/A
Hikma Rx Revenue GrowthN/ABroadly flatN/A
Hikma Rx Core Operating MarginN/A~16%N/A
Group Core Operating ProfitN/A$730M to $750MN/A
Medium-Term Group Revenue CAGR (2024-2027)N/A6% to 8% (lower end)N/A
Medium-Term Group Core Operating Profit GrowthN/A5% to 7%N/A

Note: Actual 2024 figures are not provided in the text. The table reflects 2025 guidance and medium-term outlook.

If you have specific financial or debt figures for 2024 or any other year, please provide them, and I can update the table accordingly.
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
AUTO
Auto Trader Group plc
Positive
Half Year Results
**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)** **Financial Performance Highlights:** - **Revenue Growth:** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million). - **Profitability:** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million. - **EPS Growth:** Basic earnings per share (EPS) increased by 11% to 17.26 pence. - **Cash Flow:** Cash generated from operations rose by 7% to £215.4 million. - **Shareholder Returns:** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence). **Strategic and Operational Updates:** - **AI Innovation:** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts. - **Deal Builder Growth:** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025). - **Market Position:** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly. - **New Car Market:** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined. - **Used Car Market:** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed. **Future Outlook:** - Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities. - Continued focus on AI opportunities to enhance performance, efficiency, and customer experience. - Scaling Deal Builder as the core consumer proposition, deepening competitive advantage. **Sustainability and Governance:** - Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi). - Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC. **Conclusion:** Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)**
**Financial Performance Highlights**
**Revenue Growth** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million).
**Profitability** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million.
**EPS Growth** Basic earnings per share (EPS) increased by 11% to 17.26 pence.
**Cash Flow** Cash generated from operations rose by 7% to £215.4 million.
**Shareholder Returns** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence).
**Strategic and Operational Updates**
**AI Innovation** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts.
**Deal Builder Growth** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025).
**Market Position** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly.
**New Car Market** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined.
**Used Car Market** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed.
**Future Outlook**
Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities.
Continued focus on AI opportunities to enhance performance, efficiency, and customer experience.
Scaling Deal Builder as the core consumer proposition, deepening competitive advantage.
**Sustainability and Governance**
Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi).
Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC.
**Conclusion**
Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
Here is the HTML table code comparing the financials and debt year on year for Auto Trader Group PLC:
MetricH1 2026H1 2025Change
Revenue£317.7m£302.5m5%
Operating Profit£200.1m£188.4m6%
Operating Profit Margin63%62%1% pts
Profit Before Tax£199.3m£187.5m6%
Basic Earnings Per Share17.26p15.56p11%
Cash Generated from Operations£215.4m£201.6m7%
Net Cash£5.2m£15.1m(£9.9m)
Debt (Syndicated RCF)£15.0m£0m£15.0m
**Key Observations:** * **Revenue and Profit Growth:** Auto Trader Group PLC experienced a 5% increase in revenue and a 6% increase in operating profit year on year. * **Margin Improvement:** Operating profit margin improved by 1 percentage point to 63%. * **Earnings Per Share Growth:** Basic earnings per share increased by 11% to 17.26p. * **Cash Flow Improvement:** Cash generated from operations increased by 7% to £215.4m. * **Debt Increase:** The company drew £15.0m from its Syndicated RCF, resulting in a decrease in net cash from £15.1m to £5.2m. This table provides a concise overview of the key financial metrics and debt position of Auto Trader Group PLC, highlighting the year-on-year changes.
06:01
Open Terminal ↗ RNS Source
80 Positive
FTC
Filtronic
Positive
€7m contract for satellite constellation programme
**Summary:** Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
**Summary**
Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
NewContract
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
IMI
IMI PLC
Positive
Trading Update
**Summary:** IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**. Key highlights include: - **Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%). - **Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**. - Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers. - The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns. Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
**Summary**
IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**.
Key highlights include
**Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%).
**Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**.
Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers.
The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns.
Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
Below is an HTML table comparing the year-on-year financials and debt based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and organic growth comparisons.
Metric2024 (Previous Year)2025 (Current Year)Year-on-Year Change
Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Automation Sector Organic Revenue Growth (Year-to-Date)N/A+8%+8% (from 2024 baseline)
Process Automation Organic Revenue Growth (Year-to-Date)N/A+14%+14% (from 2024 baseline)
Life Technology Sector Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Climate Control Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Life Science & Fluid Control Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Transport Organic Revenue Growth (Year-to-Date)N/A-9%-9% (from 2024 baseline)
Exchange Rate Impact on Revenue (Full Year)N/A-1%-1% (compared to 2024)
Exchange Rate Impact on Adjusted Operating Profit (Full Year)N/A-1.5%-1.5% (compared to 2024)
Adjusted Basic Earnings per Share (Full Year Guidance)N/A129p - 136pN/A (Guidance for 2025)
Debt (Year-on-Year)Not ProvidedNot ProvidedN/A
### Notes: 1. **Debt Information**: The provided text does not include specific debt figures, so the table reflects this as "Not Provided." 2. **Organic Growth**: All organic growth figures are based on the comparisons provided in the text for 2025 relative to 2024. 3. **Exchange Rate Impact**: The impact of exchange rates on revenue and adjusted operating profit is included as per the text. 4. **Earnings per Share**: The adjusted basic earnings per share guidance for 2025 is included as provided. This table can be embedded in an HTML document for display.
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
ITV
ITV PLC
Positive
ITV plc Q3 Trading Update
**ITV PLC Q3 Trading Update Summary (November 2025):** ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include: - **Revenue Growth:** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX. - **Advertising Performance:** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty. - **Cost Management:** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand. - **ITV Studios:** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms. - **Digital Growth:** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026. - **Outlook:** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness. - **Liquidity:** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025. CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
**ITV PLC Q3 Trading Update Summary (November 2025):**
ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include
**Revenue Growth** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX.
**Advertising Performance** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty.
**Cost Management** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand.
**ITV Studios** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms.
**Digital Growth** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026.
**Outlook** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness.
**Liquidity** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025.
CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
Below is an HTML table comparing the financials and debt year-on-year based on the provided text:
Metric2024 (£m)2025 (£m)Change (£m)Change (%)
Total Group Revenue2,7412,795542%
Total Group External Revenue2,3212,404834%
ITV Studios Revenue1,2171,35013311%
Media & Entertainment (M&E) Revenue1,5241,445(79)(5%)
Total Advertising Revenue (TAR)1,3131,247(66)(5%)
Digital Advertising RevenueN/AUp 15%Growth driven by ITVX
Total Digital Revenue3844324813%
Net DebtN/A508(78)Decreased from £586m (June 2025)
### Key Notes: 1. **Revenue Comparisons**: All figures are for the nine months ending 30 September, comparing 2025 to 2024. 2. **Debt**: Net debt is provided for 2025, with a decrease from £586 million in June 2025 to £508 million in September 2025. 3. **Digital Revenue**: 2024 figures were restated to £384 million due to changes in categorization. 4. **TAR**: Expected to decline by 6% for the full year 2025 compared to 2024, with a 9% decline in Q4 2025. This table provides a concise comparison of key financials and debt between 2024 and 2025 based on the provided text.
06:01
Open Terminal ↗ RNS Source
80 Positive
FDEV
Frontier Developments Plc
Positive
A STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO
**Summary:** Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*. **Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum. **Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion. Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later. The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
**Summary**
Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*.
**Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum.
**Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion.
Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later.
The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
Launch
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
HWDN
Howden Joinery Group Plc
Positive
Trading Update
**Summary:** Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include: 1. **Sales Growth**: - **Group Sales**: +2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis. - **UK Sales**: +2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1. - **International Sales**: +14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland. 2. **Performance Drivers**: - Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens. - High stock availability, market-leading product lineup, and exceptional customer service supported growth. 3. **Outlook**: - The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million. - CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives. 4. **Operational Highlights**: - £8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%. - Continued expansion of the in-stock, trade model internationally. Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
**Summary**
Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include
1. **Sales Growth**
**Group Sales**+2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis.
**UK Sales**+2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1.
**International Sales**+14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland.
2. **Performance Drivers**
Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens.
High stock availability, market-leading product lineup, and exceptional customer service supported growth.
3. **Outlook**
The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million.
CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives.
4. **Operational Highlights**
£8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%.
Continued expansion of the in-stocktrade model internationally.
Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
Below is the HTML table code comparing the financials and sales growth year-on-year based on the provided text: < lang="en">Howden Joinery Group PLC Financials Comparison

Howden Joinery Group PLC - Sales Growth Comparison (2024 vs 2025)

MetricPeriods 7 to 11Year-to-dateSame Depot Basis (Periods 7 to 11)Same Depot Basis (Year-to-date)
UK Sales Growth (%)+2.4%+2.7%+1.1%+1.4%
International Sales Growth (%)+14.7%+13.4%+9.3%+9.6%
Group Sales Growth (%)+2.8%+3.0%+1.4%+1.7%

Notes:

  • 1. There were two fewer trading days in H1 2025 versus the prior year. Numbers reported are unadjusted.
  • 2. Same depot basis excludes depots opened in the current year and the prior year.
  • 3. International growth is shown in local currency.
  • 4. 2025 Full Year Profit Before Tax consensus is £331m (2024: £328.1m).
### Key Features of the Table: 1. **Metrics Compared**: Sales growth percentages for UK, International, and Group segments. 2. **Periods**: Compares Periods 7 to 11 and Year-to-date for both 2024 and 2025. 3. **Same Depot Basis**: Includes growth excluding newly opened depots for a like-for-like comparison. 4. **Notes**: Additional context for adjustments and definitions. This table provides a clear year-on-year comparison of Howden Joinery Group PLC's financial performance based on the provided text.
06:01
Open Terminal ↗ RNS Source
80 Positive
PMGR
Portmeirion Group
Positive
Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company
**Summary:** Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options: 1. **Rollover Option**: Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance. 2. **Cash Option**: Receive a cash exit at net asset value, less associated costs. The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs. Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed. The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter. The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
**Summary**
Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options
1. **Rollover Option**Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance.
2. **Cash Option**Receive a cash exit at net asset value, less associated costs.
The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs.
Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed.
The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter.
The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
Proposals
06:01
Open Terminal ↗ RNS Source
80 Positive
CRH
CRH PLC
Positive
CRH Continues Share Buyback Program
**Summary:** CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018. CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States. Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission. **Key Points:** - CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018. - A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026. - Repurchased shares will be canceled to reduce share capital. - Future buybacks depend on capital needs and market conditions. - Forward-looking statements are subject to risks and uncertainties.
**Summary**
CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018.
CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States.
Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission.
**Key Points**
CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018.
A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026.
Repurchased shares will be canceled to reduce share capital.
Future buybacks depend on capital needs and market conditions.
Forward-looking statements are subject to risks and uncertainties.
BuyBack
06:01
Open Terminal ↗ RNS Source
Market Pulse --
Up
0
Down
0
Good0
Bad0
AI Net0
Most Active Tickers 0
No active AI ticker data for this session.
Strongest Bullish 0
No bullish tickers scored yet.
Strongest Bearish 0
No bearish tickers scored yet.
XSG
XSG
Price --
Move --
News 0
Mode AI
Site ↗
🤖 AI Chartist
Full AI chart intelligence
LSTM forecast path, EMA stack, RSI, MACD, support & resistance — all live in the Chart tab.
XSG logo
Ticker Overview

XSG

Pulse--
AI Net0
Market News592
Up
0
Down
0
🏢
Company Overview
Profile · broker target · market cap · sector · catalyst count
Select a ticker above
AI VIP Intelligence

Signal Storm

⚡ Live 2025-11-06 592 alerts
XSG
XSG Xeros Technology Group Plc
17:33
Market

Proposed Fundraise

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
17:04
Market

Director/PDMR Shareholding

Open Terminal Source RNS
THRG
THRG Throgmorton Trust Plc
17:04
Market

Transaction in Own Shares

Open Terminal Source RNS
0RYA
0RYA Ryanair Holdings plc
17:01
Market

Notification of Transactions by PDMR

Open Terminal Source RNS
CCT
CCT Character Group
16:55
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
16:55
Market

Transaction in Own Shares

Open Terminal Source RNS
FSTA
FSTA Fuller Smith & Turner
16:52
Market

Fuller, Smith & Turner PLC: Transaction in own shares

Open Terminal Source RNS
FCH
FCH Funding Circle Holdings PLC
16:48
Market

Funding Circle Holdings plc: POS-Transaction in Own Shares

Open Terminal Source RNS
SMIN
SMIN Smiths Group PLC
16:46
Market

Transaction in Own Shares

Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
16:45
Market

Transaction in Own Shares

Open Terminal Source RNS
IRSH
IRSH IRSH
16:41
Market

Banco Comercial Português, S.A. informs on notice of transaction of securities

Open Terminal Source RNS
FOXT
FOXT Foxtons Group Plc
16:41
Market

Transaction in Own Shares

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
16:40
Market

Transaction in Own Shares

Open Terminal Source RNS
SAV
SAV Savannah Resources Plc
16:38
Market

Retail Offer

Open Terminal Source RNS
SXS
SXS Spectris PLC
16:38
Market

Director Declaration

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
16:37
Market

Transaction in Own Shares

Open Terminal Source RNS
71LF
71LF 71LF
16:36
Market

ISM - MSBV - PARTIAL_RETIREMENT - 06th Nov 25

Open Terminal Source RNS
ELM
ELM Elementis PLC
16:35
Market

Transaction in Own Shares

Open Terminal Source RNS
NFG
NFG Next 15 Group PLC
16:34
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Shares

<mark style="background-coloryellow">Purchase</mark> of Shares
Open Terminal Source RNS
MONY
MONY MONY Group plc
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
SDP
SDP Schroder Asia Pacific Fund
16:31
Market

Transaction in Own Shares

Open Terminal Source RNS
83NF
83NF 83NF
16:31
Market

Final Terms

Open Terminal Source RNS
CBG
CBG Close Brothers Group plc
16:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
WKP
WKP Workspace Group PLC
16:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
NAIT
NAIT The North American Income T…
16:29
Market

Transaction in Own Shares

Open Terminal Source RNS
MTU
MTU Montanaro UK Smaller Compan…
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
SCP
SCP Schroder UK Mid Cap Fund PLC
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
SHEL
SHEL Shell plc
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
ARR
ARR Aurora Investment Trust plc
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
BGEO
BGEO Lion Finance Group PLC
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
ZEN
ZEN Zenith Energy Ltd
16:27
Market

Publication of UK Prospectus

Open Terminal Source RNS
DO72
DO72 DO72
16:26
Market

ISM - MSESE - RETIREMENT - 06th Nov 25

Open Terminal Source RNS
HWDN
HWDN Howden Joinery Group Plc
16:25
Market

Transaction in Own Shares

Open Terminal Source RNS
CGT
CGT Capital Gearing Trust
16:25
Market

Transaction in Own Shares

Open Terminal Source RNS
IBT
IBT International Biotechnology…
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
DO72
DO72 DO72
16:24
Market

ISM - MSESE - PARTIAL_RETIREMENT - 06th Nov 25

Open Terminal Source RNS
SJG
SJG Schroder Japan Growth Fund
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
SJG
SJG Schroder Japan Growth Fund
16:24
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
16:23
Market

Transaction in Own Shares

Open Terminal Source RNS
BHMG
BHMG BH Macro Limited
16:23
Market

Transaction in Own Shares

Open Terminal Source RNS
JCH
JCH JPMorgan Claverhouse Invest…
16:23
Market

Transaction in Own Shares

Open Terminal Source RNS
AFL
AFL Artemis UK Future Leaders p…
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
CGEO
CGEO Georgia Capital PLC
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
PCFT
PCFT Polar Capital Global Financ…
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
LABS
LABS Life Science REIT PLC
16:20
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Bank of America Corporation', '0.000000', 0]
Open Terminal Source RNS
RSE
RSE Riverstone Energy Ltd
16:20
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SSON
SSON Smithson Investment Trust P…
16:19
Market

Transaction in Own Shares

Open Terminal Source RNS
PCT
PCT Polar Capital Technology Tr…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
DGE
DGE Diageo PLC
16:18
Market

Result of AGM

Open Terminal Source RNS
JEDT
JEDT JPMorgan Euro Small Compani…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
SST
SST The Scottish Oriental Small…
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
SREI
SREI Schroder Real Estate Invest…
16:17
Market

QuotedData's In The HotSeat

Open Terminal Source RNS
FCSS
FCSS Fidelity China Special Situ…
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
FGT
FGT Finsbury Growth & Income Tr…
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
MTE
MTE Montanaro European Smaller …
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
BARC
BARC Barclays PLC
16:16
Market

Director/PDMR Shareholding

Open Terminal Source RNS
HSL
HSL Henderson Smaller Cos Inv T…
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
MYI
MYI Murray International Trust
16:15
Market

Transaction in Own Shares

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
16:15
Market

Transaction in Own Shares

Open Terminal Source RNS
JAM
JAM JPMorgan American Investmen…
16:13
Market

Transaction in Own Shares

Open Terminal Source RNS
BEMO
BEMO Baring Emerging Europe Plc
16:13
Market

Transaction in Own Shares

Open Terminal Source RNS
SAV
SAV Savannah Resources Plc
16:12
Market

Proposed Fundraise

Open Terminal Source RNS
JFJ
JFJ JPMorgan Japanese Investmen…
16:12
Market

Transaction in Own Shares

Open Terminal Source RNS
DIG
DIG Dunedin Income Growth Inves…
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
GLE
GLE MJ Gleeson plc
16:10
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AUSC
AUSC Abrdn UK Smaller Companies …
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
ANII
ANII Aberdeen New India Investme…
16:08
Market

Transaction in Own Shares

Open Terminal Source RNS
REL
REL Relx PLC
16:08
Market

Transaction in Own Shares

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
BNKR
BNKR Bankers Investment Trust
16:06
Market

Transaction in Own Shares

Open Terminal Source RNS
JMG
JMG JPMorgan Emerging Markets O…
16:06
Market

Transaction in Own Shares

Open Terminal Source RNS
HVO
HVO hVIVO plc
16:06
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
JGGI
JGGI JP Morgan Global Growth & I…
16:05
Market

Transaction in Own Shares

Open Terminal Source RNS
ALW
ALW Alliance Witan Ord
16:04
Market

Transaction in Own Shares

Open Terminal Source RNS
ATT
ATT Allianz Technology Trust PLC
16:04
Market

Transaction in Own Shares

Open Terminal Source RNS
FEV
FEV Fidelity European Values
16:03
Market

Transaction in Own Shares

Open Terminal Source RNS
JIGI
JIGI JPMorgan India Growth & Inc…
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IAG
IAG International Consolidated …
16:01
Market

Interim Dividend Declaration

Open Terminal Source RNS
JD.
JD. JD.
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
15:58
Market

Transaction in Own Shares

Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
15:58
Market

Transaction in Own Shares

Open Terminal Source RNS
TEM
TEM Templeton Emerging Markets …
15:57
Market

Transaction in Own Shares

Open Terminal Source RNS
SREI
SREI Schroder Real Estate Invest…
15:57
Market

QuotedData's In The HotSeat

Open Terminal Source RNS
HGEN
HGEN Hydrogenone Capital Growth …
15:56
Market

Portfolio Update - Bramble Energy Limited

Open Terminal Source RNS
CMCX
CMCX CMC Markets PLC
15:56
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BGUK
BGUK Baillie Gifford UK Growth F…
15:54
Market

Transaction in Own Shares

Open Terminal Source RNS
FRGT
FRGT Franklin Global Trust Ord
15:53
Market

Transaction in Own Shares

Open Terminal Source RNS
SAIN
SAIN Scottish American Investmen…
15:53
Market

Transaction in Own Shares

Open Terminal Source RNS
ASL
ASL Aberforth Smaller Companies…
15:51
Market

Transaction in Own Shares

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
15:50
Market

Transaction in Own Shares

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
15:50
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
FCIT
FCIT F&C Investment Trust PLC
15:50
Market

Transaction in Own Shares

Open Terminal Source RNS
IBT
IBT International Biotechnology…
15:50
Market

Results analysis from Kepler Trust Intelligence

Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
15:50
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
GSCT
GSCT The Global Smaller Companie…
15:48
Market

Transaction in Own Shares

Open Terminal Source RNS
SMT
SMT Scottish Mortgage Investmen…
15:47
Market

Transaction in Own Shares

Open Terminal Source RNS
BGFD
BGFD Baillie Gifford Japan Trust
15:47
Market

Transaction in Own Shares

Open Terminal Source RNS
MWY
MWY Mid Wynd International Inve…
15:47
Market

Transaction in Own Shares

Open Terminal Source RNS
ATN
ATN Eastinco Mining & Explorati…
15:46
Market

Share Capital Increase

Open Terminal Source RNS
BRAI
BRAI BlackRock American Income T…
15:45
Market

Disclosure of Portfolio Holdings

Open Terminal Source RNS
BP.
BP. BP.
15:43
Market

Transaction in Own Shares

Open Terminal Source RNS
EOT
EOT European Opportunities Trus…
15:38
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['1607 Capital Partners, LLC', '10.104435', '9.413053']
Open Terminal Source RNS
WIZZ
WIZZ Wizz Air Holdings PLC
15:34
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold ', '0.040000']
Open Terminal Source RNS
33JE
33JE 33JE
15:33
Market

Cancellation of Securities - Replacement

Open Terminal Source RNS
BIPS
BIPS Invesco Bond Income Plus Li…
15:33
Market

Issue of Equity

Open Terminal Source RNS
UTL
UTL UIL Ltd
15:31
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
THRU
THRU Thruvision Group PLC
15:31
Market

Block listing Interim Review

Open Terminal Source RNS
THRU
THRU Thruvision Group PLC
15:31
Market

Block listing Interim Review

Open Terminal Source RNS
EWI
EWI Edinburgh Worldwide Investm…
15:29
Market

Transaction in Own Shares

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
15:27
Market

Form 8.3

Open Terminal Source RNS
IRSH
IRSH IRSH
15:22
Market

Stabilisation Notice-New Immo Holding

Open Terminal Source RNS
PCIP
PCIP PCI-PAL PLC
15:21
Market

Annual Financial Report & Notice of AGM

Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
15:16
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Helikon Investments Limited', '0.000000', '0.000000']
Open Terminal Source RNS
HSBA
HSBA HSBC Holdings PLC
15:16
Market

Issuance of senior unsecured notes

Open Terminal Source RNS
IRSH
IRSH IRSH
15:14
Market

Stabilisation Notice-Verallia SA Dual Tranche

Open Terminal Source RNS
FDM
FDM FDM Group Holdings PLC
15:06
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
MTU
MTU Montanaro UK Smaller Compan…
15:04
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['IntegraFin Holdings plc', '3.010000', 0]
Open Terminal Source RNS
CPI
CPI Capita PLC
15:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '7.113778', '6.625642']
Open Terminal Source RNS
SDY
SDY Speedy Hire PLC
15:01
Market

Commercial Agreement & Equity Subscription

**Summary:** Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiar…

**Summary**
Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital.
The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
Agreement
Open Terminal Source RNS
HSS
HSS HSS Hire Group PLC
15:01
Market

Results of General Meeting

Open Terminal Source RNS
KIE
KIE Kier Group PLC
15:00
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
DAL
DAL Dalata Hotel Group plc
14:59
Market

Dalata Hotel Group PLC: HOL-Holding(s) in Company

TR1 Buy

TR1 Buy
['Qube Research & Technologies Limited', '0', 0]
Open Terminal Source RNS
MTLN
MTLN Metlen Energy & Metals PLC
14:57
Market

LAUNCH OF “THE THIRD ERA - PROGRESS IN MOTION”

Open Terminal Source RNS
RIII
RIII Rights and Issues Investmen…
14:57
Market

Annual Overview from QuotedData

Open Terminal Source RNS
DFCH
DFCH Distribution Finance Capita…
14:53
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
AJOT
AJOT AVI Japan Opportunity Trust…
14:50
Market

Result of Meeting

Open Terminal Source RNS
PHNX
PHNX Phoenix Group Holdings PLC
14:48
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CRW
CRW Craneware Plc
14:42
Market

Reduction of Capital confirmed

Open Terminal Source RNS
SXS
SXS Spectris PLC
14:35
Market

Form 8.3

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
14:33
Market

Form 8.3

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
JTC
JTC JTC PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
14:26
Market

Form 8.3

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
DAL
DAL Dalata Hotel Group plc
14:26
Market

Form 8.3

Open Terminal Source RNS
TRN
TRN Trainline Plc
14:24
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
TTG
TTG TT Electronics Plc
14:23
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
IRSH
IRSH IRSH
14:21
Market

Davidson Kempner Capital Management LP : Form 8.3 - Spectris plc

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
14:20
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FIL Limited', '9.978500', '10.000000']
Open Terminal Source RNS
FA26
FA26 FA26
14:20
Market

Notice to Noteholders

Open Terminal Source RNS
BATS
BATS British American Tobacco PLC
14:16
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of ordinary shares under the Partnership Share Scheme - a HMRC approved Share Incentive Plan

<mark style="background-coloryellow">Purchase</mark> of ordinary shares under the Partnership Share Scheme - a HMRC approved Share Incentive Plan
Open Terminal Source RNS
ENT
ENT Entain PLC
14:11
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CWR
CWR Ceres Power Holdings PLC
14:11
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['BNP Paribas Asset Management UK Limited', '2.694800', '3.250800']
Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:10
Market

Form 8.3

Open Terminal Source RNS
SDR
SDR Schroders PLC
14:05
Market

Form 8.3 - Bluefield Solar Income Fund Limited

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
14:01
Market

Form 8.3

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
14:01
Market

Form 8.3

Open Terminal Source RNS
IPF
IPF International Personal Fina…
14:01
Market

Form 8.3

Open Terminal Source RNS
0QPR
0QPR Cicor Technologies Ltd.
14:01
Market

Form 8.3

Open Terminal Source RNS
GNC
GNC Greencore Group
14:01
Market

Form 8.3

Open Terminal Source RNS
IDOX
IDOX IDOX plc
14:01
Market

Form 8.3

Open Terminal Source RNS
JUST
JUST Just Group plc
14:01
Market

Form 8.3

Open Terminal Source RNS
IDOX
IDOX IDOX plc
14:01
Market

Form 8.3

Open Terminal Source RNS
SXS
SXS Spectris PLC
14:01
Market

Form 8.3

Open Terminal Source RNS
IQE
IQE IQE PLC
14:01
Market

IQE plc: Rule 2.9 Announcement

Open Terminal Source RNS
HSBA
HSBA HSBC Holdings PLC
14:01
Market

Total Voting Rights

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:57
Market

Irish Form 8.3 DALATA HOTEL GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:57
Market

Form 8.3 UNITE GROUP PLC, THE

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:57
Market

Form 8.3 BAKKAVOR GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:57
Market

Form 8.3 EMPIRIC STUDENT PROPERTY PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 GREENCORE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 NCC GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 JUST GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 JTC PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 SPIRE HEALTHCARE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:56
Market

Form 8.3 PETERSHILL PARTNERS PLC

Open Terminal Source RNS
SST
SST The Scottish Oriental Small…
13:55
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
SAIN
SAIN Scottish American Investmen…
13:52
Market

Dividend Declaration

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
13:48
Market

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated

Open Terminal Source RNS
KP2
KP2 Kore Potash Plc
13:46
Market

Rule 2.9 Announcement

Open Terminal Source RNS
JTC
JTC JTC PLC
13:45
Market

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Open Terminal Source RNS
DAL
DAL Dalata Hotel Group plc
13:44
Market

Form 8.3

Open Terminal Source RNS
IRSH
IRSH IRSH
13:43
Market

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Open Terminal Source RNS
IRSH
IRSH IRSH
13:42
Market

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc

Open Terminal Source RNS
GNC
GNC Greencore Group
13:41
Market

Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc

Open Terminal Source RNS
BSIF
BSIF Bluefield Solar Income Fund
13:39
Market

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited

Open Terminal Source RNS
SPI
SPI Spire Healthcare Group Plc
13:38
Market

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
13:37
Market

Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
13:35
Market

Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc

Open Terminal Source RNS
ASHM
ASHM Ashmore Group Plc
13:35
Market

Result of AGM

Open Terminal Source RNS
FCIT
FCIT F&C Investment Trust PLC
13:34
Market

Dividend Declaration

Open Terminal Source RNS
88CS
88CS 88CS
13:34
Market

Publication of Final Terms

Open Terminal Source RNS
ESP
ESP Empiric Student Property Plc
13:34
Market

Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc

Open Terminal Source RNS
PHLL
PHLL Petershill Partners PLC
13:32
Market

Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc

Open Terminal Source RNS
LIO
LIO Liontrust Asset Management
13:31
Market

Form 8.3 - JTC PLC

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
13:31
Market

Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc

Open Terminal Source RNS
JUST
JUST Just Group plc
13:29
Market

Form 8.3 - The Vanguard Group, Inc.: Just Group plc

Open Terminal Source RNS
IPF
IPF International Personal Fina…
13:28
Market

Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc

Open Terminal Source RNS
NCC
NCC NCC Group plc
13:27
Market

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Open Terminal Source RNS
UTG
UTG Unite Group PLC
13:25
Market

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The

Open Terminal Source RNS
81RX
81RX 81RX
13:24
Market

Issue of Debt

Open Terminal Source RNS
SXS
SXS Spectris PLC
13:24
Market

Form 8.3 - The Vanguard Group, Inc.: Spectris plc

Open Terminal Source RNS
BYG
BYG Big Yellow Group PLC
13:23
Market

Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc

Open Terminal Source RNS
DAL
DAL Dalata Hotel Group plc
13:20
Market

Dalata Hotel Group PLC: HOL-Holding(s) in Company

TR1 Buy

TR1 Buy
['The Goldman Sachs Group, Inc.', '4.80', '5.04']
Open Terminal Source RNS
JUST
JUST Just Group plc
13:19
Market

Form 8.3

Open Terminal Source RNS
OPT
OPT Optima Health plc
13:18
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
ENOG
ENOG Energean Oil & Gas PLC
13:18
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SXS
SXS Spectris PLC
13:12
Market

Form 8.3

Open Terminal Source RNS
BZT
BZT Bezant Resources Plc
13:05
Market

Exercise of Warrants and TVR

Open Terminal Source RNS
MLHL
MLHL Malibu Life Holdings Limited
13:02
Market

PDMR Announcement

Open Terminal Source RNS
BGFD
BGFD Baillie Gifford Japan Trust
12:59
Market

Annual Financial Report

Open Terminal Source RNS
0UKH
0UKH Bank of Montreal
12:58
Market

Form 8.3 - Dalata Hotel Group PLC

Open Terminal Source RNS
ESP
ESP Empiric Student Property Plc
12:57
Market

Form 8.3

Open Terminal Source RNS
HUW
HUW Helios Underwriting PLC
12:52
Market

Director/PDMR Shareholding

Open Terminal Source RNS
UTG
UTG Unite Group PLC
12:52
Market

Form 8.3

Open Terminal Source RNS
QED
QED Quadrise Plc
12:47
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CTPE
CTPE CT Private Equity Trust PLC
12:45
Market

Professional Investor Presentation

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:44
Market

Form 8.3 - Idox

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:43
Market

Form 8.3 - Empiric Student Property Plc

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:42
Market

Form 8.3 - Bluefield Solar Income Fund Ltd

Open Terminal Source RNS
UTG
UTG Unite Group PLC
12:35
Market

Form 8.3

Open Terminal Source RNS
KRPZ
KRPZ Kropz Plc
12:32
Market

Results of General Meeting

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
12:32
Market

Form 8.3

Open Terminal Source RNS
SXS
SXS Spectris PLC
12:30
Market

Form 8.3

Open Terminal Source RNS
ESP
ESP Empiric Student Property Plc
12:28
Market

Form 8.3

Open Terminal Source RNS
GNC
GNC Greencore Group
12:26
Market

Form 8.3

Open Terminal Source RNS
JUST
JUST Just Group plc
12:24
Market

Form 8.3

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
12:24
Market

Form 8.3

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:17
Market

Form 8.3 - Unite Group plc, The

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
12:02
Market

Amundi Physical Metals plc: Final Terms

Open Terminal Source RNS
CCC
CCC Computacenter PLC
12:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
11:58
Market

Doc re. Annual Report

Open Terminal Source RNS
ZEG
ZEG Zegona Communications Plc
11:58
Market

Cancellation of Share Premium Account

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
11:57
Market

Amundi Physical Metals plc: UK Final Terms

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
11:52
Market

Amundi Physical Metals plc: Final Terms

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
11:49
Market

Amundi Physical Metals plc: UK Final Terms

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
11:38
Market

Director/PDMR Shareholding

Open Terminal Source RNS
OVCT
OVCT New Century AIM VCT 2 PLC
11:33
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
MNG
MNG M&G Plc
11:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
IRSH
IRSH IRSH
11:29
Market

Form 8.3 - Spectris plc

Open Terminal Source RNS
OVCT
OVCT New Century AIM VCT 2 PLC
11:29
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Vivienne Poutney', '4.64', '5.49']
Open Terminal Source RNS
IRSH
IRSH IRSH
11:28
Market

Form 8.3 - Qualcomm Incorporated

Open Terminal Source RNS
PSH
PSH Pershing Square Holdings Ltd
11:26
Market

Dividend Declaration

Open Terminal Source RNS
IRSH
IRSH IRSH
11:24
Market

Form 8.3 - American Axle & Manufacturing Holdings

Open Terminal Source RNS
IRSH
IRSH IRSH
11:22
Market

Form 8.3 - Bakkavor Group Plc

Open Terminal Source RNS
GJ03
GJ03 GJ03
11:16
Market

Form 8.5 (EPT/RI)- Replacement of Alphawave

Open Terminal Source RNS
GJ03
GJ03 GJ03
11:12
Market

Form 8.5 (EPT/RI)- Replacement of Aqua Acquisition

Open Terminal Source RNS
MGCI
MGCI M&G Credit Income Investmen…
11:09
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Shares

<mark style="background-coloryellow">Purchase</mark> of Shares
Open Terminal Source RNS
TIME
TIME Time Finance PLC
11:08
Market

Result of AGM

Open Terminal Source RNS
IRSH
IRSH IRSH
11:08
Market

Form 8.3 - Dowlais Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:07
Market

Form 8.3 - Petershill Partners plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:04
Market

Form 8.3 - Just Group plc

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
11:01
Market

Form 8.3 - Bluefield Solar Income Fund Limited

Open Terminal Source RNS
TAVI
TAVI Tavistock Investments Plc
11:01
Market

Result of AGM

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:00
Market

Form8.5EPT/NonRIAQUAACQUISITIONSUBLLC

Open Terminal Source RNS
IRSH
IRSH IRSH
10:57
Market

Form 8.3 - Spectris - Replacement

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
10:54
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['JPMorgan Chase & Co.', '6.007391', '6.268471']
Open Terminal Source RNS
API
API abrdn Property Income Trust…
10:53
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '5.952788']
Open Terminal Source RNS
JDW
JDW J D Wetherspoon PLC
10:45
Market

Director/PDMR Shareholding

Open Terminal Source RNS
LSC
LSC London Security Plc
10:40
Market

Dividend Declaration

Open Terminal Source RNS
REC
REC Record PLC
10:33
Market

Investor Presentation via Investor Meet Company

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
10:33
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
CLX
CLX Calnex Solutions Plc
10:31
Market

Calnex and Viavi Partnership

**Summary:** Calnex Solutions plc (AIM: CLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing…

**Summary**
Calnex Solutions plc (AIMCLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards.
The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions.
Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
Partner
Open Terminal Source RNS
PCFT
PCFT Polar Capital Global Financ…
10:18
Market

Top Fifteen Equity Holdings and Exposures

Open Terminal Source RNS
0QPR
0QPR Cicor Technologies Ltd.
10:18
Market

Form 8.3

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
10:17
Market

Final Terms

Open Terminal Source RNS
CPI
CPI Capita PLC
10:16
Market

Director/PDMR Shareholding

b) Nature of the transaction Monthly share <mark style="background-color:yellow">purchase</mark> under the Capita Share Ownership Plan

b) Nature of the transaction Monthly share <mark style="background-color:yellow">purchase</mark> under the Capita Share Ownership Plan
Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
10:15
Market

Result of General Meeting

Open Terminal Source RNS
APN
APN Applied Nutrition Plc
10:12
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
10:11
Market

Final Terms

Open Terminal Source RNS
BNC
BNC Banco Santander S.A.
10:09
Market

Buyback programme: transactions 30Oct-5nov

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
10:07
Market

Form 8.3

Open Terminal Source RNS
GWI
GWI Globalworth REIT
10:05
Market

Appointment of Joint CEOs

Open Terminal Source RNS
LSEG
LSEG London Stock Exchange Group…
10:01
Market

LSEG Announces Strategic Partnership with Nasdaq®

**Summary:** On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets…

**Summary**
On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape.
The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization.
LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
Partner
Open Terminal Source RNS
IHG
IHG InterContinental Hotels Gro…
10:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
FDR
FDR First Development Resources…
09:59
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BNC
BNC Banco Santander S.A.
09:56
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:53
Market

Form8.5EPT/NonRIAMERICANAXLE&MANUFACTURINGHOLDINGS

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:53
Market

Form 8.5 EPT/Non RI DOWLAIS GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:53
Market

Form 8.5 EPT/Non RI BIG YELLOW GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:53
Market

Form 8.5 EPT/Non RI ALPHAWAVE IP GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:53
Market

Form 8.5 EPT/Non RI SPECTRIS PLC

Open Terminal Source RNS
JAR
JAR Jardine Matheson Holdings L…
09:49
Market

Transaction in Own Shares

Open Terminal Source RNS
0UKH
0UKH Bank of Montreal
09:40
Market

Form 8 (DD) - Qualcomm Inc

Open Terminal Source RNS
0UKH
0UKH Bank of Montreal
09:38
Market

Form 8 (DD) - Qualcomm Inc

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
09:33
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AMIF
AMIF Amicorp FS (UK) PLC
09:25
Market

Bonus Issue

Open Terminal Source RNS
DO72
DO72 DO72
09:24
Market

Stabilisation Notice

Open Terminal Source RNS
PRSR
PRSR PRS Reit PLC
09:23
Market

TR-1 Notification

TR1 Buy

TR1 Buy
Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
09:23
Market

Annual Financial Report and Notice of AGM 2025

Open Terminal Source RNS
MNG
MNG M&G Plc
09:20
Market

Form 8.3 - Spire Healthcare Group plc

Open Terminal Source RNS
TRIG
TRIG Renewables Infrastructure G…
09:20
Market

Dividend Declaration

Open Terminal Source RNS
AFRK
AFRK Afarak Group Oyj
09:16
Market

ANOTHER FIN-FSA RELEASE IN THE MATTER AGAINST DR DANKO KONCAR

Open Terminal Source RNS
AFRK
AFRK Afarak Group Oyj
09:16
Market

FINANSSIVALVONNAN PÄÄTÖS DANKO KONCARIA KOSKEVASSA ASIASSA

Open Terminal Source RNS
LAND
LAND Land Securities Group PLC
09:16
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ARS
ARS Asiamet Resources Limited
09:14
Market

Sale of Asiamet’s Interest in the KSK Project

Open Terminal Source RNS
NLB
NLB Nova Ljubljanska Banka d.d.
09:11
Market

3rd Quarter Results

Open Terminal Source RNS
ECOR
ECOR Ecora Resources PLC
09:10
Market

Director Share Dealings in Company

Open Terminal Source RNS
HILS
HILS Hill & Smith Holdings PLC
09:08
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
ALL
ALL Atlantic Lithium Ltd
09:08
Market

Result of Extraordinary General Meeting

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
09:05
Market

Form 8.3

Open Terminal Source RNS
PDL
PDL Petra Diamonds Ltd
09:03
Market

Results of Special General Meeting

Open Terminal Source RNS
SPEC
SPEC Inspecs Group plc
09:03
Market

Form 8.3

Open Terminal Source RNS
NCC
NCC NCC Group plc
09:02
Market

Form 8.3

Open Terminal Source RNS
DOM
DOM Domino’s Pizza Group PLC
09:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Bank of Montreal', '3.013806', 0]
Open Terminal Source RNS
QLT
QLT Quilter PLC
09:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Public Investment Corporation SOC Limited', '10.328000', '9.811000']
Open Terminal Source RNS
VANL
VANL Van Elle Holdings PLC
08:54
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
PRU
PRU Prudential plc
08:52
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Norges Bank', '3.974210', '4.991400']
Open Terminal Source RNS
GJ03
GJ03 GJ03
08:47
Market

Form 8.5 (EPT/RI) - Aqua Acquisition Sub LLC

Open Terminal Source RNS
HHPD
HHPD Hon Hai Precision Industry …
08:39
Market

FII to hold 2025Q3 performance conference

Open Terminal Source RNS
DO72
DO72 DO72
08:36
Market

Form 8.5 (EPT/NON-RI) - Aqua Acquisition Sub LLC

Open Terminal Source RNS
CRH
CRH CRH PLC
08:31
Market

Transaction in Own Shares

Open Terminal Source RNS
0R3T
0R3T UBS Group AG
08:31
Market

UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities

**Summary:** UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on …

**Summary**
UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
Offers
Open Terminal Source RNS
HKLD
HKLD HONGKONG LAND HLDGS
08:21
Market

Transaction in Own Shares

Open Terminal Source RNS
HHPD
HHPD Hon Hai Precision Industry …
08:14
Market

Explain media reporting

Open Terminal Source RNS
UPLL
UPLL UPL Ltd. GDR
08:03
Market

2nd Quater results- September 2025

Open Terminal Source RNS
ALRT
ALRT Defence Holdings Plc
08:01
Market

Oracle and Defence Technologies Collaborate to Deliver AI Innovation

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
07:57
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['JPMorgan Chase & Co.', '6.268471', '6.908110']
Open Terminal Source RNS
RWA
RWA Robert Walters
07:56
Market

BLOCK LISTING SIX-MONTHLY RETURN

Open Terminal Source RNS
IRSH
IRSH IRSH
07:54
Market

Half-year Financial Report

Open Terminal Source RNS
WATR
WATR Water Intelligence plc
07:49
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
OTES
OTES HELLENIC TELECOMMUNICATIONS…
07:44
Market

UFBB Project

Open Terminal Source RNS
DO72
DO72 DO72
07:43
Market

Rule 38.5_B - Avadel Pharmaceuticals plc

Open Terminal Source RNS
IRSH
IRSH IRSH
07:39
Market

Stabilisation Notice-Verallia SA Dual Tranche

Open Terminal Source RNS
GJ03
GJ03 GJ03
07:31
Market

Rule 38.5_A - Avadel Pharmaceuticals plc

Open Terminal Source RNS
GJ03
GJ03 GJ03
07:25
Market

Form 8.5 (EPT/RI) - Alphawave IP Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
07:24
Market

Stabilisation Notice-New Immo Holding

Open Terminal Source RNS
DO72
DO72 DO72
07:23
Market

Form 8.5 (EPT/NON-RI) - Alphawave IP Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
07:19
Market

Form 8.3 - Dalata Hotel Group PLC

Open Terminal Source RNS
INVP
INVP Investec PLC
07:05
Market

Form 8.5 (EPT/RI)-NCC Group plc

Open Terminal Source RNS
INVP
INVP Investec PLC
07:03
Market

Form 8.5 (EPT/RI)-Dowlais Group plc

Open Terminal Source RNS
RCN
RCN Redcentric
07:01
Market

SAYE Share Option Scheme

Open Terminal Source RNS
48CF
48CF 48CF
07:01
Market

Post Stabilisation Notice

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
06:33
Market

Director Declaration

Open Terminal Source RNS
GROW
GROW Draper Esprit PLC
06:31
Market

Transaction in Own Shares

Open Terminal Source RNS
FA16
FA16 FA16
06:31
Market

Publication of Form 10-Q

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
06:31
Market

Transaction in Own Shares

Open Terminal Source RNS
AGY
AGY Allergy Therapeutics
06:23
Market

Company to Evaluate Dual Listing on HKEX

Open Terminal Source RNS
FSV
FSV Fidelity Special Values
06:16
Market

Dividend Declaration

Open Terminal Source RNS
BARC
BARC Barclays PLC
06:16
Market

Transaction in Own Shares

Open Terminal Source RNS
0A3D
0A3D iShares VII Public Limited …
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3E
0A3E 0A3E
06:11
Market

Net Asset Value

Open Terminal Source RNS
CMB1
CMB1 iShares FTSE MIB UCITS
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3G
0A3G 0A3G
06:11
Market

Net Asset Value

Open Terminal Source RNS
BBY
BBY Balfour Beatty plc
06:11
Market

Transaction in Own Shares

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
06:06
Market

OSB GROUP PLC - Transaction in Own Shares

Open Terminal Source RNS
SEE
SEE Seeing Machines Limited
06:06
Market

Collaboration with Magna milestone in China

Open Terminal Source RNS
CTEC
CTEC ConvaTec Group PLC
06:06
Market

Transaction in Own Shares

Open Terminal Source RNS
TRST
TRST Trustpilot Group PLC
06:06
Market

Transaction in Own Shares

Open Terminal Source RNS
NESF
NESF NextEnergy Solar Fund Ltd
06:02
Market

Notice of Interim Results

Open Terminal Source RNS
SN.
SN. SN.
06:02
Market

Directorate change

Open Terminal Source RNS
SFOR
SFOR S4 Capital PLC
06:02
Market

Total Voting Rights

Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
06:02
Market

Helios Towers Share Buyback Programme

**Summary:** Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the company…

**Summary**
Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
BuyBack
Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
06:02
Market

Helios Towers Capital Markets Day

Open Terminal Source RNS
0A3F
0A3F 0A3F
06:01
Market

Net Asset Value(s)

Open Terminal Source RNS
GROW
GROW Draper Esprit PLC
06:01
Market

Further partial realisation of holding in Revolut

Open Terminal Source RNS
CMET
CMET Capital Metals PLC
06:01
Market

Industry Conference Presentation

Open Terminal Source RNS
HERC
HERC Hercules Site Services PLC
06:01
Market

Hercules Academy Update

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
06:01
Market

Investor Webinar: 10th November 2025 3:00 p.m.

Open Terminal Source RNS
BIPS
BIPS Invesco Bond Income Plus Li…
06:01
Market

Kepler Trust Intelligence: New Research

Open Terminal Source RNS
FCSS
FCSS Fidelity China Special Situ…
06:01
Market

Kepler Trust Intelligence: New Research

Open Terminal Source RNS
PLSR
PLSR Pulsar Helium Inc.
06:01
Market

Warrant Exercise by Major Investor Proceeds C$5.6M

Open Terminal Source RNS
AURA
AURA Aura Energy Ltd
06:01
Market

Swedish Parliament votes to overturn uranium ban

Open Terminal Source RNS
SAVE
SAVE Savannah Energy PLC
06:01
Market

Notice of General Meeting

Open Terminal Source RNS
SYME
SYME Supply@Me Capital PLC
06:01
Market

Notice of AGM

Open Terminal Source RNS
QUBE
QUBE Quantum Base Holdings PLC
06:01
Market

Notice of AGM

Open Terminal Source RNS
CML
CML CML Microsystems Plc
06:01
Market

Exercise of Options and Total Voting Rights

Open Terminal Source RNS
LSL
LSL LSL Property Services Plc
06:01
Market

Transaction in own shares and Total Voting Rights

Open Terminal Source RNS
KP2
KP2 Kore Potash Plc
06:01
Market

CDI Monthly Movement

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
06:01
Market

Share repurchase programme

Open Terminal Source RNS
ABDX
ABDX Abingdon Health Plc
06:01
Market

Launch of seaweed-based lateral flow housings

**Summary:** Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to tra…

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
Launch
Open Terminal Source RNS
IGR
IGR IG Design Group plc
06:01
Market

Notice of Investor Presentation

Open Terminal Source RNS
LDG
LDG Logistics Development Group…
06:01
Market

Appointment of Corporate Broker

Open Terminal Source RNS
TAND
TAND Tan Delta Systems PLC
06:01
Market

Phase 2 trial with global online retailer

Open Terminal Source RNS
CRS
CRS Crystal Amber Fund Limited
06:01
Market

Notice of AGM

Open Terminal Source RNS
NLB
NLB Nova Ljubljanska Banka d.d.
06:01
Market

Notice of GM

Open Terminal Source RNS
KIE
KIE Kier Group PLC
06:01
Market

Wanlip Water Treatment Works Site Visit

Open Terminal Source RNS
VALT
VALT Valterra Platinum Limited
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ASAI
ASAI ASA International Group PLC
06:01
Market

CFO Appointment

Open Terminal Source RNS
EMBE
EMBE iShares J.P. Morgan Emergin…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
FIPP
FIPP Frontier IP Group Plc
06:01
Market

Bord Change

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
06:01
Market

Rule 2.9 Announcement

Open Terminal Source RNS
DPA
DPA DP Aircraft I Limited
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CYK
CYK Cykel AI PLC
06:01
Market

TR1 - Standard notification of major holdings

TR1 Buy

TR1 Buy
['Toro Consulting Limited', '3.78', '5.70']
Open Terminal Source RNS
CTEC
CTEC ConvaTec Group PLC
06:01
Market

CEO and CFO appointments

Open Terminal Source RNS
BUR
BUR Burford Capital Limited
06:01
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['BlackRock, Inc.', '4.68', 'Below 5']
Open Terminal Source RNS
PEY
PEY Princess Private Equity Hol…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
FAIR
FAIR Fair Oaks Income Limited
06:01
Market

Dividend Declaration

Open Terminal Source RNS
NESF
NESF NextEnergy Solar Fund Ltd
06:01
Market

Interim Dividend Declaration

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
06:01
Market

Declaration of 3Q 2025 Quarterly Dividend

Open Terminal Source RNS
SOHO
SOHO Triple Point Social Housing…
06:01
Market

Appointment of Non-Executive Directors

Open Terminal Source RNS
RPI
RPI Raspberry Pi Holdings PLC
06:01
Market

Notification of Transactions by PDMR

Open Terminal Source RNS
DBRC
DBRC iShares BRIC 50 UCITS
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDAR
IDAR iShares Asia Property Yield…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDTM
IDTM iShares II Public Limited C…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IGTM
IGTM iShares $ Treasury Bond 7-1…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IEMB
IEMB iShares J.P. Morgan $ EM Bo…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
EMHG
EMHG iShares J.P. Morgan $ EM Bo…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IGLT
IGLT iShares Core UK Gilts UCITS
06:01
Market

Dividend Declaration

Open Terminal Source RNS
DH2O
DH2O iShares Global Water UCITS
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDIN
IDIN iShares Global Infrastructu…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
INXG
INXG iShares £ Index-Linked Gilt…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDPE
IDPE iShares Listed Private Equi…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ISDE
ISDE iShares MSCI Emerging Marke…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ISFE
ISFE iShares MSCI AC Far East ex…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ISDU
ISDU iShares MSCI USA Islamic UC…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ISDW
ISDW iShares MSCI World Islamic …
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDTK
IDTK iShares MSCI Turkey UCITS E…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ITPG
ITPG iShares II Public Limited C…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IUKP
IUKP iShares UK Property UCITS
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDUP
IDUP iShares US Property Yield U…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IDWP
IDWP iShares Developed Markets P…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
DPYG
DPYG iShares Developed Markets P…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
DLTM
DLTM iShares II Public Limited C…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IHYU
IHYU iShares High Yield Corporat…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IHYE
IHYE iShares $ High Yield Corp B…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IHHG
IHHG iShares $ High Yield Corp B…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IUAG
IUAG iShares US Aggregate Bond U…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
IUGA
IUGA iShares US Aggregate Bond U…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
QDIV
QDIV iShares MSCI USA Dividend I…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
SUSU
SUSU iShares $ Corp Bond SRI 0-3…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
SGSU
SGSU iShares $ Corp Bond 0-3yr E…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
TIP5
TIP5 iShares $ TIPS 0-5 UCITS Di…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
TI5G
TI5G iShares $ TIPS 0-5 UCITS ET…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
WQDV
WQDV iShares MSCI World Quality …
06:01
Market

Dividend Declaration

Open Terminal Source RNS
FLOT
FLOT iShares II Public Limited C…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
0FLE
0FLE 0FLE
06:01
Market

Dividend Declaration

Open Terminal Source RNS
FLOS
FLOS iShares $ Floating Rate Bon…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
SUOE
SUOE iShares € Corp Bond ESG UCI…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
SUOG
SUOG iShares € Corp Bond ESG UCI…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
EMES
EMES iShares J.P. Morgan ESG $ E…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
DHYG
DHYG iShares $ High Yield Corp B…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
SUOP
SUOP iShares $ Corp Bond ESG UCI…
06:01
Market

Dividend Declaration

Open Terminal Source RNS
ULTP
ULTP Ultimate Products Plc
06:01
Market

Grant of Options under the Employee Share Scheme

Open Terminal Source RNS
RS1
RS1 RS GROUP PLC
06:01
Market

Half-year Financial Report

**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)** **Financial Performance Highlights:** - **Revenue:** £1,403 million, down 3% year-on-year; like-for-like down 1%, with growth in Q2. - **Adjusted Operating Profit:** £122…

**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)**
**Financial Performance Highlights**
**Revenue:** £1403 milliondown 3% year-on-year
like-for-like down 1%with growth in Q2.
**Adjusted Operating Profit** £122 million, down 8% year-on-year
like-for-like down 7%.
**Operating Profit Margin:** 8.7%down 0.5 percentage points.
**Profit Before Tax:** £112 millionup 7% year-on-year.
**Basic Earnings Per Share:** 17.7pup 8% year-on-year.
**Interim Dividend:** 8.7pup 2%.
**Key Performance Indicators**
**Gross Margin** Improved by 0.4 percentage points to 43.1%.
**Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target.
**Net Debt** Reduced by £31 million to £333 million.
**Net Debt to Adjusted EBITDA** Improved to 1.0x from 1.3x.
**Strategic and Operational Progress**
**Restructuring Benefits** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023.
**Growth Accelerators** RS PRO like-for-like revenue up 4%
Service solutions up 7%.
**Organic Investment** £19 million in H1 2025/26, part of planned £35-£40 million for the full year.
**Regional Performance**
**EMEA** Revenue down 2% like-for-like
operating profit down 9%.
**Americas** Revenue up 1% like-for-like
operating profit down 9%.
**Asia Pacific** Revenue up 4% like-for-like
operating profit up 42%.
**Full Year Outlook**
Unchanged, with expectations of slight gross margin improvement and continued cost management.
Capital expenditure forecast at around £50 million.
Progressive dividend policy maintained.
**Sustainability and ESG**
**Better World Product Range** Expanded to over 33,000 products.
**Emissions Intensity** Reduced by 35% from the 2019/20 baseline.
**Employee Engagement** Increased to 73%.
**Going Concern and Risks**
The Board has assessed the Groups ability to continue as a going concern for at least 12 months.
Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change.
**Conclusion**
RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
Here is the HTML table code comparing the financials and debt year on year for RS Group PLC:
MetricH1 2025/26H1 2024/25Change
Revenue£1,403m£1,441m(3%)
Adjusted operating profit£122m£133m(8%)
Adjusted operating profit margin8.7%9.2%(0.5) pts
Adjusted profit before tax£112m£118m(6%)
Adjusted basic earnings per share17.6p18.5p(5%)
Net debt£(333)m£(437)m£104m improvement
Net debt to adjusted EBITDA1.0x1.3x0.3x improvement
**Key takeaways:** * **Revenue decline:** Revenue decreased by 3% year-on-year, primarily due to a 1% like-for-like decline and adverse currency movements. * **Profit margin compression:** Adjusted operating profit margin decreased by 0.5 percentage points due to increased investment in strategic initiatives. * **Improved debt position:** Net debt decreased significantly by £104 million, leading to a lower net debt to adjusted EBITDA ratio, indicating improved financial health. This table provides a concise comparison of key financial metrics and debt levels for RS Group PLC between H1 2025/26 and H1 2024/25.
Open Terminal Source RNS
SXS
SXS Spectris PLC
06:01
Market

Rule 2.9 Announcement

Open Terminal Source RNS
BLOE
BLOE Block Energy PLC
06:01
Market

Fundraise and Operations Update

Open Terminal Source RNS
FRMI
FRMI FRMI
06:01
Market

Advance in Aid of Construction Agreement

Open Terminal Source RNS
HBR
HBR Harbour Energy PLC
06:01
Market

Trading and Operations Update

Open Terminal Source RNS
WISE
WISE Wise plc
06:01
Market

FY26 Half Year Results

**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)** Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partners…

**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)**
Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include
### **Financial Performance**
**Revenue Growth**Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million).
**Active Customers**Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion.
**Customer Holdings**Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature.
**Underlying Profit Before Tax (PBT)**Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth.
**Reported Profit Before Tax**Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields.
### **Operational Highlights**
**Infrastructure Expansion**Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly.
**Regulatory Approvals**Secured approvals in the UAE to expand product offerings in the region.
**Product Enhancements**Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil.
**Partnerships**Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume.
### **Strategic Investments**
**Team Growth**: Added over 1000 employeesfocusing on servicingcomplianceand AI-driven efficiencies.
**Marketing**Increased brand marketing spend across key markets to drive awareness and organic growth.
**Technology**Invested £144 million in product development, enhancing core products and launching new features.
### **Future Outlook**
**Dual Listing**On track for a US listing in Q2 2026 to increase visibility and access to capital.
**Growth Targets**Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs.
**Innovation**Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention.
### **Management Commentary**
CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability.
### **Conclusion**
Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
Here’s an HTML table comparing the financials and debt year on year for Wise PLC based on the provided text:
MetricH1 FY2025 (£m)H1 FY2026 (£m)YoY Change (£m)YoY Change (%)
Revenue591.9658.066.111%
Underlying Interest Income (first 1% yield)70.591.521.030%
Underlying Income662.4749.587.113%
Cost of Sales(152.9)(173.7)(20.8)14%
Net Credit Losses on Financial Assets(4.5)(4.6)(0.1)2%
Underlying Gross Profit505.0571.266.213%
Administrative Expenses(366.7)(465.9)(99.2)27%
Net Interest Income from Corporate Investments15.923.77.849%
Other Operating Income, Net2.33.81.565%
Underlying Operating Profit156.5132.8(23.7)(15%)
Finance Expense(9.4)(10.8)(1.4)15%
Underlying Profit Before Tax147.1122.0(25.1)(17%)
Reported Profit Before Tax292.5254.6(37.9)(13%)
Profit for the Period217.3187.2(30.1)(14%)
Borrowings (Revolving Credit Facility)98.1198.5100.4102%
### Key Highlights: 1. **Revenue Growth**: Revenue increased by 11% YoY from £591.9m to £658.0m. 2. **Underlying Income Growth**: Underlying income grew by 13% YoY from £662.4m to £749.5m. 3. **Administrative Expenses Increase**: Administrative expenses rose by 27% YoY from £366.7m to £465.9m. 4. **Underlying Profit Before Tax Decline**: Underlying profit before tax decreased by 17% YoY from £147.1m to £122.0m. 5. **Borrowings Increase**: Borrowings under the Revolving Credit Facility increased by 102% YoY from £98.1m to £198.5m. This table provides a clear comparison of key financial metrics and debt levels between H1 FY2025 and H1 FY2026 for Wise PLC.
Open Terminal Source RNS
STAN
STAN Standard Chartered PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EUZ
EUZ Europa Metals Ltd
06:01
Market

Proposed Acquisition of Marula Africa Mining Ltd

Open Terminal Source RNS
ESNT
ESNT Essentra PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MBH
MBH Michelmersh Brick Holdings …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
APTD
APTD Aptitude Software Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CRE
CRE Conduit Holdings Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MTLN
MTLN Metlen Energy & Metals PLC
06:01
Market

NINE MONTHS 2025 TRADING UPDATE

Open Terminal Source RNS
CCEP
CCEP Coca-Cola Europacific Partn…
06:01
Market

Transactions in Own Shares

Open Terminal Source RNS
VCP
VCP Victoria PLC
06:01
Market

Half-Year Trading Update

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
GROC
GROC Greenroc Mining PLC
06:01
Market

Amitsoq Update

Open Terminal Source RNS
BBOX
BBOX Tritax Big Box REIT plc
06:01
Market

Successful pricing of new £300m 7 year bond

Open Terminal Source RNS
AEP
AEP Anglo-Eastern Plantations P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BT.A
BT.A BT.A
06:01
Market

Half-year Financial Report

Open Terminal Source RNS
ENET
ENET Ethernity Networks Ltd
06:01
Market

Placing, CLN and Notice of EGM

Open Terminal Source RNS
VRCI
VRCI Verici Dx Plc
06:01
Market

Provider Participation Agreement with Prime Health

**Summary:** Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based …

**Summary**
Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future.
**Key Points**
Verici Dx signs Provider Participation Agreement with Prime Health Services.
Agreement leverages Prime Health’s PPO network for predictable healthcare pricing.
Expands Verici Dx’s patient scope and enhances private payor coverage.
Prime Health’s network includes 850,000+ providers and 35 million annual claims.
Partnership seen as a strategic step for Verici Dx’s commercial growth.
Agreement
Open Terminal Source RNS
SN.
SN. SN.
06:01
Market

Smith+Nephew Third Quarter 2025 Trading Report

Open Terminal Source RNS
SFOR
SFOR S4 Capital PLC
06:01
Market

Third Quarter Trading Update

**S4Capital plc Third Quarter Trading Update Summary (November 6, 2025)** **Key Highlights:** 1. **Financial Performance:** - **Q3 2025:** - Billings up 1.9% reported, 5.1% like-for-like. - Revenue down 3.4% reporte…

**S4Capital plc Third Quarter Trading Update Summary (November 6, 2025)**
**Key Highlights**
1. **Financial Performance**
**Q3 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 3.4% reported1.0% like-for-like.
Net revenue down 6.9% reported4.4% like-for-likewith sequential improvement from Q2.
Marketing Services net revenue down 2.8% like-for-like
Technology Services down 16.5% like-for-like.
**Nine Months 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 11.1% reported8.4% like-for-like.
Net revenue down 10.8% reported8.2% like-for-like.
Marketing Services net revenue down 5.2% like-for-like
Technology Services down 29.6% like-for-like.
2. **Regional Performance**
**Americas** (80% of net revenue)Q3 net revenue up 1.6% like-for-like
nine months down 5.6%.
**EMEA**Q3 net revenue down 26.2%
nine months down 17.3%.
**Asia-Pacific**Q3 net revenue down 16.2%
nine months down 15.3%.
3. **Outlook**
Full-year 2025 like-for-like net revenue expected to decline by upper single digits.
Operational EBITDA target remains unchanged, broadly similar to 2024.
Net debt target for year-end£100–£140 million.
Potential for enhanced final dividend if second-half performance and liquidity targets are met.
4. **New Business and AI Focus**
Significant new business wins, including General Motors, Amazon, T-Mobile, and two unannounced US-based Global FMCG companies.
AI-driven initiatives improving visualisation, copywriting, and hyper-personalisation, with clients excited about cost savings and ROI.
Revenue model shifting from time-based to output-based, leveraging AI tools like Runway, Luma, and Unreal.
5. **Balance Sheet and Liquidity**
Q3 net debt at £151 million (1.8x EBITDA), up slightly due to dividend payments, restructuring costs, and FX headwinds.
Sufficient liquidity with long-dated debt maturities and covenant compliance.
6. **ESG Commitment**
Continued focus on people fulfilmentenvironmental responsibilityand transparency.
Maintained B Corp status and improved Ecovadis score.
7. **Strategic Focus**
Unitary digital transformation model resonating with clients, emphasizing "faster, better, cheaper, more."
Rebranded as Monks, with streamlined Marketing and Technology Services practices.
**Executive Commentary (Sir Martin Sorrell):**
Clients remain cautious due to global macroeconomic volatility, particularly in technology sectors.
AI adoption is accelerating, with significant opportunities for efficiency and growth.
Cost control and cash management remain priorities, with a focus on profitability and debt reduction.
**Conclusion**
Despite challenging market conditions, S4Capital is leveraging AI-driven innovation and cost restructuring to improve performance, with a focus on new business wins and operational efficiency. The company remains committed to its digital transformation strategy and long-term growth objectives.
Here’s an HTML table comparing the financials and debt year-on-year based on the provided text:
MetricThree Months Ended 30 Sep 2025Nine Months Ended 30 Sep 2025Three Months Ended 30 Sep 2024Nine Months Ended 30 Sep 2024
Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (£m)Reported (£m)Like-for-like (£m)
Billings490.95.1%1,416.85.1%481.65.1%1,390.55.1%
Revenue191.7-1.0%552.1-8.4%198.4-1.0%620.9-8.4%
Net Revenue167.0-4.4%495.2-8.2%179.3-4.4%555.4-8.2%
Net Debt (£m)151-151-180194180194
Leverage (x EBITDA)1.8-1.8-----
### Key Notes: 1. **Billings**: Both reported and like-for-like figures show a 1.9% increase for the nine months ended 30 Sep 2025 compared to 2024. 2. **Revenue**: Reported revenue decreased by 3.4% for Q3 2025 and 11.1% for the nine months, while like-for-like figures show a smaller decline of 1.0% and 8.4%, respectively. 3. **Net Revenue**: Reported net revenue decreased by 6.9% for Q3 2025 and 10.8% for the nine months, with like-for-like figures showing a 4.4% and 8.2% decline, respectively. 4. **Net Debt**: Net debt decreased to £151 million in 2025 from £180 million in 2024 (or £194 million on a like-for-like basis). 5. **Leverage**: Leverage ratio improved to 1.8x EBITDA in 2025 from a covenant limit of 4.5x EBITDA. This table provides a clear comparison of key financial metrics and debt levels between 2024 and 2025.
Open Terminal Source RNS
WKP
WKP Workspace Group PLC
06:01
Market

Qube to build new creator hub at The Old Dairy

Open Terminal Source RNS
OCN
OCN Ocean Wilsons Holdings Ltd
06:01
Market

Q3 2025 Business Update

Open Terminal Source RNS
AZN
AZN AstraZeneca PLC
06:01
Market

9M and Q3 2025 results

## AstraZeneca 9M and Q3 2025 Results Summary: **Strong Performance and Pipeline Progress:** AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements. **Financial Highlig…

## AstraZeneca 9M and Q3 2025 Results Summary
**Strong Performance and Pipeline Progress:**
AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements.
**Financial Highlights (9M 2025)**
* **Revenue Growth** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%).
* **Core EPS Growth** Core EPS rose by 15% to $7.04, reflecting improved profitability.
* **Operating Profit Increase** Core operating profit grew by 13%, demonstrating operational efficiency.
**Pipeline Achievements**
* **16 Positive Phase III Readouts** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas.
* **31 Regulatory Approvals** The company secured 31 approvals in major regions for various medicines, expanding patient access.
* **Strong Oncology Pipeline** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi.
**Strategic Initiatives**
* **US Expansion** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs.
* **Acquisition of SixPeaks Bio AG** This acquisition strengthens AstraZenecas position in weight management therapies.
* **Koselugo Agreement with Merck** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency.
**Future Outlook**
* **Reiterated Guidance** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth.
* **Sustainability Leadership** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings.
**Key Takeaways**
AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
Here is a comparison of AstraZeneca's financials and debt year on year, presented as an HTML table:
Metric9M 20259M 2024% ChangeQ3 2025Q3 2024% Change
Total Revenue$43,236m$39,182m10%$15,191m$13,565m12%
Reported EPS ($)$5.10$3.5743%$1.64$0.9277%
Core EPS ($)$7.04N/A15%$2.38N/A14%
Net Debt$23,965m$26,348m-9%N/AN/AN/A
Capital Expenditure$2,091m$1,415m48%N/AN/AN/A

Note: The above table provides a high-level comparison of key financials and debt metrics. For a detailed analysis, please refer to the original text.

Key Observations:

  • Total Revenue increased by 10% year-on-year in 9M 2025, driven by growth in all Therapy Areas.
  • Reported EPS increased significantly by 43% in 9M 2025, while Core EPS increased by 15%.
  • Net Debt decreased by 9% in the nine months to 30 September 2025, reflecting improved financial position.
  • Capital Expenditure increased by 48% in 9M 2025, primarily due to investment in manufacturing projects and technology upgrades.
This table provides a concise comparison of AstraZeneca's financials and debt year on year, highlighting key metrics such as Total Revenue, Reported EPS, Core EPS, Net Debt, and Capital Expenditure. The observations section summarizes the main trends and changes in these metrics.
Open Terminal Source RNS
SBRY
SBRY J Sainsbury PLC
06:01
Market

Half-Year Report

**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)** **Financial Performance Highlights:** - **Sales Growth:** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Mer…

**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)**
**Financial Performance Highlights**
**Sales Growth** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%.
**Profitability** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year.
**Cash Flow** Retail free cash flow was £310 million, on track to exceed £500 million for the full year.
**Bank Disposal** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks.
**Dividends** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million.
**Strategic Initiatives and Market Position:**
**Value and Quality Focus** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items.
**Innovation and Range Expansion** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains.
**Operational Efficiency** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases.
**Sustainability** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts.
**Outlook and Guidance**
**Profit Guidance** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million.
**Strategic Commitments** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction.
**Nectar Loyalty Program** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth.
**Argos Transformation** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency.
**Conclusion**
Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
Here is the comparison of financials and debt year on year in an HTML table format:
Metric2024/25 (28 weeks)2025/26 (28 weeks)YoY Change
Retail sales (excl. VAT, excl. fuel)£14,865m£15,577m4.8%
Retail underlying operating profit£503m£504m0.2%
Underlying profit before tax£309m£340m10%
Retail free cash flow£425m£310m(£115)m
Net debt (inc. lease liabilities)£(5,584)m£(5,527)m£57m
Non-lease net debt£(152)m£(81)m£71m
**Key Observations:** * **Sales Growth:** Retail sales (excluding VAT and fuel) increased by 4.8% year-on-year, driven by grocery and general merchandise sales growth. * **Profitability:** Underlying profit before tax increased by 10%, while retail underlying operating profit remained relatively stable with a slight increase of 0.2%. * **Cash Flow:** Retail free cash flow decreased by £115 million, primarily due to reduced working capital inflow and higher capital expenditure. * **Debt:** Net debt (including lease liabilities) decreased by £57 million, and non-lease net debt decreased by £71 million, indicating improved liquidity. This table provides a concise overview of the key financial metrics and debt position, highlighting areas of growth, stability, and changes in liquidity.
Open Terminal Source RNS
MERC
MERC Mercia Technologies PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HSX
HSX Hiscox Ltd
06:01
Market

Q3 2025 Trading Statement

Open Terminal Source RNS
BPM
BPM B P Marsh and Partners PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AFC
AFC AFC Energy plc
06:01
Market

Trading Update for Year Ended 31 October 2025

**Summary:** AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developm…

**Summary**
AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including
1. **Partnerships and Deployments**Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner.
2. **Product Development**The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026.
3. **Joint Ventures**A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting.
4. **Strategic Restructuring**A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments.
5. **Financials**Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability.
6. **Market Opportunities**AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition.
CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
MetricFY24FY25Change
Cash, Cash Equivalents, and Short-Term Deposits (£m)15.425.3+9.9 (+64.3%)
Revenue (£k)4,000107-3,893 (-97.3%)
Headcount ReductionN/A-17N/A
Annualised Cost Savings in FY26 (£m)N/A1.5N/A
### Explanation: 1. **Cash, Cash Equivalents, and Short-Term Deposits**: Increased from £15.4m in FY24 to £25.3m in FY25, a rise of £9.9m (+64.3%). 2. **Revenue**: Decreased significantly from £4m in FY24 to £107k in FY25, a drop of £3.893m (-97.3%), attributed to the strategic reset announced in March 2025. 3. **Headcount Reduction**: FY25 saw a net reduction of 17 employees as part of the business reorganisation. 4. **Annualised Cost Savings**: Expected savings of £1.5m in FY26 due to restructuring efforts. This table provides a clear year-on-year comparison of key financial metrics and debt-related changes.
Open Terminal Source RNS
VTU
VTU Vertu Motors Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
NG.
NG. NG.
06:01
Market

National Grid plc Half-Year Results 2025/26

Open Terminal Source RNS
DGE
DGE Diageo PLC
06:01
Market

Diageo issues fiscal 26 Q1 trading statement

**Diageo Fiscal 26 Q1 Trading Statement Summary** **Key Highlights:** - **Flat Organic Net Sales Growth:** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a …

**Diageo Fiscal 26 Q1 Trading Statement Summary**
**Key Highlights**
**Flat Organic Net Sales Growth** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact.
**Regional Performance**
**Strengths** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM).
**Weaknesses** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%.
**Strategic Focus** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics.
**Fiscal 26 Outlook**
Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness.
Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings.
Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years.
**Management Commentary** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture.
**Regional Breakdown**
1. **North America (38% of net sales)** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence.
2. **Europe (25% of net sales)** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye.
3. **Asia Pacific (18% of net sales)** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India.
4. **LAC (11% of net sales)** Organic net sales grew 10.9%, led by Brazil’s double-digit growth.
5. **Africa (8% of net sales)** Organic net sales grew 8.9%, with strong performance in East and South Africa.
**Key Initiatives**
**Accelerate Programme** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications.
**Disposals** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations.
**Financial Guidance**
Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion.
Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28.
**Conclusion**
Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
Below is the HTML table code comparing the financials and debt year on year based on the provided text:
MetricF26 (2025)F25 (2024)Reported Growth YoY %Organic Growth YoY %
Net Sales$4,875$4,986(2.2)0.0
Volume++-2.9
Price/Mix--(2.8)(2.8)
Free Cash Flow$3,000$2,70011.1-
Capital Expenditure$1.2-1.3bn$1.5bn(13.3)-(20.0)-
Effective Interest Rate4.0%4.1%(2.4)-
Tax Rate25.0%24.9%0.4-
Net Debt to Adjusted EBITDATarget: 2.5-3.0x by F28---
### Notes: 1. **Net Sales**: Reported net sales declined by 2.2% YoY, while organic net sales growth was flat. 2. **Volume**: Organic volume growth was 2.9%. 3. **Price/Mix**: Organic price/mix declined by 2.8%. 4. **Free Cash Flow**: Expected to increase to $3 billion in F26 from $2.7 billion in F25. 5. **Capital Expenditure**: Expected to be at the lower end of $1.2-1.3 billion in F26 compared to $1.5 billion in F25. 6. **Effective Interest Rate**: Slightly decreased to 4.0% in F26 from 4.1% in F25. 7. **Tax Rate**: Expected to be around 25.0% in F26 compared to 24.9% in F25. 8. **Net Debt to Adjusted EBITDA**: Target is to be within 2.5-3.0x by F28. This table provides a clear comparison of key financial metrics and debt-related figures between F26 (2025) and F25 (2024).
Open Terminal Source RNS
PLUS
PLUS Plus500 Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VOD
VOD Vodafone Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TSCO
TSCO Tesco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HBR
HBR Harbour Energy PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KGF
KGF Kingfisher PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PSON
PSON Pearson PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CVSG
CVSG CVS Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
06:01
Market

Helios Towers 3rd Quarter Results

Open Terminal Source RNS
ORIT
ORIT Octopus Renewables Infra Tr…
06:01
Market

Statement re Government Consultation on Indexation

Open Terminal Source RNS
HSX
HSX Hiscox Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BWY
BWY Bellway PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
LSEG
LSEG London Stock Exchange Group…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AO.
AO. AO.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HIK
HIK Hikma Pharmaceuticals PLC
06:01
Market

November Trading Statement

**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:** Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include: 1. **Performance Acro…

**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:**
Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include
1. **Performance Across Segments**
**Injectables** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%.
**Branded** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%.
**Hikma Rx** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%.
2. **Organisational Changes**
Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies.
Dr Bill Larkins stepped down as head of Injectables
CEO Riad Mishlawi will serve as interim head until a replacement is found.
3. **Full Year 2025 Outlook**
Group revenue growth maintained at 4-6%.
Core operating profit range tightened to $730-$750 million, in line with market expectations.
4. **Medium-Term Outlook (2024-2027)**
Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges.
Group revenue CAGR revised to the lower end of 6-8%.
Core operating profit growth adjusted to 5-7%, down from 7-9%.
Long-term target of $5 billion revenue by 2030 remains unchanged.
5. **Strategic Focus**
Continued investment in R&D and manufacturing capacity expansion to support growth.
Confidence in revised targets despite medium-term adjustments.
Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
The provided text does not contain specific financial or debt figures for a year-on-year comparison. However, I can create a general HTML table structure based on the guidance and outlook provided in the text. If you have specific financial data, please provide it, and I can tailor the table accordingly. Here’s a basic HTML table structure based on the available information: < lang="en">Hikma Pharmaceuticals Financials and Debt Comparison

Hikma Pharmaceuticals Financials and Debt Comparison (2024 vs 2025 Guidance)

Metric2024 (Actual)2025 (Guidance)Change
Group Revenue GrowthN/A4% to 6%N/A
Injectables Revenue GrowthN/A7% to 9%N/A
Injectables Core Operating MarginN/A32% to 33%N/A
Branded Revenue GrowthN/A6% to 7%N/A
Branded Core EBIT MarginN/A~25%N/A
Hikma Rx Revenue GrowthN/ABroadly flatN/A
Hikma Rx Core Operating MarginN/A~16%N/A
Group Core Operating ProfitN/A$730M to $750MN/A
Medium-Term Group Revenue CAGR (2024-2027)N/A6% to 8% (lower end)N/A
Medium-Term Group Core Operating Profit GrowthN/A5% to 7%N/A

Note: Actual 2024 figures are not provided in the text. The table reflects 2025 guidance and medium-term outlook.

If you have specific financial or debt figures for 2024 or any other year, please provide them, and I can update the table accordingly.
Open Terminal Source RNS
AUTO
AUTO Auto Trader Group plc
06:01
Market

Half Year Results

**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)** **Financial Performance Highlights:** - **Revenue Growth:** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader r…

**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)**
**Financial Performance Highlights**
**Revenue Growth** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million).
**Profitability** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million.
**EPS Growth** Basic earnings per share (EPS) increased by 11% to 17.26 pence.
**Cash Flow** Cash generated from operations rose by 7% to £215.4 million.
**Shareholder Returns** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence).
**Strategic and Operational Updates**
**AI Innovation** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts.
**Deal Builder Growth** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025).
**Market Position** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly.
**New Car Market** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined.
**Used Car Market** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed.
**Future Outlook**
Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities.
Continued focus on AI opportunities to enhance performance, efficiency, and customer experience.
Scaling Deal Builder as the core consumer proposition, deepening competitive advantage.
**Sustainability and Governance**
Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi).
Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC.
**Conclusion**
Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
Here is the HTML table code comparing the financials and debt year on year for Auto Trader Group PLC:
MetricH1 2026H1 2025Change
Revenue£317.7m£302.5m5%
Operating Profit£200.1m£188.4m6%
Operating Profit Margin63%62%1% pts
Profit Before Tax£199.3m£187.5m6%
Basic Earnings Per Share17.26p15.56p11%
Cash Generated from Operations£215.4m£201.6m7%
Net Cash£5.2m£15.1m(£9.9m)
Debt (Syndicated RCF)£15.0m£0m£15.0m
**Key Observations:** * **Revenue and Profit Growth:** Auto Trader Group PLC experienced a 5% increase in revenue and a 6% increase in operating profit year on year. * **Margin Improvement:** Operating profit margin improved by 1 percentage point to 63%. * **Earnings Per Share Growth:** Basic earnings per share increased by 11% to 17.26p. * **Cash Flow Improvement:** Cash generated from operations increased by 7% to £215.4m. * **Debt Increase:** The company drew £15.0m from its Syndicated RCF, resulting in a decrease in net cash from £15.1m to £5.2m. This table provides a concise overview of the key financial metrics and debt position of Auto Trader Group PLC, highlighting the year-on-year changes.
Open Terminal Source RNS
BASC
BASC Brown Advisory US Smaller C…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HGT
HGT HG Capital Trust PLC
06:01
Market

3rd Quarter Results

**Summary:** HgCapital Trust PLC (HgT) announced its third-quarter results for the period ending September 30, 2025, highlighting a resilient performance driven by its portfolio of software and services businesses. Key highlights include:…

**Summary**
HgCapital Trust PLC (HgT) announced its third-quarter results for the period ending September 30, 2025, highlighting a resilient performance driven by its portfolio of software and services businesses. Key highlights include
1. **NAV Performance**Net Asset Value (NAV) per share increased by 2.4%, reaching £5.50, with total net assets at £2.5 billion.
2. **Share Price**The share price decreased by 2.7% to £4.99, resulting in a market capitalization of £2.3 billion.
3. **Portfolio Growth**Strong trading performance contributed 4% to portfolio growth, partially offset by lower valuation multiples and increased net debt.
4. **Long-Term Performance**The portfolio reported 18% sales growth and 19% EBITDA growth over the last 12 months, with a 33% EBITDA margin.
5. **Liquidity and Investments**Available liquid resources stood at £379 million (15% of NAV), with £49.7 million invested in Q3, primarily in A-LIGN, a cyber compliance services provider.
6. **Realisations**£7 million was realized from the partial sale of Trackunit, with an additional £30 million expected from the post-period exit of GTreasury.
7. **Historical Returns**An investment of £1,000 twenty years ago would now be worth £13,364, outperforming the FTSE All-Share Index, which would be worth £3,762.
HgT remains focused on delivering consistent long-term returns by investing in unquoted companies with potential for strategic and operational value creation. The trust continues to screen an attractive pipeline of opportunities, with further liquidity events expected in the coming months.
Below is the HTML table code comparing the key financials and debt year on year based on the provided text. Since the text only provides data for Q3 2025, I’ve structured the table to compare Q3 2025 with implied or assumed Q3 2024 data (where available). If no direct comparison is possible, the table reflects only the 2025 data.
MetricQ3 2024 (Assumed/Implied)Q3 2025Change
NAV per Share£5.37 (implied from +2.4% growth)£5.50+2.4%
Net Assets£2.44 billion (implied)£2.5 billion+2.5%
Share Price£5.13 (implied from -2.7% decrease)£4.99-2.7%
Market Capitalisation£2.36 billion (implied)£2.3 billion-2.5%
Portfolio Growth (Trading)N/A+4%N/A
Sales Growth (Last 12 Months)N/A+18%N/A
EBITDA Growth (Last 12 Months)N/A+19%N/A
EBITDA MarginN/A33%N/A
Net DebtN/AIncreased (exact figure not provided)N/A
Liquid ResourcesN/A£379 millionN/A
Bank Facility DrawnN/A£46 millionN/A
Co-investments as % of NAV9%10%+1%
### Notes: 1. **Assumed/Implied Values**: For metrics like NAV per share and share price, implied 2024 values are calculated based on the percentage changes provided for 2025. 2. **Missing Data**: Some metrics (e.g., net debt, liquid resources in 2024) are not provided in the text, so they are marked as "N/A". 3. **Percentage Changes**: Changes are calculated where possible, but some metrics lack historical data for comparison. This table provides a structured comparison based on the available information.
Open Terminal Source RNS
IWG
IWG IWG PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IIG
IIG Intuitive Investments Group…
06:01
Market

Trading Statement

Open Terminal Source RNS
DLN
DLN Derwent London PLC
06:01
Market

Third Quarter Business Update

Open Terminal Source RNS
ESO
ESO EPE Special Opportunities L…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IBT
IBT International Biotechnology…
06:01
Market

Final Results

Open Terminal Source RNS
HTG
HTG Hunting PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IPO
IPO IP Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PTEC
PTEC Playtech Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VTY
VTY Vistry Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BATS
BATS British American Tobacco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VTY
VTY Vistry Group PLC
06:01
Market

Trading update

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CARD
CARD Card Factory PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CAML
CAML Central Asia Metals Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BAB
BAB Babcock International Group…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FTC
FTC Filtronic
06:01
Market

€7m contract for satellite constellation programme

**Summary:** Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a ma…

**Summary**
Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
NewContract
Open Terminal Source RNS
IMI
IMI IMI PLC
06:01
Market

Trading Update

**Summary:** IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to ach…

**Summary**
IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**.
Key highlights include
**Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%).
**Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**.
Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers.
The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns.
Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
Below is an HTML table comparing the year-on-year financials and debt based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and organic growth comparisons.
Metric2024 (Previous Year)2025 (Current Year)Year-on-Year Change
Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Automation Sector Organic Revenue Growth (Year-to-Date)N/A+8%+8% (from 2024 baseline)
Process Automation Organic Revenue Growth (Year-to-Date)N/A+14%+14% (from 2024 baseline)
Life Technology Sector Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Climate Control Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Life Science & Fluid Control Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Transport Organic Revenue Growth (Year-to-Date)N/A-9%-9% (from 2024 baseline)
Exchange Rate Impact on Revenue (Full Year)N/A-1%-1% (compared to 2024)
Exchange Rate Impact on Adjusted Operating Profit (Full Year)N/A-1.5%-1.5% (compared to 2024)
Adjusted Basic Earnings per Share (Full Year Guidance)N/A129p - 136pN/A (Guidance for 2025)
Debt (Year-on-Year)Not ProvidedNot ProvidedN/A
### Notes: 1. **Debt Information**: The provided text does not include specific debt figures, so the table reflects this as "Not Provided." 2. **Organic Growth**: All organic growth figures are based on the comparisons provided in the text for 2025 relative to 2024. 3. **Exchange Rate Impact**: The impact of exchange rates on revenue and adjusted operating profit is included as per the text. 4. **Earnings per Share**: The adjusted basic earnings per share guidance for 2025 is included as provided. This table can be embedded in an HTML document for display.
Open Terminal Source RNS
HSW
HSW Hostelworld Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ONWD
ONWD Onward Opportunities Ltd
06:01
Market

Issue of Equity

Open Terminal Source RNS
HICL
HICL HICL Infrastructure Company…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PRU
PRU Prudential plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BTRW
BTRW Barratt Redrow plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BA.
BA. BA.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CRCL
CRCL Corcel PLC
06:01
Market

Permit for Seismic & Exploration Drilling KON-16

Open Terminal Source RNS
ROCK
ROCK Rockfire Resources plc
06:01
Market

Molaoi Drilling Update

Open Terminal Source RNS
KIE
KIE Kier Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ITV
ITV ITV PLC
06:01
Market

ITV plc Q3 Trading Update

**ITV PLC Q3 Trading Update Summary (November 2025):** ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include…

**ITV PLC Q3 Trading Update Summary (November 2025):**
ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include
**Revenue Growth** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX.
**Advertising Performance** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty.
**Cost Management** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand.
**ITV Studios** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms.
**Digital Growth** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026.
**Outlook** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness.
**Liquidity** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025.
CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
Below is an HTML table comparing the financials and debt year-on-year based on the provided text:
Metric2024 (£m)2025 (£m)Change (£m)Change (%)
Total Group Revenue2,7412,795542%
Total Group External Revenue2,3212,404834%
ITV Studios Revenue1,2171,35013311%
Media & Entertainment (M&E) Revenue1,5241,445(79)(5%)
Total Advertising Revenue (TAR)1,3131,247(66)(5%)
Digital Advertising RevenueN/AUp 15%Growth driven by ITVX
Total Digital Revenue3844324813%
Net DebtN/A508(78)Decreased from £586m (June 2025)
### Key Notes: 1. **Revenue Comparisons**: All figures are for the nine months ending 30 September, comparing 2025 to 2024. 2. **Debt**: Net debt is provided for 2025, with a decrease from £586 million in June 2025 to £508 million in September 2025. 3. **Digital Revenue**: 2024 figures were restated to £384 million due to changes in categorization. 4. **TAR**: Expected to decline by 6% for the full year 2025 compared to 2024, with a 9% decline in Q4 2025. This table provides a concise comparison of key financials and debt between 2024 and 2025 based on the provided text.
Open Terminal Source RNS
WTB
WTB Whitbread PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRN
TRN Trainline Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SSPG
SSPG SSP Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IPX
IPX Impax Asset Management Grou…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SEQI
SEQI Sequoia Econ Infrastructure
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GBG
GBG GB Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RKT
RKT Reckitt Benckiser Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IGG
IGG IG Group Holdings PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OTB
OTB On The Beach Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HAS
HAS Hays plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CAN
CAN Groupe Canal Plus
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INF
INF Informa PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PIN
PIN Pantheon International PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PETS
PETS Pets at Home Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FUTR
FUTR Future PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
WOSG
WOSG Watches Of Switzerland Grou…
06:01
Market

H1 FY26 Trading Update

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
06:01
Market

3Q and 9M 2025 Results Report

Open Terminal Source RNS
GSK
GSK GSK plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HVPE
HVPE HarbourVest Global Private …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CHRY
CHRY Chrysalis Investments Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IAG
IAG International Consolidated …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ACSO
ACSO Accesso Technology Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MTO
MTO Mitie Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
STAF
STAF Staffline Group Plc
06:01
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
INPP
INPP International Public Partne…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CLDN
CLDN Caledonia Investments
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
QQ.
QQ. QQ.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TATE
TATE Tate & Lyle PLC
06:01
Market

Half-year Financial Report

Open Terminal Source RNS
KYGA
KYGA Kerry Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GFTU
GFTU Grafton Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
UKW
UKW Greencoat UK Wind PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
WIX
WIX Wickes Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GMR
GMR Gaming Realms plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RR.
RR. RR.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HRI
HRI Herald Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FDEV
FDEV Frontier Developments Plc
06:01
Market

A STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO

**Summary:** Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*. **Jurassic World E…

**Summary**
Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*.
**Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum.
**Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion.
Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later.
The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
Launch
Open Terminal Source RNS
DRX
DRX Drax Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EDIN
EDIN Edinburgh Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CNA
CNA Centrica PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRIG
TRIG Renewables Infrastructure G…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AHT
AHT Ashtead Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SRP
SRP Serco Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ECEL
ECEL Eurocell PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MAST
MAST MAST Energy Developments PLC
06:01
Market

Hindlip breaks ground and update on 7 MW purchase

Open Terminal Source RNS
GFM
GFM Griffin Mining
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MGAM
MGAM Morgan Advanced Materials p…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KNOS
KNOS Kainos Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PAY
PAY PayPoint plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
JSG
JSG Johnson Service Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FEVR
FEVR Fevertree Drinks Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MRO
MRO Melrose Industries PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HWDN
HWDN Howden Joinery Group Plc
06:01
Market

Trading Update

**Summary:** Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include: 1. **Sales Growth**: …

**Summary**
Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include
1. **Sales Growth**
**Group Sales**+2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis.
**UK Sales**+2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1.
**International Sales**+14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland.
2. **Performance Drivers**
Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens.
High stock availability, market-leading product lineup, and exceptional customer service supported growth.
3. **Outlook**
The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million.
CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives.
4. **Operational Highlights**
£8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%.
Continued expansion of the in-stocktrade model internationally.
Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
Below is the HTML table code comparing the financials and sales growth year-on-year based on the provided text: < lang="en">Howden Joinery Group PLC Financials Comparison

Howden Joinery Group PLC - Sales Growth Comparison (2024 vs 2025)

MetricPeriods 7 to 11Year-to-dateSame Depot Basis (Periods 7 to 11)Same Depot Basis (Year-to-date)
UK Sales Growth (%)+2.4%+2.7%+1.1%+1.4%
International Sales Growth (%)+14.7%+13.4%+9.3%+9.6%
Group Sales Growth (%)+2.8%+3.0%+1.4%+1.7%

Notes:

  • 1. There were two fewer trading days in H1 2025 versus the prior year. Numbers reported are unadjusted.
  • 2. Same depot basis excludes depots opened in the current year and the prior year.
  • 3. International growth is shown in local currency.
  • 4. 2025 Full Year Profit Before Tax consensus is £331m (2024: £328.1m).
### Key Features of the Table: 1. **Metrics Compared**: Sales growth percentages for UK, International, and Group segments. 2. **Periods**: Compares Periods 7 to 11 and Year-to-date for both 2024 and 2025. 3. **Same Depot Basis**: Includes growth excluding newly opened depots for a like-for-like comparison. 4. **Notes**: Additional context for adjustments and definitions. This table provides a clear year-on-year comparison of Howden Joinery Group PLC's financial performance based on the provided text.
Open Terminal Source RNS
KLR
KLR Keller Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
13SG
13SG 13SG
06:01
Market

FAB EMTN Series 179 - CNY150m FXD due 2031

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EYE
EYE Eagle Eye Solutions Group p…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VOF
VOF VinaCapital Vietnam Opportu…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AVAP
AVAP Avation PLC
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['1. Rangeley Capital LLC', '0', '5.96']
Open Terminal Source RNS
VEIL
VEIL Vietnam Enterprise Investme…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AVAP
AVAP Avation PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
0QPR
0QPR Cicor Technologies Ltd.
06:01
Market

Disclosure under Rule 2.10(c) of the Takeover Code

Open Terminal Source RNS
IHG
IHG InterContinental Hotels Gro…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FSV
FSV Fidelity Special Values
06:01
Market

Annual Financial Report

Open Terminal Source RNS
TFIF
TFIF TwentyFour Income Fund Ltd
06:01
Market

Notice of Interim Results and Investor Presentation via Investor Meet Company

Open Terminal Source RNS
PMGZ
PMGZ PMGR Securities 2025 PLC
06:01
Market

Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company

Open Terminal Source RNS
WWH
WWH Worldwide Healthcare Trust …
06:01
Market

Chair Succession

Open Terminal Source RNS
MLHL
MLHL Malibu Life Holdings Limited
06:01
Market

Third Point Master Fund October 2025 Performance

Open Terminal Source RNS
PMGR
PMGR Portmeirion Group
06:01
Market

Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company

**Summary:** Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options: …

**Summary**
Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options
1. **Rollover Option**Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance.
2. **Cash Option**Receive a cash exit at net asset value, less associated costs.
The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs.
Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed.
The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter.
The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
Proposals
Open Terminal Source RNS
BOY
BOY Bodycote PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
JZCP
JZCP JZ Capital Partners Ltd
06:01
Market

Interim Results for the Period Ended 31 August 2025

Open Terminal Source RNS
OXIG
OXIG Oxford Instruments PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BRIG
BRIG BlackRock Income and Growth…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
AUGM
AUGM Augmentum Fintech PLC
06:01
Market

Factsheet Issued

Open Terminal Source RNS
FSG
FSG Foresight Group Holdings Li…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CRH
CRH CRH PLC
06:01
Market

CRH Reports Third Quarter 2025 Results

**Summary of CRHs Third Quarter 2025 Results:** CRH PLC, a leading provider of building materials, reported strong third-quarter 2025 results, highlighting continued growth and strategic advancements. Key takeaways include: 1. **Financia…

**Summary of CRHs Third Quarter 2025 Results:**
CRH PLC, a leading provider of building materials, reported strong third-quarter 2025 results, highlighting continued growth and strategic advancements. Key takeaways include
1. **Financial Performance**
**Revenue Growth** Total revenues increased by 5% year-over-year to $11.1 billion, driven by favorable demand, strong commercial execution, and contributions from acquisitions.
**Net Income and EBITDA** Net income rose by 9% to $1.5 billion, while Adjusted EBITDA grew by 10% to $2.7 billion. Margins expanded, with net income margin up 50 basis points to 13.7% and Adjusted EBITDA margin up 100 basis points to 24.3%.
**Earnings Per Share (EPS)** Diluted EPS increased by 12% to $2.21.
2. **Strategic Initiatives**
**Acquisitions** CRH invested $3.5 billion in 27 value-accretive acquisitions year-to-date, including nine acquisitions totaling $2.5 billion in Q3. The company maintains an active pipeline of opportunities.
**Shareholder Returns** CRH returned $1.1 billion to shareholders year-to-date through share buybacks and declared a quarterly dividend of $0.37 per share, a 6% increase year-over-year.
3. **Segment Performance**
**Americas Materials Solutions** Revenues grew by 6%, with Adjusted EBITDA up 5%, driven by strong demand and pricing momentum.
**Americas Building Solutions** Revenues increased by 2%, with Adjusted EBITDA up 22%, supported by acquisitions and optimization initiatives.
**International Solutions** Revenues rose by 5%, with Adjusted EBITDA up 15%, driven by operational efficiencies and acquisitions.
4. **Outlook**
**2025 Guidance** CRH reaffirmed its net income guidance and raised the midpoint of its Adjusted EBITDA guidance, reflecting continued strategic execution and market strength.
**2026 Expectations** The company anticipates favorable market dynamics, supported by infrastructure investment and reindustrialization activity, despite subdued residential new-build activity.
5. **Balance Sheet and Liquidity**
**Net Debt** Increased to $15.0 billion due to acquisitions, shareholder returns, and capital expenditures, partially offset by operating cash flows. CRH maintains a robust balance sheet with $4.3 billion in cash and equivalents.
**Credit Rating** CRH remains committed to maintaining its investment-grade credit rating.
6. **Leadership Commentary**
CEO Jim Mintern emphasized CRH’s superior strategy, connected portfolio, and leading performance, positioning the company for continued growth and value creation in 2026.
Overall, CRH’s Q3 2025 results underscore its strong operational execution, strategic growth initiatives, and commitment to shareholder value, despite a dynamic market environment.
Here’s an HTML table comparing the financials and debt year-on-year for CRH based on the provided text:
MetricQ3 2025Q3 2024YoY Change
Total Revenues$11.1bn$10.5bn+5%
Net Income$1.5bn$1.4bn+9%
Net Income Margin13.7%13.2%+50bps
Adjusted EBITDA$2.7bn$2.5bn+10%
Adjusted EBITDA Margin24.3%23.3%+100bps
Diluted Earnings Per Share$2.21$1.97+12%
Total Short and Long-Term Debt$18.7bn$14.0bn+33.6%
Net Debt$15.0bn$10.5bn+42.9%
### Explanation: - **Total Revenues, Net Income, Margins, and EPS**: These metrics are directly compared year-on-year, showing growth rates or margin improvements. - **Debt Metrics**: Total short and long-term debt and Net Debt are compared, highlighting the significant increase in debt levels year-on-year. This table provides a clear comparison of key financial and debt metrics between Q3 2025 and Q3 2024.
Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
06:01
Market

OSB GROUP PLC - Trading Update for the nine months to 30 September 2025

Open Terminal Source RNS
CRH
CRH CRH PLC
06:01
Market

CRH declares quarterly dividend

Open Terminal Source RNS
NBPE
NBPE NB Private Equity Partners …
06:01
Market

NB Private Equity Partners Announces Capital Allocation Framework Update

Open Terminal Source RNS
NBPE
NBPE NB Private Equity Partners …
06:01
Market

NBPE Announces Transaction in Own Shares

Open Terminal Source RNS
PSH
PSH Pershing Square Holdings Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CRH
CRH CRH PLC
06:01
Market

CRH Continues Share Buyback Program

**Summary:** CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. …

**Summary**
CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018.
CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States.
Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission.
**Key Points**
CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018.
A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026.
Repurchased shares will be canceled to reduce share capital.
Future buybacks depend on capital needs and market conditions.
Forward-looking statements are subject to risks and uncertainties.
BuyBack
Open Terminal Source RNS
CRH
CRH CRH PLC
06:01
Market

CRH plc Form 10-Q for the quarterly period ended September 30, 2025

Open Terminal Source RNS
DEC
DEC Diversified Energy Company …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
0RLW
0RLW Commerzbank AG
05:07
Market

Commerzbank continues growth trajectory: Record operating result after nine months

Open Terminal Source RNS

Digested News

The ticker catalyst tape is rendered as native mobile cards. Articles and ticker links stay clickable.

EOT logo
Latest RNS 15:38
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.104435', '9.413053']
WIZZ logo
Latest RNS 15:34
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold ', '0.040000']
MTU logo
Latest RNS 15:04
MTU

Holding(s) in Company

Montanaro UK Smaller Companies Investment Trust PLC

TR1 Buy
['IntegraFin Holdings plc', '3.010000', 0]
CPI logo
Latest RNS 15:01
CPI

Holding(s) in Company

Capita PLC

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '7.113778', '6.625642']
SDY logo
Latest RNS 15:01
SDY

Commercial Agreement & Equity Subscription

Speedy Hire PLC

**Summary**
Speedy Hire PLC, the UKs leading tools and equipment hire services company, announced an update on its commercial agreement and investment in ProService Building Services Marketplace plc. On October 6, 2025, Speedys subsidiary, Speedy Asset Services, signed a comprehensive commercial hire and services supply agreement with HSS ProService Limited (ProService), a subsidiary of HSS Hire Group plc (to be renamed ProService Building Services Marketplace plc). As part of the deal, ProService plc agreed to issue 79,368,711 shares to Speedy, representing approximately 9.99% of its post-subscription issued share capital.
The transaction, which includes the share subscription and an asset purchase agreement (HSS APA), was conditional upon approval by ProService plc shareholders, who passed the required resolutions at a general meeting. The deal remains subject to satisfaction of a condition from the Competition and Markets Authority (CMA) and admission of the subscribed shares to trading on AIM, anticipated for November 17, 2025. The CMA has confirmed it has no further questions regarding the transaction but cannot satisfy its condition until the dealing day before admission.
Agreement
BATS logo
Latest RNS 14:16
BATS

Director/PDMR Shareholding

British American Tobacco PLC

<mark style="background-coloryellow">Purchase</mark> of ordinary shares under the Partnership Share Scheme - a HMRC approved Share Incentive Plan
CWR logo
Latest RNS 14:11
CWR

Holding(s) in Company

Ceres Power Holdings PLC

TR1 Buy
['BNP Paribas Asset Management UK Limited', '2.694800', '3.250800']
IPF logo
Latest RNS 14:01
IPF

Form 8.3

International Personal Finance PLC

ESP logo
Latest RNS 12:57
ESP

Form 8.3

Empiric Student Property Plc

ESP logo
Latest RNS 12:28
ESP

Form 8.3

Empiric Student Property Plc

API logo
Latest RNS 10:53
API

Holding(s) in Company

abrdn Property Income Trust Ltd.

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '5.952788']
CLX logo
Latest RNS 10:31
CLX

Calnex and Viavi Partnership

Calnex Solutions Plc

**Summary**
Calnex Solutions plc (AIMCLX) and VIAVI Solutions Inc. (NASDAQ: VIAV) have partnered to provide comprehensive <mark style="background-color:yellow">test</mark> solutions for Open RAN (O-RAN) products, addressing the growing need for pre-certification validation in the telecom infrastructure market. The collaboration offers three integrated testbeds that simplify and reduce the cost of in-house Open RAN testing, enabling manufacturers of O-RU, O-DU, and O-CU equipment to perform full O-RAN and 3GPP conformance testing while emulating real-world network impairments. This partnership aims to accelerate innovation in 5G and 6G systems by ensuring adherence to performance, security, interoperability, and reliability standards.
The shift to Open RAN and AI-RAN has opened the telecom market to new entrants, including startups and university spinouts, but has also introduced challenges in multivendor ecosystem compatibility. Calnex and VIAVI’s combined expertise eliminates the traditional complexities of setting up in-house test labs, which often require equipment from multiple vendors and extensive debugging. Early customer feedback has been positive, and both companies anticipate maximizing the partnership’s potential across key regions.
Calnex specializes in test and measurement solutions for telecoms and cloud computing, while VIAVI is a global leader in network test, monitoring, and assurance solutions. Together, they aim to streamline Open RAN development and reduce the risk of certification failures, ultimately fostering faster innovation in the telecom industry.
Partner
CPI logo
Latest RNS 10:16
CPI

Director/PDMR Shareholding

Capita PLC

b) Nature of the transaction Monthly share <mark style="background-color:yellow">purchase</mark> under the Capita Share Ownership Plan
LSEG logo
Latest RNS 10:01
LSEG

LSEG Announces Strategic Partnership with Nasdaq®

London Stock Exchange Group PLC

**Summary**
On November 6, 2025, the London Stock Exchange Group (LSEG) announced a strategic partnership with Nasdaq to enhance private markets data distribution. Under the agreement, LSEG will license Nasdaq eVestment’s private markets datasets, including Market Lens insights, hedge fund data, and Limited Partner (LP) intelligence. The partnership also includes exclusive distribution of Nasdaq’s private market datasets, benchmarks, and deal-level insights, which will be integrated into LSEG’s Workspace and Datafeeds platforms. This collaboration aims to increase transparency and improve decision-making capabilities in the private investment landscape.
The partnership builds on LSEG’s recent launch of the UK’s first Private Securities Market in September 2025 and aligns with Nasdaq’s strategy to enhance transparency and liquidity in private markets. Key executives from both companies emphasized the combined offering’s ability to provide comprehensive, actionable intelligence for General Partners (GPs), Limited Partners (LPs), and advisors, streamlining workflows across investment targeting, deal execution, fundraising, and portfolio optimization.
LSEG, a global financial markets infrastructure and data provider, and Nasdaq, a leader in market technology and data, aim to create a best-in-class solution for the private markets ecosystem. The announcement was distributed via Reach, the non-regulatory press release service of RNS, part of the London Stock Exchange.
Partner
QLT logo
Latest RNS 09:01
QLT

Holding(s) in Company

Quilter PLC

TR1 Buy
['Public Investment Corporation SOC Limited', '10.328000', '9.811000']
0R3T logo
Latest RNS 08:31
0R3T

UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities

UBS Group AG

**Summary**
UBS Group AG and UBS AG announced the results and upsizing of their cash tender offers for specific debt securities, increasing the Maximum Purchase Consideration from $4 billion to $8.6 billion. The offers, which expired on November 5, 2025, saw a combined aggregate principal amount of $8,544,989,115 in notes validly tendered and not withdrawn, with an additional $29,350,000 tendered under guaranteed delivery procedures. UBS accepted $7,668,817,115 in notes for purchase across six of the seven series (Acceptance Priority Levels 1–6), excluding Level 7 notes, which were not accepted. The settlement dates are November 7, 2025 (Initial Settlement) and November 10, 2025 (Guaranteed Delivery Settlement). Holders of accepted notes will receive the applicable Total Consideration and Accrued Coupon Payment in cash. UBS Investment Bank acted as Dealer Manager, with D.F. King & Co., Inc. and UBS AG serving as Tender Agents. The press release emphasizes that it is not an offer to purchase or sell securities and advises holders to consult their own advisors before making decisions.
Offers
0A3D logo
Latest RNS 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

HTWS logo
Latest RNS 06:02
HTWS

Helios Towers Share Buyback Programme

Helios Towers Plc

**Summary**
Helios Towers PLC, a leading independent telecom tower company operating in Africa and the Middle East, announced the launch of a **$75 million share buyback programme** on November 6, 2025. The programme, part of the companys disciplined capital allocation strategy, reflects its strong balance sheet, cash generation, and confidence in long-term growth. An initial tranche of **$25 million** will begin immediately under a non-discretionary agreement with Jefferies International Limited, with additional tranches expected in due course. Repurchased shares will be cancelled, aiming to return surplus capital to shareholders and optimize the capital structure. The programme, authorized by shareholders, allows for the purchase of up to **105,270,000 ordinary shares** and is expected to complete by the end of 2026, subject to market conditions. Helios Towers will provide updates in compliance with UK regulations. The company emphasizes its role in enhancing digital connectivity across its markets through colocation and operational excellence.
BuyBack
ABDX logo
Latest RNS 06:01
ABDX

Launch of seaweed-based lateral flow housings

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has launched seaweed-based lateral flow test (LFT) housings as a sustainable alternative to traditional plastic housings. This innovation aims to reduce the significant plastic waste generated by the over 2 billion LFTs used annually worldwide. The company has partnered exclusively with Symbio Technologies Ltd (SymbioTex) to supply compostable, bio-based material derived from red seaweed, which can be molded using standard injection techniques. Prototypes have been developed for both standard and mid-stream urine sample formats, including pregnancy tests. The seaweed-based housings maintain the functionality of traditional tests while offering an eco-friendly solution. This initiative aligns with Abingdon Health’s commitment to sustainability and leverages renewable resources without requiring new manufacturing infrastructure. The launch underscores the company’s role in addressing environmental concerns in the med-tech industry.
Launch
BUR logo
Latest RNS 06:01
BUR

Holding(s) in Company

Burford Capital Limited

<mark style="background-coloryellow">TR1</mark> Buy
['BlackRock, Inc.', '4.68', 'Below 5']
RS1 logo
Latest RNS 06:01
RS1

Half-year Financial Report

RS GROUP PLC

**Summary of RS Group PLC Half-Year Financial Report (H1 2025/26)**
**Financial Performance Highlights**
**Revenue:** £1403 milliondown 3% year-on-year
like-for-like down 1%with growth in Q2.
**Adjusted Operating Profit** £122 million, down 8% year-on-year
like-for-like down 7%.
**Operating Profit Margin:** 8.7%down 0.5 percentage points.
**Profit Before Tax:** £112 millionup 7% year-on-year.
**Basic Earnings Per Share:** 17.7pup 8% year-on-year.
**Interim Dividend:** 8.7pup 2%.
**Key Performance Indicators**
**Gross Margin** Improved by 0.4 percentage points to 43.1%.
**Adjusted Operating Cash Flow Conversion:** 107%, exceeding the 80% target.
**Net Debt** Reduced by £31 million to £333 million.
**Net Debt to Adjusted EBITDA** Improved to 1.0x from 1.3x.
**Strategic and Operational Progress**
**Restructuring Benefits** £9 million in H1 2025/26, with a cumulative total of £47 million since April 2023.
**Growth Accelerators** RS PRO like-for-like revenue up 4%
Service solutions up 7%.
**Organic Investment** £19 million in H1 2025/26, part of planned £35-£40 million for the full year.
**Regional Performance**
**EMEA** Revenue down 2% like-for-like
operating profit down 9%.
**Americas** Revenue up 1% like-for-like
operating profit down 9%.
**Asia Pacific** Revenue up 4% like-for-like
operating profit up 42%.
**Full Year Outlook**
Unchanged, with expectations of slight gross margin improvement and continued cost management.
Capital expenditure forecast at around £50 million.
Progressive dividend policy maintained.
**Sustainability and ESG**
**Better World Product Range** Expanded to over 33,000 products.
**Emissions Intensity** Reduced by 35% from the 2019/20 baseline.
**Employee Engagement** Increased to 73%.
**Going Concern and Risks**
The Board has assessed the Groups ability to continue as a going concern for at least 12 months.
Principal risks include cybersecurity, geopolitical and macroeconomic environment, and climate change.
**Conclusion**
RS Group PLCs first-half performance was in line with expectations, with strategic initiatives driving operational improvements and market share gains. The Group remains confident in its medium-term financial targets, supported by ongoing investments and a focus on sustainable value creation.
Here is the HTML table code comparing the financials and debt year on year for RS Group PLC:
MetricH1 2025/26H1 2024/25Change
Revenue£1,403m£1,441m(3%)
Adjusted operating profit£122m£133m(8%)
Adjusted operating profit margin8.7%9.2%(0.5) pts
Adjusted profit before tax£112m£118m(6%)
Adjusted basic earnings per share17.6p18.5p(5%)
Net debt£(333)m£(437)m£104m improvement
Net debt to adjusted EBITDA1.0x1.3x0.3x improvement
**Key takeaways:** * **Revenue decline:** Revenue decreased by 3% year-on-year, primarily due to a 1% like-for-like decline and adverse currency movements. * **Profit margin compression:** Adjusted operating profit margin decreased by 0.5 percentage points due to increased investment in strategic initiatives. * **Improved debt position:** Net debt decreased significantly by £104 million, leading to a lower net debt to adjusted EBITDA ratio, indicating improved financial health. This table provides a concise comparison of key financial metrics and debt levels for RS Group PLC between H1 2025/26 and H1 2024/25.
WISE logo
Latest RNS 06:01
WISE

FY26 Half Year Results

Wise plc

**Summary of Wise PLCs Half-Year Results for FY26 (Ended 30 September 2025)**
Wise PLC reported strong financial performance for the first half of FY26, driven by strategic investments in infrastructure, product innovation, and partnerships to capture a larger share of the £32 trillion cross-border payments market. Key highlights include
### **Financial Performance**
**Revenue Growth**Revenue increased by 11% to £658.0 million (H1 FY25: £591.9 million).
**Active Customers**Active customers grew by 18% to 13.4 million, with cross-border volume up 24% to £84.9 billion.
**Customer Holdings**Customer holdings rose 37% to £25.3 billion, including £5 billion in the Wise Assets feature.
**Underlying Profit Before Tax (PBT)**Underlying PBT was £122.0 million, with a margin of 16.3%, reflecting continued investment in growth.
**Reported Profit Before Tax**Reported PBT was £254.6 million, down 13% due to strategic investments and lower interest yields.
### **Operational Highlights**
**Infrastructure Expansion**Wise became a direct participant in 7 domestic payment systems, including Pix (Brazil) and Zengin (Japan), with 74% of transfers completed instantly.
**Regulatory Approvals**Secured approvals in the UAE to expand product offerings in the region.
**Product Enhancements**Launched Travel Hub for travelers, accounts for under-18s, and Wise Assets in Brazil.
**Partnerships**Announced new Wise Platform partnerships with Upwork, MBSB Bank, and Lunar, contributing to 5% of total cross-border volume.
### **Strategic Investments**
**Team Growth**: Added over 1000 employeesfocusing on servicingcomplianceand AI-driven efficiencies.
**Marketing**Increased brand marketing spend across key markets to drive awareness and organic growth.
**Technology**Invested £144 million in product development, enhancing core products and launching new features.
### **Future Outlook**
**Dual Listing**On track for a US listing in Q2 2026 to increase visibility and access to capital.
**Growth Targets**Reiterated guidance for 15-20% underlying income growth and a 16% PBT margin for FY26, excluding dual-listing costs.
**Innovation**Exploring stablecoins and digital assets while ensuring regulatory compliance and financial crime prevention.
### **Management Commentary**
CEO Kristo Käärmann emphasized Wise’s focus on long-term growth, infrastructure improvements, and product innovation to achieve its vision of becoming the global network for cross-border payments. CFO Emmanuel Thomassin highlighted disciplined capital allocation and sustainable growth, with investments balanced against profitability.
### **Conclusion**
Wise PLC continues to strengthen its position in the cross-border payments market through strategic investments, regulatory advancements, and product enhancements. Despite short-term margin pressures, the company remains focused on long-term growth and profitability, supported by a robust financial framework and expanding global footprint.
Here’s an HTML table comparing the financials and debt year on year for Wise PLC based on the provided text:
MetricH1 FY2025 (£m)H1 FY2026 (£m)YoY Change (£m)YoY Change (%)
Revenue591.9658.066.111%
Underlying Interest Income (first 1% yield)70.591.521.030%
Underlying Income662.4749.587.113%
Cost of Sales(152.9)(173.7)(20.8)14%
Net Credit Losses on Financial Assets(4.5)(4.6)(0.1)2%
Underlying Gross Profit505.0571.266.213%
Administrative Expenses(366.7)(465.9)(99.2)27%
Net Interest Income from Corporate Investments15.923.77.849%
Other Operating Income, Net2.33.81.565%
Underlying Operating Profit156.5132.8(23.7)(15%)
Finance Expense(9.4)(10.8)(1.4)15%
Underlying Profit Before Tax147.1122.0(25.1)(17%)
Reported Profit Before Tax292.5254.6(37.9)(13%)
Profit for the Period217.3187.2(30.1)(14%)
Borrowings (Revolving Credit Facility)98.1198.5100.4102%
### Key Highlights: 1. **Revenue Growth**: Revenue increased by 11% YoY from £591.9m to £658.0m. 2. **Underlying Income Growth**: Underlying income grew by 13% YoY from £662.4m to £749.5m. 3. **Administrative Expenses Increase**: Administrative expenses rose by 27% YoY from £366.7m to £465.9m. 4. **Underlying Profit Before Tax Decline**: Underlying profit before tax decreased by 17% YoY from £147.1m to £122.0m. 5. **Borrowings Increase**: Borrowings under the Revolving Credit Facility increased by 102% YoY from £98.1m to £198.5m. This table provides a clear comparison of key financial metrics and debt levels between H1 FY2025 and H1 FY2026 for Wise PLC.
VRCI logo
Latest RNS 06:01
VRCI

Provider Participation Agreement with Prime Health

Verici Dx Plc

**Summary**
Verici Dx PLC, a developer of advanced clinical diagnostics for organ transplants, announced on November 6, 2025, that it has signed a **Provider Participation Agreement** with **Prime Health Services**, a leading U.S.-based healthcare technology company. This agreement is part of Prime Health’s **Preferred Provider Organization (PPO)** network, which aims to bring predictability and consistency to healthcare pricing by negotiating discounted rates with insurance companies. The partnership benefits Verici Dx by expanding its patient reach, increasing coverage from private payors, and reducing reimbursement denials. Prime Health’s extensive network, which includes over 850,000 providers across all 50 U.S. states and processes 35 million claims annually, offers significant growth opportunities for Verici Dx. Patti Connolly, COO of Verici Dx, highlighted the agreement as a key milestone in accelerating the company’s commercial expansion. Verici Dx plans to announce further similar agreements in the future.
**Key Points**
Verici Dx signs Provider Participation Agreement with Prime Health Services.
Agreement leverages Prime Health’s PPO network for predictable healthcare pricing.
Expands Verici Dx’s patient scope and enhances private payor coverage.
Prime Health’s network includes 850,000+ providers and 35 million annual claims.
Partnership seen as a strategic step for Verici Dx’s commercial growth.
Agreement
SFOR logo
Latest RNS 06:01
SFOR

Third Quarter Trading Update

S4 Capital PLC

**S4Capital plc Third Quarter Trading Update Summary (November 6, 2025)**
**Key Highlights**
1. **Financial Performance**
**Q3 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 3.4% reported1.0% like-for-like.
Net revenue down 6.9% reported4.4% like-for-likewith sequential improvement from Q2.
Marketing Services net revenue down 2.8% like-for-like
Technology Services down 16.5% like-for-like.
**Nine Months 2025**
Billings up 1.9% reported5.1% like-for-like.
Revenue down 11.1% reported8.4% like-for-like.
Net revenue down 10.8% reported8.2% like-for-like.
Marketing Services net revenue down 5.2% like-for-like
Technology Services down 29.6% like-for-like.
2. **Regional Performance**
**Americas** (80% of net revenue)Q3 net revenue up 1.6% like-for-like
nine months down 5.6%.
**EMEA**Q3 net revenue down 26.2%
nine months down 17.3%.
**Asia-Pacific**Q3 net revenue down 16.2%
nine months down 15.3%.
3. **Outlook**
Full-year 2025 like-for-like net revenue expected to decline by upper single digits.
Operational EBITDA target remains unchanged, broadly similar to 2024.
Net debt target for year-end£100–£140 million.
Potential for enhanced final dividend if second-half performance and liquidity targets are met.
4. **New Business and AI Focus**
Significant new business wins, including General Motors, Amazon, T-Mobile, and two unannounced US-based Global FMCG companies.
AI-driven initiatives improving visualisation, copywriting, and hyper-personalisation, with clients excited about cost savings and ROI.
Revenue model shifting from time-based to output-based, leveraging AI tools like Runway, Luma, and Unreal.
5. **Balance Sheet and Liquidity**
Q3 net debt at £151 million (1.8x EBITDA), up slightly due to dividend payments, restructuring costs, and FX headwinds.
Sufficient liquidity with long-dated debt maturities and covenant compliance.
6. **ESG Commitment**
Continued focus on people fulfilmentenvironmental responsibilityand transparency.
Maintained B Corp status and improved Ecovadis score.
7. **Strategic Focus**
Unitary digital transformation model resonating with clients, emphasizing "faster, better, cheaper, more."
Rebranded as Monks, with streamlined Marketing and Technology Services practices.
**Executive Commentary (Sir Martin Sorrell):**
Clients remain cautious due to global macroeconomic volatility, particularly in technology sectors.
AI adoption is accelerating, with significant opportunities for efficiency and growth.
Cost control and cash management remain priorities, with a focus on profitability and debt reduction.
**Conclusion**
Despite challenging market conditions, S4Capital is leveraging AI-driven innovation and cost restructuring to improve performance, with a focus on new business wins and operational efficiency. The company remains committed to its digital transformation strategy and long-term growth objectives.
Here’s an HTML table comparing the financials and debt year-on-year based on the provided text:
MetricThree Months Ended 30 Sep 2025Nine Months Ended 30 Sep 2025Three Months Ended 30 Sep 2024Nine Months Ended 30 Sep 2024
Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (%)Reported (£m)Like-for-like (£m)Reported (£m)Like-for-like (£m)
Billings490.95.1%1,416.85.1%481.65.1%1,390.55.1%
Revenue191.7-1.0%552.1-8.4%198.4-1.0%620.9-8.4%
Net Revenue167.0-4.4%495.2-8.2%179.3-4.4%555.4-8.2%
Net Debt (£m)151-151-180194180194
Leverage (x EBITDA)1.8-1.8-----
### Key Notes: 1. **Billings**: Both reported and like-for-like figures show a 1.9% increase for the nine months ended 30 Sep 2025 compared to 2024. 2. **Revenue**: Reported revenue decreased by 3.4% for Q3 2025 and 11.1% for the nine months, while like-for-like figures show a smaller decline of 1.0% and 8.4%, respectively. 3. **Net Revenue**: Reported net revenue decreased by 6.9% for Q3 2025 and 10.8% for the nine months, with like-for-like figures showing a 4.4% and 8.2% decline, respectively. 4. **Net Debt**: Net debt decreased to £151 million in 2025 from £180 million in 2024 (or £194 million on a like-for-like basis). 5. **Leverage**: Leverage ratio improved to 1.8x EBITDA in 2025 from a covenant limit of 4.5x EBITDA. This table provides a clear comparison of key financial metrics and debt levels between 2024 and 2025.
AZN logo
Latest RNS 06:01
AZN

9M and Q3 2025 results

AstraZeneca PLC

## AstraZeneca 9M and Q3 2025 Results Summary
**Strong Performance and Pipeline Progress:**
AstraZenecas 9M and Q3 2025 results showcase continued strong commercial performance and significant pipeline advancements.
**Financial Highlights (9M 2025)**
* **Revenue Growth** Total revenue increased by 11% to $43.236 billion, driven by growth across all Therapy Areas, particularly Oncology (16%) and R&I (13%).
* **Core EPS Growth** Core EPS rose by 15% to $7.04, reflecting improved profitability.
* **Operating Profit Increase** Core operating profit grew by 13%, demonstrating operational efficiency.
**Pipeline Achievements**
* **16 Positive Phase III Readouts** AstraZeneca announced 16 positive Phase III trial results, including significant advancements in hypertension (baxdrostat), breast cancer (Enhertu, Datroway), and other areas.
* **31 Regulatory Approvals** The company secured 31 approvals in major regions for various medicines, expanding patient access.
* **Strong Oncology Pipeline** Oncology remains a key focus with 16 positive Phase III readouts and approvals for medicines like Enhertu, Datroway, and Imfinzi.
**Strategic Initiatives**
* **US Expansion** AstraZeneca is investing heavily in the US, including a $4.5 billion manufacturing facility in Virginia and a historic agreement with the US government to lower medicine costs.
* **Acquisition of SixPeaks Bio AG** This acquisition strengthens AstraZenecas position in weight management therapies.
* **Koselugo Agreement with Merck** A simplified agreement for Koselugo development and commercialization enhances focus and efficiency.
**Future Outlook**
* **Reiterated Guidance** AstraZeneca maintains its Total Revenue and Core EPS guidance for FY 2025, expecting high single-digit revenue growth and low double-digit Core EPS growth.
* **Sustainability Leadership** Recognized for sustainability efforts, AstraZeneca ranks highly in global sustainability rankings.
**Key Takeaways**
AstraZenecas 9M and Q3 2025 results demonstrate robust financial performance, significant pipeline progress, and strategic initiatives aimed at long-term growth. The companys focus on innovation, geographic expansion, and sustainability positions it well for continued success in the pharmaceutical industry.
Here is a comparison of AstraZeneca's financials and debt year on year, presented as an HTML table:
Metric9M 20259M 2024% ChangeQ3 2025Q3 2024% Change
Total Revenue$43,236m$39,182m10%$15,191m$13,565m12%
Reported EPS ($)$5.10$3.5743%$1.64$0.9277%
Core EPS ($)$7.04N/A15%$2.38N/A14%
Net Debt$23,965m$26,348m-9%N/AN/AN/A
Capital Expenditure$2,091m$1,415m48%N/AN/AN/A

Note: The above table provides a high-level comparison of key financials and debt metrics. For a detailed analysis, please refer to the original text.

Key Observations:

  • Total Revenue increased by 10% year-on-year in 9M 2025, driven by growth in all Therapy Areas.
  • Reported EPS increased significantly by 43% in 9M 2025, while Core EPS increased by 15%.
  • Net Debt decreased by 9% in the nine months to 30 September 2025, reflecting improved financial position.
  • Capital Expenditure increased by 48% in 9M 2025, primarily due to investment in manufacturing projects and technology upgrades.
This table provides a concise comparison of AstraZeneca's financials and debt year on year, highlighting key metrics such as Total Revenue, Reported EPS, Core EPS, Net Debt, and Capital Expenditure. The observations section summarizes the main trends and changes in these metrics.
SBRY logo
Latest RNS 06:01
SBRY

Half-Year Report

J Sainsbury PLC

**Summary of Sainsbury (J) PLC Half-Year Report (28 weeks ended 13 September 2025)**
**Financial Performance Highlights**
**Sales Growth** Sainsburys sales (excluding fuel) increased by 5.2%, with Grocery sales up 5.3% and General Merchandise & Clothing sales rising 3.3%. Argos sales grew by 2.3%, while Fuel sales declined by 11.3%.
**Profitability** Retail underlying operating profit reached £504 million, in line with the previous year, despite higher employment and regulatory costs. Statutory profit after tax was £165 million, up from £76 million in the same period last year.
**Cash Flow** Retail free cash flow was £310 million, on track to exceed £500 million for the full year.
**Bank Disposal** Proceeds from the bank disposal are expected to exceed £400 million, with £250 million returned to shareholders via a special dividend and £150 million allocated for share buybacks.
**Dividends** Interim dividend increased by 5% to 4.1 pence per share. Total cash returns to shareholders in FY 2025/26 are expected to surpass £800 million.
**Strategic Initiatives and Market Position:**
**Value and Quality Focus** Sainsburys continued to emphasize value, quality, and service, driving market share gains. Initiatives like Aldi Price Match and personalized Nectar Prices helped customers save on essential items.
**Innovation and Range Expansion** Launched new Taste the Difference Discovery ranges, offering restaurant-quality food at home, and expanded premium own-label share gains.
**Operational Efficiency** Invested in technology and automation to improve store and logistics operations, alongside hourly colleague pay increases.
**Sustainability** Committed to tackling food poverty, supporting farmers, and promoting sustainable practices, including Fairtrade initiatives and reducing environmental impacts.
**Outlook and Guidance**
**Profit Guidance** Expects Retail underlying operating profit to exceed £1 billion for FY 2025/26, with Retail free cash flow over £500 million.
**Strategic Commitments** On track to deliver on eight key commitments, including food volume growth ahead of the market, £1 billion in cost savings, and higher customer satisfaction.
**Nectar Loyalty Program** Expanded personalized savings and launched Nectar360 Pollen, a retail media platform, to drive revenue growth.
**Argos Transformation** Strengthened online offer, improved digital customer journey, and optimized store presence for better efficiency.
**Conclusion**
Sainsburys demonstrated resilience and growth in a competitive market, driven by a strong focus on value, quality, and innovation. Strategic investments in technology, sustainability, and customer experience, coupled with efficient cost management, position the company for continued success. Enhanced shareholder returns and a robust financial outlook underscore confidence in the companys future performance.
Here is the comparison of financials and debt year on year in an HTML table format:
Metric2024/25 (28 weeks)2025/26 (28 weeks)YoY Change
Retail sales (excl. VAT, excl. fuel)£14,865m£15,577m4.8%
Retail underlying operating profit£503m£504m0.2%
Underlying profit before tax£309m£340m10%
Retail free cash flow£425m£310m(£115)m
Net debt (inc. lease liabilities)£(5,584)m£(5,527)m£57m
Non-lease net debt£(152)m£(81)m£71m
**Key Observations:** * **Sales Growth:** Retail sales (excluding VAT and fuel) increased by 4.8% year-on-year, driven by grocery and general merchandise sales growth. * **Profitability:** Underlying profit before tax increased by 10%, while retail underlying operating profit remained relatively stable with a slight increase of 0.2%. * **Cash Flow:** Retail free cash flow decreased by £115 million, primarily due to reduced working capital inflow and higher capital expenditure. * **Debt:** Net debt (including lease liabilities) decreased by £57 million, and non-lease net debt decreased by £71 million, indicating improved liquidity. This table provides a concise overview of the key financial metrics and debt position, highlighting areas of growth, stability, and changes in liquidity.
AFC logo
Latest RNS 06:01
AFC

Trading Update for Year Ended 31 October 2025

AFC Energy plc

**Summary**
AFC Energy Plc, a leading provider of hydrogen and clean power generation technologies, released a trading update for the financial year ended 31 October 2025 (FY25). The company highlighted significant strategic and developmental progress, including
1. **Partnerships and Deployments**Multiple fuel cell generator deployments through the Speedy Hydrogen Solutions joint venture and successful completion of the first phase of a Joint Development Agreement (JDA) with an S&P 500 partner.
2. **Product Development**The Hy5 decentralized portable cracker unit is on track to provide the lowest-cost bulk hydrogen in the UK by the end of 2026. The next-generation S+30 30kW liquid-cooled fuel cell generators, with 85% lower production costs, are set for delivery in 2026.
3. **Joint Ventures**A partnership with Industrial Chemicals Group Limited (ICGL) aims to produce hydrogen for commercial use by H1 2026, subject to permitting.
4. **Strategic Restructuring**A business reorganization reduced headcount and costs, saving £1.5m annually in FY26, while strengthening leadership with new appointments.
5. **Financials**Cash reserves increased to £25.3m (from £15.4m in FY24), but revenue dropped to £107k due to a strategic reset to accelerate commercial viability.
6. **Market Opportunities**AFC Energy sees growing demand for fuel cells and hydrogen, particularly in AI data centers, positioning itself as a key player in the clean energy transition.
CEO John Wilson expressed confidence in 2026 as a year of converting opportunities into contractual orders and achieving sustained revenue growth without government subsidies.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
MetricFY24FY25Change
Cash, Cash Equivalents, and Short-Term Deposits (£m)15.425.3+9.9 (+64.3%)
Revenue (£k)4,000107-3,893 (-97.3%)
Headcount ReductionN/A-17N/A
Annualised Cost Savings in FY26 (£m)N/A1.5N/A
### Explanation: 1. **Cash, Cash Equivalents, and Short-Term Deposits**: Increased from £15.4m in FY24 to £25.3m in FY25, a rise of £9.9m (+64.3%). 2. **Revenue**: Decreased significantly from £4m in FY24 to £107k in FY25, a drop of £3.893m (-97.3%), attributed to the strategic reset announced in March 2025. 3. **Headcount Reduction**: FY25 saw a net reduction of 17 employees as part of the business reorganisation. 4. **Annualised Cost Savings**: Expected savings of £1.5m in FY26 due to restructuring efforts. This table provides a clear year-on-year comparison of key financial metrics and debt-related changes.
DGE logo
Latest RNS 06:01
DGE

Diageo issues fiscal 26 Q1 trading statement

Diageo PLC

**Diageo Fiscal 26 Q1 Trading Statement Summary**
**Key Highlights**
**Flat Organic Net Sales Growth** Diageo reported flat organic net sales growth in Q1 FY26 (ended 30 September 2025), with a 2.9% increase in volume offset by a 2.8% decline in price/mix. Reported net sales declined by 2.2% to $4.9 billion, primarily due to disposals and negligible foreign exchange impact.
**Regional Performance**
**Strengths** Growth in Europe, Latin America, and Caribbean (LAC), and Africa offset by weakness in Asia Pacific (APAC) and North America (NAM).
**Weaknesses** Chinese white spirits (CWS) in China and softer US consumer environment negatively impacted results. CWS weakness alone reduced group net sales by ~2.5%.
**Strategic Focus** Diageo is advancing its **Accelerate programme**, aiming for $625 million in cost savings over three years. The program focuses on agility, cost efficiency, and leveraging AI for better analytics.
**Fiscal 26 Outlook**
Organic net sales growth expected to be **flat to slightly down**, including impacts from CWS and US consumer softness.
Organic operating profit growth projected at **low to mid-single digit**, supported by cost savings.
Free cash flow target maintained at **~$3 billion**, with expectations of growth in future years.
**Management Commentary** Interim CEO Nik Jhangiani emphasized adapting to evolving consumer trends, strengthening commercial execution, and embedding a performance-driven culture.
**Regional Breakdown**
1. **North America (38% of net sales)** Organic net sales declined 2.7% due to softer spirits market, competitive pressure in tequila, and weak consumer confidence.
2. **Europe (25% of net sales)** Organic net sales grew 3.5%, driven by Guinness and strong performance in Türkiye.
3. **Asia Pacific (18% of net sales)** Organic net sales declined 7.5%, primarily due to CWS weakness in China, partially offset by growth in India.
4. **LAC (11% of net sales)** Organic net sales grew 10.9%, led by Brazil’s double-digit growth.
5. **Africa (8% of net sales)** Organic net sales grew 8.9%, with strong performance in East and South Africa.
**Key Initiatives**
**Accelerate Programme** Progressing well, with focus on cost efficiency, AI-driven analytics, and process simplifications.
**Disposals** Completed sales of Seychelles Breweries, Guinness Ghana Breweries, and Diageo Operations Italy S.p.A. to streamline operations.
**Financial Guidance**
Tax rate expected at ~25%, effective interest rate at ~4.0%, and capital expenditure at the lower end of $1.2-$1.3 billion.
Leverage ratio target of 2.5-3.0x net debt to adjusted EBITDA to be achieved by FY28.
**Conclusion**
Diageo’s Q1 FY26 results reflect challenges in China and the US but highlight resilience in other regions. The company remains focused on strategic initiatives to drive growth, improve efficiency, and deliver on financial commitments.
Below is the HTML table code comparing the financials and debt year on year based on the provided text:
MetricF26 (2025)F25 (2024)Reported Growth YoY %Organic Growth YoY %
Net Sales$4,875$4,986(2.2)0.0
Volume++-2.9
Price/Mix--(2.8)(2.8)
Free Cash Flow$3,000$2,70011.1-
Capital Expenditure$1.2-1.3bn$1.5bn(13.3)-(20.0)-
Effective Interest Rate4.0%4.1%(2.4)-
Tax Rate25.0%24.9%0.4-
Net Debt to Adjusted EBITDATarget: 2.5-3.0x by F28---
### Notes: 1. **Net Sales**: Reported net sales declined by 2.2% YoY, while organic net sales growth was flat. 2. **Volume**: Organic volume growth was 2.9%. 3. **Price/Mix**: Organic price/mix declined by 2.8%. 4. **Free Cash Flow**: Expected to increase to $3 billion in F26 from $2.7 billion in F25. 5. **Capital Expenditure**: Expected to be at the lower end of $1.2-1.3 billion in F26 compared to $1.5 billion in F25. 6. **Effective Interest Rate**: Slightly decreased to 4.0% in F26 from 4.1% in F25. 7. **Tax Rate**: Expected to be around 25.0% in F26 compared to 24.9% in F25. 8. **Net Debt to Adjusted EBITDA**: Target is to be within 2.5-3.0x by F28. This table provides a clear comparison of key financial metrics and debt-related figures between F26 (2025) and F25 (2024).
HIK logo
Latest RNS 06:01
HIK

November Trading Statement

Hikma Pharmaceuticals PLC

**Hikma Pharmaceuticals PLC November 2025 Trading Statement Summary:**
Hikma Pharmaceuticals PLC reaffirmed its 2025 financial guidance and provided updates on its medium-term growth outlook. Key highlights include
1. **Performance Across Segments**
**Injectables** Trading in line with expectations, with strong performance in Europe and MENA. Launched Starjemza® (ustekinumab-hmny) and TyzavanTM (vancomycin). Revenue growth expected at 7-9%, with core operating margin of 32-33%.
**Branded** Strong performance in MENA, driven by oncology and chronic illness treatments. Revenue growth expected at 6-7%, with core EBIT margin near 25%.
**Hikma Rx** Stable performance, supported by complex products. Revenue expected to be flat, with core operating margin around 16%.
2. **Organisational Changes**
Centralised R&D under a global structure, led by Hafrun Fridriksdottir, to accelerate pipeline development and synergies.
Dr Bill Larkins stepped down as head of Injectables
CEO Riad Mishlawi will serve as interim head until a replacement is found.
3. **Full Year 2025 Outlook**
Group revenue growth maintained at 4-6%.
Core operating profit range tightened to $730-$750 million, in line with market expectations.
4. **Medium-Term Outlook (2024-2027)**
Injectables margins expected around 30%, reflecting delays in Bedford facility production due to supply chain challenges.
Group revenue CAGR revised to the lower end of 6-8%.
Core operating profit growth adjusted to 5-7%, down from 7-9%.
Long-term target of $5 billion revenue by 2030 remains unchanged.
5. **Strategic Focus**
Continued investment in R&D and manufacturing capacity expansion to support growth.
Confidence in revised targets despite medium-term adjustments.
Hikma remains committed to its global strategy, focusing on innovation, partnerships, and operational efficiency to drive long-term growth. A Q&A webinar for analysts was announced to provide further details.
The provided text does not contain specific financial or debt figures for a year-on-year comparison. However, I can create a general HTML table structure based on the guidance and outlook provided in the text. If you have specific financial data, please provide it, and I can tailor the table accordingly. Here’s a basic HTML table structure based on the available information: < lang="en">Hikma Pharmaceuticals Financials and Debt Comparison

Hikma Pharmaceuticals Financials and Debt Comparison (2024 vs 2025 Guidance)

Metric2024 (Actual)2025 (Guidance)Change
Group Revenue GrowthN/A4% to 6%N/A
Injectables Revenue GrowthN/A7% to 9%N/A
Injectables Core Operating MarginN/A32% to 33%N/A
Branded Revenue GrowthN/A6% to 7%N/A
Branded Core EBIT MarginN/A~25%N/A
Hikma Rx Revenue GrowthN/ABroadly flatN/A
Hikma Rx Core Operating MarginN/A~16%N/A
Group Core Operating ProfitN/A$730M to $750MN/A
Medium-Term Group Revenue CAGR (2024-2027)N/A6% to 8% (lower end)N/A
Medium-Term Group Core Operating Profit GrowthN/A5% to 7%N/A

Note: Actual 2024 figures are not provided in the text. The table reflects 2025 guidance and medium-term outlook.

If you have specific financial or debt figures for 2024 or any other year, please provide them, and I can update the table accordingly.
AUTO logo
Latest RNS 06:01
AUTO

Half Year Results

Auto Trader Group plc

**Summary of Auto Trader Group PLC Half-Year Results (6 Months Ended 30 September 2025)**
**Financial Performance Highlights**
**Revenue Growth** Group revenue increased by 5% to £317.7 million, driven by a 5% rise in Autotrader revenue (£296.3 million) and a 13% increase in Autorama revenue (£21.4 million).
**Profitability** Group operating profit grew by 6% to £200.1 million, with Autotrader operating profit up 5% to £208.0 million. Autorama losses were halved year-on-year to £1.4 million.
**EPS Growth** Basic earnings per share (EPS) increased by 11% to 17.26 pence.
**Cash Flow** Cash generated from operations rose by 7% to £215.4 million.
**Shareholder Returns** £162.2 million returned to shareholders through £100.2 million in share buybacks and £62.0 million in dividends. Interim dividend declared at 3.8 pence per share (up from 3.5 pence).
**Strategic and Operational Updates**
**AI Innovation** Launched **Co-Driver**, a generative AI product helping retailers create high-quality vehicle listings faster, improving both retailer efficiency and buyer experience. Over 10,000 customers have used Co-Driver to deliver 1 million improved adverts.
**Deal Builder Growth** Scaled Deal Builder to over 4,000 live retailers (up from 1,500 in September 2024), with 52,000 deals submitted in H1 2026 (vs. 23,000 in H1 2025).
**Market Position** Maintained dominance with over 75% of minutes spent on automotive marketplaces, 9x larger than the nearest competitor. Cross-platform visits rose 1% to 83.3 million monthly.
**New Car Market** New car stock on the platform increased by 10% to 22,000, with 24% being electric vehicles (EVs). Total deliveries grew 16% to 3,687, though van and pickup sales declined.
**Used Car Market** Strong demand with record cross-platform visits and engagement. Unique cars sold increased by 2%, with a slight rise in sales speed.
**Future Outlook**
Full-year outlook remains unchanged, with confidence in strong market position, customer value, and unique data/technology capabilities.
Continued focus on AI opportunities to enhance performance, efficiency, and customer experience.
Scaling Deal Builder as the core consumer proposition, deepening competitive advantage.
**Sustainability and Governance**
Committed to net-zero emissions by 2040 and halving carbon emissions by 2030 (validated by SBTi).
Board changes include new Independent Non-Executive Directors (Megan Quinn and Adam Jay) and the departure of COO Catherine Faiers to Moonpig Group PLC.
**Conclusion**
Auto Trader Group delivered robust financial results, driven by strategic AI investments, operational scaling, and market leadership. The company remains well-positioned for future growth, supported by innovation, strong cash generation, and a clear strategic focus.
Here is the HTML table code comparing the financials and debt year on year for Auto Trader Group PLC:
MetricH1 2026H1 2025Change
Revenue£317.7m£302.5m5%
Operating Profit£200.1m£188.4m6%
Operating Profit Margin63%62%1% pts
Profit Before Tax£199.3m£187.5m6%
Basic Earnings Per Share17.26p15.56p11%
Cash Generated from Operations£215.4m£201.6m7%
Net Cash£5.2m£15.1m(£9.9m)
Debt (Syndicated RCF)£15.0m£0m£15.0m
**Key Observations:** * **Revenue and Profit Growth:** Auto Trader Group PLC experienced a 5% increase in revenue and a 6% increase in operating profit year on year. * **Margin Improvement:** Operating profit margin improved by 1 percentage point to 63%. * **Earnings Per Share Growth:** Basic earnings per share increased by 11% to 17.26p. * **Cash Flow Improvement:** Cash generated from operations increased by 7% to £215.4m. * **Debt Increase:** The company drew £15.0m from its Syndicated RCF, resulting in a decrease in net cash from £15.1m to £5.2m. This table provides a concise overview of the key financial metrics and debt position of Auto Trader Group PLC, highlighting the year-on-year changes.
HGT logo
Latest RNS 06:01
HGT

3rd Quarter Results

HG Capital Trust PLC

**Summary**
HgCapital Trust PLC (HgT) announced its third-quarter results for the period ending September 30, 2025, highlighting a resilient performance driven by its portfolio of software and services businesses. Key highlights include
1. **NAV Performance**Net Asset Value (NAV) per share increased by 2.4%, reaching £5.50, with total net assets at £2.5 billion.
2. **Share Price**The share price decreased by 2.7% to £4.99, resulting in a market capitalization of £2.3 billion.
3. **Portfolio Growth**Strong trading performance contributed 4% to portfolio growth, partially offset by lower valuation multiples and increased net debt.
4. **Long-Term Performance**The portfolio reported 18% sales growth and 19% EBITDA growth over the last 12 months, with a 33% EBITDA margin.
5. **Liquidity and Investments**Available liquid resources stood at £379 million (15% of NAV), with £49.7 million invested in Q3, primarily in A-LIGN, a cyber compliance services provider.
6. **Realisations**£7 million was realized from the partial sale of Trackunit, with an additional £30 million expected from the post-period exit of GTreasury.
7. **Historical Returns**An investment of £1,000 twenty years ago would now be worth £13,364, outperforming the FTSE All-Share Index, which would be worth £3,762.
HgT remains focused on delivering consistent long-term returns by investing in unquoted companies with potential for strategic and operational value creation. The trust continues to screen an attractive pipeline of opportunities, with further liquidity events expected in the coming months.
Below is the HTML table code comparing the key financials and debt year on year based on the provided text. Since the text only provides data for Q3 2025, I’ve structured the table to compare Q3 2025 with implied or assumed Q3 2024 data (where available). If no direct comparison is possible, the table reflects only the 2025 data.
MetricQ3 2024 (Assumed/Implied)Q3 2025Change
NAV per Share£5.37 (implied from +2.4% growth)£5.50+2.4%
Net Assets£2.44 billion (implied)£2.5 billion+2.5%
Share Price£5.13 (implied from -2.7% decrease)£4.99-2.7%
Market Capitalisation£2.36 billion (implied)£2.3 billion-2.5%
Portfolio Growth (Trading)N/A+4%N/A
Sales Growth (Last 12 Months)N/A+18%N/A
EBITDA Growth (Last 12 Months)N/A+19%N/A
EBITDA MarginN/A33%N/A
Net DebtN/AIncreased (exact figure not provided)N/A
Liquid ResourcesN/A£379 millionN/A
Bank Facility DrawnN/A£46 millionN/A
Co-investments as % of NAV9%10%+1%
### Notes: 1. **Assumed/Implied Values**: For metrics like NAV per share and share price, implied 2024 values are calculated based on the percentage changes provided for 2025. 2. **Missing Data**: Some metrics (e.g., net debt, liquid resources in 2024) are not provided in the text, so they are marked as "N/A". 3. **Percentage Changes**: Changes are calculated where possible, but some metrics lack historical data for comparison. This table provides a structured comparison based on the available information.
FTC logo
Latest RNS 06:01
FTC

€7m contract for satellite constellation programme

Filtronic

**Summary**
Filtronic plc, a UK-based designer and manufacturer of advanced RF solutions, has secured a €7 million multi-year contract with a leading European aerospace manufacturer. The contract involves supplying RF assemblies for a major Low Earth Orbit (LEO) satellite constellation program, highlighting Filtronics expertise in space technology and its ability to meet the demanding requirements of LEO environments. This deal strengthens Filtronics position in the growing satellite market, particularly for Non-Terrestrial Networks, Mobile Satellite Services, and Direct-to-Device connectivity. The contract underscores the companys diversification across space market customers and its commitment to innovation in RF and mmWave technologies. Filtronic, with over 45 years of experience, operates globally and is listed on the AIM market of the London Stock Exchange.
NewContract
IMI logo
Latest RNS 06:01
IMI

Trading Update

IMI PLC

**Summary**
IMI PLC, a global leader in fluid and motion control, reported an **excellent third-quarter performance** for 2025, with **organic revenue up 12% year-over-year** and **5% higher year-to-date**. The company is on track to achieve its **fourth consecutive year of mid-single-digit organic revenue growth** and reconfirmed its full-year guidance, expecting adjusted basic earnings per share between **129p and 136p**.
Key highlights include
**Automation** (64% of 2024 sales) led growth with **17% organic revenue increase** in Q3, driven by **Process Automation** (up 26% in Q3) and **Industrial Automation** (up 2%).
**Life Technology** (36% of 2024 sales) saw **4% organic revenue growth**, with **Climate Control** (up 5%) and **Life Science & Fluid Control** (up 13%) performing well, offset by a **9% decline in Transport**.
Strong performance was attributed to **rising global energy demand**, **high-margin aftermarket orders** (up 7% year-to-date), and **demand for energy-efficient solutions** in buildings and data centers.
The company’s **One IMI operating model** and **growth strategy** continue to drive success, supported by a **strong balance sheet** enabling investment in organic growth, acquisitions, and shareholder returns.
Exchange rate fluctuations are expected to negatively impact full-year revenue by **1%** and adjusted operating profit by **1.5%**. IMI will announce its full-year results on **6 March 2026**.
Below is an HTML table comparing the year-on-year financials and debt based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and organic growth comparisons.
Metric2024 (Previous Year)2025 (Current Year)Year-on-Year Change
Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Automation Sector Organic Revenue Growth (Year-to-Date)N/A+8%+8% (from 2024 baseline)
Process Automation Organic Revenue Growth (Year-to-Date)N/A+14%+14% (from 2024 baseline)
Life Technology Sector Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Climate Control Organic Revenue Growth (Year-to-Date)N/A+5%+5% (from 2024 baseline)
Life Science & Fluid Control Organic Revenue Growth (Year-to-Date)N/A+1%+1% (from 2024 baseline)
Transport Organic Revenue Growth (Year-to-Date)N/A-9%-9% (from 2024 baseline)
Exchange Rate Impact on Revenue (Full Year)N/A-1%-1% (compared to 2024)
Exchange Rate Impact on Adjusted Operating Profit (Full Year)N/A-1.5%-1.5% (compared to 2024)
Adjusted Basic Earnings per Share (Full Year Guidance)N/A129p - 136pN/A (Guidance for 2025)
Debt (Year-on-Year)Not ProvidedNot ProvidedN/A
### Notes: 1. **Debt Information**: The provided text does not include specific debt figures, so the table reflects this as "Not Provided." 2. **Organic Growth**: All organic growth figures are based on the comparisons provided in the text for 2025 relative to 2024. 3. **Exchange Rate Impact**: The impact of exchange rates on revenue and adjusted operating profit is included as per the text. 4. **Earnings per Share**: The adjusted basic earnings per share guidance for 2025 is included as provided. This table can be embedded in an HTML document for display.
ITV logo
Latest RNS 06:01
ITV

ITV plc Q3 Trading Update

ITV PLC

**ITV PLC Q3 Trading Update Summary (November 2025):**
ITV PLC reported a strong Q3 performance for the nine months ending September 2025, exceeding market expectations despite a challenging advertising environment. Key highlights include
**Revenue Growth** Total Group revenue grew 2% year-to-date (YTD), driven by an 11% increase in ITV Studios and a 15% rise in digital advertising, fueled by the success of ITVX.
**Advertising Performance** Total advertising revenue (TAR) was flat in Q3, ahead of guidance, but down 5% YTD due to a strong 2024 comparator (Mens Euros). TAR is expected to decline by 9% in Q4 2025 due to economic uncertainty.
**Cost Management** ITV identified £35 million in temporary savings for Q4 in Media & Entertainment (M&E), primarily from content and discretionary spend, to offset reduced advertising demand.
**ITV Studios** On track to deliver full-year revenue growth with a 13-15% margin, supported by strong demand from global streaming platforms.
**Digital Growth** Digital revenues grew 13%, with ITVX streaming hours up 14%. ITV remains on track to achieve £750 million in digital revenues by 2026.
**Outlook** Full-year guidance remains unchanged, with ITV Studios expected to meet revenue and margin targets. M&E digital advertising revenue is expected to grow, but TAR will decline due to economic softness.
**Liquidity** ITV maintains strong liquidity with £1.377 billion in total liquidity and net debt of £508 million as of September 2025.
CEO Carolyn McCall emphasized ITVs resilience, strategic cost management, and confidence in delivering growth in ITV Studios and digital revenues, despite macroeconomic challenges. The company remains focused on its "More Than TV" strategy and expects to outperform the broadcast advertising market in Q4.
Below is an HTML table comparing the financials and debt year-on-year based on the provided text:
Metric2024 (£m)2025 (£m)Change (£m)Change (%)
Total Group Revenue2,7412,795542%
Total Group External Revenue2,3212,404834%
ITV Studios Revenue1,2171,35013311%
Media & Entertainment (M&E) Revenue1,5241,445(79)(5%)
Total Advertising Revenue (TAR)1,3131,247(66)(5%)
Digital Advertising RevenueN/AUp 15%Growth driven by ITVX
Total Digital Revenue3844324813%
Net DebtN/A508(78)Decreased from £586m (June 2025)
### Key Notes: 1. **Revenue Comparisons**: All figures are for the nine months ending 30 September, comparing 2025 to 2024. 2. **Debt**: Net debt is provided for 2025, with a decrease from £586 million in June 2025 to £508 million in September 2025. 3. **Digital Revenue**: 2024 figures were restated to £384 million due to changes in categorization. 4. **TAR**: Expected to decline by 6% for the full year 2025 compared to 2024, with a 9% decline in Q4 2025. This table provides a concise comparison of key financials and debt between 2024 and 2025 based on the provided text.
FDEV logo
Latest RNS 06:01
FDEV

A STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO

Frontier Developments Plc

**Summary**
Frontier Developments PLC, a leading UK-based video game developer and publisher, announced strong performance and updates for two of its flagship franchises: *Jurassic World Evolution* and *Planet Zoo*.
**Jurassic World Evolution 3** launched on October 21, 2025, exceeding expectations with over 500,000 units sold in just over two weeks, surpassing the equivalent period sales of its predecessor. The game received excellent player engagement and critic reviews, with ongoing post-launch updates planned to sustain momentum.
**Planet Zoo**, Frontiers best-selling game to date with over 5.5 million units sold and £145 million in revenue, will receive a sequel scheduled for release in the 2027 financial year (June 2026 - May 2027). The sequel builds on the success of the original, which has fostered a vibrant global community celebrated for its creativity and passion.
Frontiers CEO, Jonny Watts, expressed enthusiasm for both titles, highlighting the strong launch of *Jurassic World Evolution 3* and the community-driven success of *Planet Zoo*. Further details on the *Planet Zoo* sequel will be announced later.
The updates position Frontier for a robust financial year, particularly ahead of the festive sales period.
Launch
HWDN logo
Latest RNS 06:01
HWDN

Trading Update

Howden Joinery Group Plc

**Summary**
Howden Joinery Group PLC, the UKs largest trade kitchen supplier, released a trading update on November 6, 2025, highlighting strong trading momentum and confirming its 2025 outlook. Key points include
1. **Sales Growth**
**Group Sales**+2.8% vs. 2024 (Periods 7-11), +1.4% on a same-depot basis.
**UK Sales**+2.4% vs. 2024, +1.1% on a same-depot basis, with record sales during the peak trading period ending November 1.
**International Sales**+14.7% vs. 2024, +9.3% on a same-depot basis, driven by success in France, Belgium, and Ireland.
2. **Performance Drivers**
Strong demand across all kitchen price ranges, with innovation in Good and Better ranges and significant growth in Best kitchens.
High stock availability, market-leading product lineup, and exceptional customer service supported growth.
3. **Outlook**
The company remains on track to meet 2025 expectations, with profit before tax in line with market consensus of £331 million.
CEO Andrew Livingston emphasized the strength of the business model and successful execution of strategic initiatives.
4. **Operational Highlights**
£8 million in incremental sales booked on the final day of the peak period will be recognized in Period 12, improving UK growth to 3.1% and Group growth to 3.5%.
Continued expansion of the in-stocktrade model internationally.
Howden Joinery Group reaffirmed its position as a market leader, despite challenging market conditions, and remains confident in its full-year performance.
Below is the HTML table code comparing the financials and sales growth year-on-year based on the provided text: < lang="en">Howden Joinery Group PLC Financials Comparison

Howden Joinery Group PLC - Sales Growth Comparison (2024 vs 2025)

MetricPeriods 7 to 11Year-to-dateSame Depot Basis (Periods 7 to 11)Same Depot Basis (Year-to-date)
UK Sales Growth (%)+2.4%+2.7%+1.1%+1.4%
International Sales Growth (%)+14.7%+13.4%+9.3%+9.6%
Group Sales Growth (%)+2.8%+3.0%+1.4%+1.7%

Notes:

  • 1. There were two fewer trading days in H1 2025 versus the prior year. Numbers reported are unadjusted.
  • 2. Same depot basis excludes depots opened in the current year and the prior year.
  • 3. International growth is shown in local currency.
  • 4. 2025 Full Year Profit Before Tax consensus is £331m (2024: £328.1m).
### Key Features of the Table: 1. **Metrics Compared**: Sales growth percentages for UK, International, and Group segments. 2. **Periods**: Compares Periods 7 to 11 and Year-to-date for both 2024 and 2025. 3. **Same Depot Basis**: Includes growth excluding newly opened depots for a like-for-like comparison. 4. **Notes**: Additional context for adjustments and definitions. This table provides a clear year-on-year comparison of Howden Joinery Group PLC's financial performance based on the provided text.
PMGR logo
Latest RNS 06:01
PMGR

Circ re- Recommended proposals for the reconstruction and voluntary winding-up of the Company

Portmeirion Group

**Summary**
Premier Miton Global Renewables Trust Plc has announced recommended proposals for its reconstruction and voluntary winding-up via a scheme of arrangement under the Insolvency Act 1986. Shareholders are offered two options
1. **Rollover Option**Transfer their investment into the Premier Miton Global Infrastructure Income Fund (Sub-Fund), an open-ended fund managed by the same investment manager, offering exposure to infrastructure securities, a dividend yield, and stronger historical performance.
2. **Cash Option**Receive a cash exit at net asset value, less associated costs.
The Sub-Fund, with net assets of £77.2 million, provides long-term income and capital growth, focusing on infrastructure investments. The proposals aim to minimize dealing costs compared to a simple winding-up, and the Company’s alternative investment fund manager (AIFM) will contribute to the scheme’s costs.
Key benefits include maintaining exposure to infrastructure investments, avoiding full portfolio realization costs, and the AIFM’s financial support. The scheme is conditional on shareholder approval at General Meetings on 25 November and 5 December 2025, FCA approval, and the Directors’ decision to proceed.
The process involves dividing the Company’s assets into three pools: a **Liquidation Pool** for liabilities, a **Rollover Pool** for shareholders choosing the Sub-Fund, and a **Cash Pool** for those opting for cash. The scheme is expected to be effective by 5 December 2025, with Sub-Fund shares issued and cash payments made shortly thereafter.
The Board unanimously recommends shareholders vote in favor of the proposals, emphasizing they are in the best interests of all shareholders.
Proposals
CRH logo
Latest RNS 06:01
CRH

CRH Reports Third Quarter 2025 Results

CRH PLC

**Summary of CRHs Third Quarter 2025 Results:**
CRH PLC, a leading provider of building materials, reported strong third-quarter 2025 results, highlighting continued growth and strategic advancements. Key takeaways include
1. **Financial Performance**
**Revenue Growth** Total revenues increased by 5% year-over-year to $11.1 billion, driven by favorable demand, strong commercial execution, and contributions from acquisitions.
**Net Income and EBITDA** Net income rose by 9% to $1.5 billion, while Adjusted EBITDA grew by 10% to $2.7 billion. Margins expanded, with net income margin up 50 basis points to 13.7% and Adjusted EBITDA margin up 100 basis points to 24.3%.
**Earnings Per Share (EPS)** Diluted EPS increased by 12% to $2.21.
2. **Strategic Initiatives**
**Acquisitions** CRH invested $3.5 billion in 27 value-accretive acquisitions year-to-date, including nine acquisitions totaling $2.5 billion in Q3. The company maintains an active pipeline of opportunities.
**Shareholder Returns** CRH returned $1.1 billion to shareholders year-to-date through share buybacks and declared a quarterly dividend of $0.37 per share, a 6% increase year-over-year.
3. **Segment Performance**
**Americas Materials Solutions** Revenues grew by 6%, with Adjusted EBITDA up 5%, driven by strong demand and pricing momentum.
**Americas Building Solutions** Revenues increased by 2%, with Adjusted EBITDA up 22%, supported by acquisitions and optimization initiatives.
**International Solutions** Revenues rose by 5%, with Adjusted EBITDA up 15%, driven by operational efficiencies and acquisitions.
4. **Outlook**
**2025 Guidance** CRH reaffirmed its net income guidance and raised the midpoint of its Adjusted EBITDA guidance, reflecting continued strategic execution and market strength.
**2026 Expectations** The company anticipates favorable market dynamics, supported by infrastructure investment and reindustrialization activity, despite subdued residential new-build activity.
5. **Balance Sheet and Liquidity**
**Net Debt** Increased to $15.0 billion due to acquisitions, shareholder returns, and capital expenditures, partially offset by operating cash flows. CRH maintains a robust balance sheet with $4.3 billion in cash and equivalents.
**Credit Rating** CRH remains committed to maintaining its investment-grade credit rating.
6. **Leadership Commentary**
CEO Jim Mintern emphasized CRH’s superior strategy, connected portfolio, and leading performance, positioning the company for continued growth and value creation in 2026.
Overall, CRH’s Q3 2025 results underscore its strong operational execution, strategic growth initiatives, and commitment to shareholder value, despite a dynamic market environment.
Here’s an HTML table comparing the financials and debt year-on-year for CRH based on the provided text:
MetricQ3 2025Q3 2024YoY Change
Total Revenues$11.1bn$10.5bn+5%
Net Income$1.5bn$1.4bn+9%
Net Income Margin13.7%13.2%+50bps
Adjusted EBITDA$2.7bn$2.5bn+10%
Adjusted EBITDA Margin24.3%23.3%+100bps
Diluted Earnings Per Share$2.21$1.97+12%
Total Short and Long-Term Debt$18.7bn$14.0bn+33.6%
Net Debt$15.0bn$10.5bn+42.9%
### Explanation: - **Total Revenues, Net Income, Margins, and EPS**: These metrics are directly compared year-on-year, showing growth rates or margin improvements. - **Debt Metrics**: Total short and long-term debt and Net Debt are compared, highlighting the significant increase in debt levels year-on-year. This table provides a clear comparison of key financial and debt metrics between Q3 2025 and Q3 2024.
CRH logo
Latest RNS 06:01
CRH

CRH Continues Share Buyback Program

CRH PLC

**Summary**
CRH plc, a leading provider of building materials, announced the completion of the la<mark style="background-color:yellow">test</mark> phase of its share buyback program, returning an additional $0.3 billion to shareholders. Between August 7, 2025, and November 5, 2025, the company repurchased 2.4 million ordinary shares listed on the New York Stock Exchange, bringing the total cash returned to shareholders under the program to $9.4 billion since its inception in May 2018.
CRH also disclosed a new arrangement with Santander US Capital Markets LLC to conduct a further buyback program, starting November 6, 2025, and ending no later than February 17, 2026. This program aims to repurchase up to $0.3 billion worth of ordinary shares (maximum 60 million shares) to reduce the company’s share capital, with repurchased shares being canceled. The buyback will comply with U.S. and UK regulatory safe harbors and will be conducted solely in the United States.
Future buyback decisions will depend on CRH’s capital needs and market conditions. The company emphasized that forward-looking statements regarding the buyback are subject to risks and uncertainties, as outlined in its filings with the U.S. Securities and Exchange Commission.
**Key Points**
CRH completed a $0.3 billion share buyback phase, totaling $9.4 billion since 2018.
A new $0.3 billion buyback program will run from November 6, 2025, to February 17, 2026.
Repurchased shares will be canceled to reduce share capital.
Future buybacks depend on capital needs and market conditions.
Forward-looking statements are subject to risks and uncertainties.
BuyBack
XSG logo
AI Chartist

XSG

Today News592
Pulse--
AI Net0
Ticker AI

XSG

AI sentiment, signals and catalyst scoring — loaded fresh from the site engine for the selected ticker.

Market AI · 2025-11-06

LONDON MARKET CLOSE: FTSE 100 slips amid BoE rate hold, fresh US falls

FTSE 100 Performance: Fell 41.30 points (0.4%) to close at 9,735.78 on Thursday, 6th Nov 2025. Other Indices: FTSE 250 down 0.9%, AIM All-Share down 0.4%, Cboe UK 100 down 0.6%, Cboe UK 250 down 1.2%, Cboe Small Co…

Market AI · 2025-11-06

LONDON MARKET MIDDAY: FTSE 100 pares loss after Bank of England holds

Date and Time: 6th Nov 2025, 12:25 FTSE 100: Down 10.20 points (0.1%) at 9,766.88, paring earlier decline after Bank of England held rates at 4.00%. FTSE 250: Up 45.77 points (0.2%) at 22,140.15. AIM All-Share:…

Market AI · 2025-11-06

LONDON BROKER RATINGS: Stifel raises HgCapital Trust to 'buy'

Here is the provided text formatted as bullet points in HTML: html 6th Nov 2025 09:34 The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: FTSE 100 LBBW raises…

Market AI · 2025-11-06

LONDON MARKET OPEN: Stocks steady before BoE amid barrage of earnings

London Stock Market: Opened steady on Thursday with mixed performance across indices; FTSE 100 down 4.21 points, FTSE 250 up 0.1%, AIM All-Share up 0.5%. Bank of England Decision: Expected to hold interest rates at…

Market AI · 2025-11-06

LONDON MARKET EARLY CALL: FTSE 100 steady before tight BoE decision

London Stocks: Expected to open flat on Thursday, with FTSE 100 futures indicating a slight rise of 0.8 points to 9,777.88. Currency Movements: Sterling rose to USD1.3057, euro to USD1.1507, and the dollar weakened…

🤖
AI Intel
Sentiment scoring · good/bad/net · catalyst intensity · AI groups
Select a ticker above
Nexus Signal

Market Pulse

--pulse
Up
0
Down
0
News592
AI Net0
Movers0
📡
Nexus Signal
Price geometry · AI sentiment · short pressure · catalyst density fused into one read
Select a ticker above
Fundamentals

XSG

MarketALL-MARKETS
RNS Today592
AI Score—
Business readCatalyst first, then balance-sheet — revenue quality, recurring income and debt maturity are the key filters after a major RNS.
Risk readWatch dilution risk, covenant headroom and customer concentration. Ask whether today's RNS changes the re-rating case.
🔭
Fundamentals
Market cap · broker target · float · valuation ratios · sector context
Select a ticker above
Financials

XSG

Earnings lensCheck if today's RNS changes revenue timing, cash conversion or funding pressure — then confirm against historical trend.
Balance-sheet lensPrioritise net cash position, debt covenants, working capital and capex direction before acting on price momentum.
Forecast lensRevenue quarterly table, EPS, PE ratios, enterprise value multiples and analyst revisions load with the selected ticker.
📊
P&L / Financials
Revenue · income · cash flow · leverage · EPS · PE ratios
Select a ticker above
Structure DNA

XSG

MarketALL-MARKETS
Up Count0
RNS Today592
Float structure Ownership pattern TR1 flow Re-rating potential
🧬
Structure DNA
Float · shares out · long/short interest · ownership concentration
Select a ticker above
RNS Today592
Up0
Down0
💎
Capital Radar
Broker targets · director dealing · TR1 flow · institution holders · market position
Select a ticker above
Short Data

XSG

RNS Today592
MarketALL-MARKETS
AI Net0
Short pressure lensShort data matters most when it conflicts with fresh catalysts — high short interest plus a positive RNS is a squeeze candidate. Low short interest plus bad news has less bounce risk.
🎯
Short Data
Holder positions · % float shorted · borrow cost · squeeze candidates
Select a ticker above
Volatility Lab

XSG

Movers0
News592
Up0
Execution lensATR defines stop width. Use it to judge whether today's RNS triggered a clean breakout or noise within the daily range.
Volume confirmsVolume expansion on catalyst day is the key signal — high volume on break through resistance confirms the move; low volume warns of fade.
⚡
Volatility Lab
ATR · realized range · volume profile · reaction zones · breakout confirmation
Select a ticker above
🧠
Ask AI
Chart context · RNS news · support/resistance · MACD · catalyst risk — all live
Target path News risk Invalidation Capital flow